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Abstract 
 
Background: The alpha+-thalassaemias are the most common monogenic 
disorders of humans, characterised by microcytic and hypochromic anaemia. 
Their high frequency reflects selective advantage against death from 
Plasmodium falciparum malaria. The most common type of alpha+-
thalassaemia amongst people of African descent is the -α3.7 deletional type 
and affects 26-33% of Ghanaians. Plasmodium falciparum malaria is a major 
cause of mortality amongst children in sub-Saharan Africa. Unlike HbAS, 
HbAC and G6PD deficiency there remains debate about whether alpha+-
thalassaemia protects against malaria and the mechanism for the protection. 
Methods: 1672 children of ≤10 years were recruited and individuals with 
G6PD deficiency, HbAC and Hb AS reported to protect against malaria were 
excluded. 732 children with Plasmodium falciparum were tested for Hb, RBC, 
MCV, MCH and parasite density. The subjects were then categorised into 
normocytic and microcytic using a cut off MCV value of 76fL and 
normochromic and hypochromic using a cut off MCH value of 25 pg. 
Microcytic hypochromic individuals were genotyped by Polymerase Chain 
Reaction for the      -α3.7 deletional thalassaemia mutation. Results: The 
frequency of Plasmodium falciparum malaria in the studied population was 
54.1%. There was a frequency of 21.0% for the heterozygous (-α/αα) and 
8.3% for the homozygous (-α/-α) alpha+-thalassaemia, resulting in a carriage 
rate (α/αα & -α/-α) of 29.3%. Among the microcytic patients, geometric mean 
parasite density (GMPD) values were lower in the presence of an alpha+-
thalassaemia genotype (-α/αα GMPD 9015, n=126 and -α/-α GMPD 6852, 
n=49) compared to normal genotype (αα/αα GMPD 51794, n=358) (p<0.001).   
Severe malaria (GMPD ≥100000/µL) was less prevalent in microcytic 
patients with an alpha+-thalassaemia genotype (-α/αα 11.9% and -α/-α 
16.3%) than either normocytic patients or microcytic patients with a normal 
genotype (32.9% and 53.6% respectively) (p<0.03). GMPD values were 
lower in hypochromic alpha+-thalassaemia genotypes (-α/αα GMPD 1728, 
n=44 and -α/-α GMPD 7160, n=23) compared to normal genotype (αα/αα 
GMPD 48997, n=141) (p<0.001), and individuals with Hb > 5 g/dL had lower 
GMPD compared to the severely anaemic (Hb ≤ 5 g/dL) (p<0.001). The 
differences in severe Plasmodium falciparum parasitaemia as well as the 
GMPD between children ≤ 60 and > 60 months for both the homozygous 
and heterozygous alpha+-thalassaemia were not significant at p=0.399 and 
p=0.207 respectively. Conclusion: The severity of Plasmodium falciparum 
parasitaemia measured, as either GMPD or prevalence of severe 
parasitaemia was significantly lower in both the -α/αα and -α/-α- groups 
compared to microcytic individuals with normal genotype. Even though 
GMPD differed significantly amongst all alpha+-thalassemia genotypes, it 
was not driven by hypochromasia. Among the homozygous and 
heterozygous alpha+-thalassaemias, children with severe anaemia had a 
significantly high GMPD than their counterparts who were not severely 
anaemic making them more susceptible to severe malaria anaemia. No loss 
of protection was seen in children younger or older than 60 months and 
therefore the protective effect from severe malaria might not wane with age. 
The mechanism of protection from severe Plasmodium falciparum malaria is 
not clear, however the influence of microcytosis and hypochromasia on 
parasite density requires more research.  
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   1.0 Literature Review          
1.1 INTRODUCTION 
Severe Plasmodium falciparum malaria is a major cause of mortality in 
children below 5 years in sub-Saharan Africa. However, the susceptibility to 
the disease is varied and human red blood cell (RBC) polymorphism 
protection from Plasmodium falciparum malaria provides a classical example 
of natural selection. The fact that individuals carrying the genetic traits are 
partially protected against severe malaria underscores the high prevalence of 
the human RBC polymorphism in areas of high Plasmodium falciparum 
malaria (Weatherall and Clegg 2010) Examples of such mutations include 
inherited blood disorders such as sickle cell trait, glucose-6-phosphate 
dehydrogenase (G6PD) deficiency, and the alpha and beta thalassaemias. 
The -α
3.7 
kb deletion alpha
+
-thalassaemias, which are predominant in Africa, 
have been suggested to confer protection from severe Plasmodium falciparum 
malaria and both the homozygous and heterozygous alpha
+
-thalassaemia has 
been implicated (Mockenhaupt et al., 2004a). 
Of the hundreds of thousands of genetic mutations that have arisen in the 
global population however, the most harmful ones usually disappear by 
affecting an individual‘s ability to reproduce; the mutations are lost before 
carriers can pass them on to their children, whereas most mutations are 
maintained in the population in low frequencies (Modell and Darlison 2008).  
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Some mutations however, can give the carrier such a large survival advantage 
that the mutations become positively selected for, leading to their presence in 
high frequencies, in some populations, (Williams, 2006a).  
These blood-related genetic disorders, it seems, are amongst some of the 
major challenges faced by health delivery systems, especially in developing 
countries (Hoffbrand et al., 2004); because of their genetic nature, most 
carriers of these disorders are not aware of their status except when tested. 
However, there are very few centres in most developing countries that are 
equipped to carry out such testing. Even where such facilities are available 
they are, more often than not, used for research purposes. This means that 
most of such carriers will be unaware of their status for the most part of their 
lives. The likelihood is that the diseased genes are inherited by offspring of 
parents who are carriers (Mentzer and Kan 2001). One of such blood-related 
genetic disorders is thalassemia, an inherited disorder of haemoglobin 
synthesis that results from an alteration in the rate of  and  globin chain 
production (Hendricks, 2003). The genes responsible for the production of the 
α-chains are located on chromosome 16 and associate with the β-globin 
genes located on chromosome 11, to form the normal adult haemoglobin 
(α2/2), (Figures 1.1 and 1.3), which plays the pivotal role of transporting 
oxygen to the cells of the body to facilitate their cellular functions (Yaish, 
2005). 
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Figure 1.1: The haemoglobin molecule: note four haem molecules tucked 
inside globin chains. (Adapted from Ciela Betty, 2007) 
 
Alpha thalassemia is a hereditary autosomal disorder resulting from the 
deficient expression of the functional α1 and/or α2 globin gene and is 
characterised by microcytic hypochromic anaemia (Harteveld and Higg, 2010). 
Chui et al., (2006) discussed the four main types of alpha thalassaemia 
genotypes, the deletion of one gene, which is of genotype (-α/αα), and people 
with this condition are referred to as ‗silent carriers,‘ and also termed as 
heterozygous alpha+-thalassaemia or alpha
+
-thalassaemia trait. These 
individuals are usually asymptomatic, have mild to moderate microcytic 
hypochromic anaemia due to compensating high red blood cell count. 
The deletion of two genes has two possible genotypic presentations, where 
there is the deletion of one gene each from the two chromosomes (-α/-α), 
(homozygous alpha
+
-thalassaemia) the other involves the deletion of the two 
genes from one of the two chromosomes (--/αα) (heterozygous α
0
-thalassemia). 
Haem 
2 1 
2 1 
HBA1 is the gene encoding 1 
globin and HBA2 is the gene 
encoding 2 globin. 
Underproduction of  globin 
chains results in 
Hb Bart’s (4) or Hb H (4). 
Deletion of one or more of 
these genes results in alpha 
thalassaemia 
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Carriers of α
0
-thalassemia are usually asymptomatic and show microcytosis 
and hypochromasia (low MCV and MCH), normal percentages of HbA2 and 
HbF and RBC inclusion bodies (Galanello et al., 1998).   
The three-gene deletion α-thalassaemias has a genotype of (--/-α) that 
produces serious haematological problems (Olivieri, 1999). Hb H generally 
results from the combination of one alpha
+
-thalassaemia (-α / or α T α /) and 
one α0 thalassaemia (- -/) defect. The disease presents with a moderately 
severe but variable anaemia, except for the rare case of α
0
 thalassaemia, 
which combines with a non-deletional mutation of α globin gene, resulting in 
hydrops fetalis (Chui et al., 2003). 
Hb H does not carry oxygen properly, making it functionally useless to the cell. 
Second, haemoglobin H protein damages the membrane that surrounds the red 
cell with the precipitation of basophilic stippling inclusion bodies thereby 
accelerating cell destruction (Chui et al., 2003, Harteveld and Higg, 2010). The 
combination of the very low production of alpha chains and destruction of red 
cells in haemoglobin H disease produces a severe, life-threatening anemia. 
Individuals with this form of α-thalassaemia suffer from severe anaemia, 
splenomegaly, bone deformities, and fatigue. Untreated, most patients die in 
childhood or early adolescence (Chui et al., 2003).  
When there is a deletion of all four genes, this form of alpha-thalassaemia 
genotypically represented as (--/--) is deadly and the condition is also referred 
as hydrops fetalis syndrome.  
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Foetuses become anaemic early in pregnancy, hydropic (retain fluids), 
frequently develop enlarged hearts and livers, and most are miscarried, or die 
shortly after birth (Yaish, 2005). 
The most common type of α-thalassaemia therefore is the deletion of one (-/α) 
or both (-/-) duplicated α genes (α α) on chromosome 16 (Lell et al., 1999). 
 In people of African descent the –α
3.7
deletional alpha+-thalassaemia is the 
most predominant (Kittamis et al., 1996, Mockenhaupt et al., 1999a). In the 
Northern and Ashanti regions of Ghana, there have been reports of the high 
prevalence of α-thalassaemia, especially heterozygous alpha+-thalassaemia 
affecting between 26-33% of the population (Mockenhaupt et al., 2001; 
2004a). Prevalence of –α
3.7
 alpha+-thalassaemia in the Mediterranean is 
about 5-10%, 20 to 30% in West Africa, and approximately 68% in the South 
Pacific (Yaish, 2005). Hendricks (2003) also reported that, amongst African 
Americans, heterozygous alpha+-thalassaemia is 30% prevalent, whereas the 
homozygous alpha+-thalassaemia is 2-3%. On the North Coast of Papua New 
Guinea (PNG), alpha+-thalassaemia is almost at fixation affecting more than 
90% of the population (Allen et al., 1997). 
Malaria reportedly accounts for 10% of Africa‘s disease burden (Abdul-Aziz, 
2006), with more than 90% of the global morbidity and mortality of malaria 
suffered by Africa (Mockenhaupt et al., 2004c), mostly affecting children less 
than 5 years old.  
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It is the single most important cause of morbidity and mortality in Ghana, 
especially in children under five years, pregnant women and the poor. Clinical 
malaria accounted for 33.45% of all outpatient attendances and 30.3% of all 
hospital admissions, 34.6% of deaths in children below the age of five and 
5.8% of total deaths. In these children, malaria is a leading cause of mortality, 
with an estimated 14,000 dying each year. Malaria is hyper endemic with year-
round transmission in the northern part of Ghana with a dry season from 
September to April and a perceptible seasonal variation. Parasite rate ranges 
from 10-70% with Plasmodium falciparum accounting for about 90-98% of all 
infections, Plasmodium malariae for 2-9%, and Plasmodium ovale for 1% 
(National Guidelines for Laboratory Diagnosis of Malaria, MOH, Ghana 2010).  
The incidence of Plasmodium falciparum malaria notwithstanding, discussions 
have been whether or not alpha+-thalassaemia individuals are protected from 
severe Plasmodium falciparum parasitaemia (Wambua, 2006; Mockenhaupt et 
al., 2004c; Pasvol, 2006; Fowkes et al., 2008; Weatherall and Clegg 2010; 
Harteveld and Higg, 2010).  
Previous studies have expressed varied opinion on the protection from severe 
Plasmodium falciparum malaria by alpha+-thalassaemia.  
Initially, not only was it suggested that alpha+-thalassaemia offered no 
protection against severe malaria, it was even reported, that 
alpha+thalassaemia predisposes one to contracting mild malaria (Williams et 
al., 1996).  
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The incidence of contracting mild malaria and protection from either 
asymptomatic Plasmodium falciparum parasitaemia or clinical episodes of 
malaria were increased among alpha
+
-thalassaemic children compared to their 
normal counterparts (Allen et al., 1993, 1997; William et al., 1996; Wambua et 
al., 2006). Alpha
+
-thalassaemia has neither been found to reduce the incidence 
of uncomplicated malaria, nor protect from malaria infection but rather 
predisposes to mild clinical malaria. The disease has however been observed to 
limits the progression to severe malaria anaemia (William et al., 1996, 2005).  
Mockenhaupt et al., (2001) suggested that alpha+-thalassaemia predisposed 
Ghanaian pregnant women to Plasmodium malariae infection. Individuals with 
the Duffy genotype (FYA/FYB) have also been suggested to be highly 
susceptible to Plasmodium vivax infection; however, the presence of the FYB-
33 allele or Duffy negative individuals provides selective advantage against 
Plasmodium vivax infection (Cavasini et al., 2007). Previous reports of 
molecular, immunological and cytometric evidence on Duffy blood group 
negative inhabitants of the Luo ethnic group and anophiline mosquito in Kenya 
suggests the transmission of Plasmodium vivax infection amongst these 
individuals (Ryan et al., 2006). 
Currently, there appears to be a common understanding that alpha+ 
thalassaemia has an ameliorating impact on severe malaria. However, unlike 
the sickle cell trait, current studies have not been able to provide plausible 
mechanisms for the protection (Pasvol, 2006, Harteveld and Higgs, 2010). 
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Imrie et al., (2004) had observed that the higher levels of haptoglobin in the 
homozygous alpha+-thalassaemia individual were toxic to Plasmodium 
falciparum in vitro by removing free haemoglobin released during haemolysis 
(Imrie et al., 2006). Fowkes et al., (2008), in a recent study conducted in 
Papua New Guinea, suggested that the increased number of abnormally small 
erythrocytes (microcytosis) associated with homozygous alpha+-thalassaemia 
might be responsible for the protection against severe malarial anaemia. 
Aside from this, there is an apparent disagreement between researchers as to 
the type of –α
3.7
 alpha+-thalassaemia genotype, which provides the 
‗ameliorating effect‘.  
Findings from Papua New Guinea concluded that both heterozygous and 
homozygous alpha+thalassaemia protect against the deadly effects of malaria 
though protection was more evident in subjects with homozygous alpha+-
thalassaemia (Allen et al., 1997).  
Similar studies in Tamale, Northern Ghana, indicated that alpha+-
thalassaemia does protect against death from malaria; however, this was only 
true for heterozygous alpha+-thalassaemia. The reasons for the lack of 
protective effect against Plasmodium falciparum in the homozygous alpha
+
-
thalassaemia were due to its low proportion and the associated statistical 
limitations (Mockenhaupt et al., 2004a). Subsequent studies in Kenya clearly 
conflicted with the Ghanaian report but agreed with the findings from Papua 
New Guinea (Williams et al., 2005b).  
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Another Ghanaian study, while agreeing with the ameliorating impact of 
alpha+-thalassaemia on malaria, however, concluded that the ‗impact‘ was 
specific and driven by protection from severe anaemia, the most prevalent 
malaria complication (May, et al., 2005). The study further reported protection 
against other malaria complications that were accompanied by anaemia. This 
concept of alpha+-thalassaemia malarial anaemia specificity is supported by 
another study from Kenya (Wambua et al., 2006).  
Though the subject of alpha+-thalassaemia and anaemia in Africa is still to be 
fully understood, a study carried out in southwest Nigeria reported that alpha+-
thalassemia contributes essentially to mild anaemia, but supposedly protects 
against severe parasitaemia (Mockenhaupt et al., 1999a).  
Later, Mockenhaupt et al., (1999b) indicated that microcytosis was significantly 
associated with protection from haemoglobin decrease due to Plasmodium 
falciparum and that the rate of infection was lower in microcytic than in 
normocytic anaemia.  
In another study, Rahim, (2008) found a considerable 20% prevalence of 
alpha
+
-thalassaemia in microcytic hypochromic (decrease size of red cell and 
haemoglobin) anaemic patients. Fowkes et al., (2008) corroborated this finding 
by indicating that red cell microcytosis was associated with homozygous 
alpha
+
-thalassaemia and might be responsible for the protection against 
severe malarial anaemia.  
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However, Nyakeriga et al., (2004b) had earlier indicated that the incidence of 
clinical malaria was significantly lower among iron-deficient children who were 
not thalassaemic than non-iron deficient children and has also been recently 
reported by Kabyemela et al., (2008) that decreased susceptibility to 
Plasmodium falciparum infection occurred in pregnant women with iron 
deficiency anaemia. 
 
1.2. TYPES OF HAEMOGLOBIN 
Three types of haemoglobin (embryonic haemoglobin, foetal haemoglobin, 
and adult haemoglobin) are synthesized. The specific arrangements of the 
globin chains of these haemoglobins are under the influence of specific 
chromosomes. The genes for beta, delta, epsilon, and gamma chains are 
contained in chromosome 11 (Harmening et al., 2001).  
Chromosome 16 contains the genes for alpha and zeta, having two genes on 
the chromosome for the production of alpha chains and one gene for the 
production of zeta chains (Figure 1.3), (Hoffbrand et al., 2004). Haemoglobin 
has a constant two alpha chains in its configuration (Ceila, 2007) (Figure 1.1). 
The β globin chain synthesis replaces the γ chain 3-6 months after birth 
despite its initially low levels. In the adult there are three types of haemoglobin 
normally present: Hb A (α2β2), Hb A2 (α2δ2) and Hb F (α2 γ2) (Hoffbrand et al., 
2004).   
   Chapter 1. Literature Review 
 
 
 
 11 
During foetal life the majority of the haemoglobin is of the Hb F type and 
consists of two alpha (α) chains and two gamma (γ) chains of which there are 
two types denoted Gγ and Aγ which are similar to β chains but differ from each 
other by only a single amino acid (Klug et al., 2000).  
During embryonic life, Hb- Gower 1(22), Hb- Gower 2(22) and Hb- Portland 
(22) dominate at different stages (Hoffbrand et al., 2004)(Figure 1.3).  
During development from the embryo to adulthood there is a decline in gamma 
chains whilst beta chains increase resulting in the adult haemoglobin A (α2 β 
2), and this is in addition to small quantities of HbA2 and Hb F (Stryer et al., 
2002; Hoffbrand and Moss 2010) 
1.2.1 Structure of haemoglobin 
The haemoglobin molecule is made up of a haem portion and a globin portion. 
The structure of the haemoglobin molecule produces an internal environment 
of hydrophobic residues, which protect the iron of haem from water and from 
oxidation and hydrophilic external residues that render the haemoglobin 
molecule soluble (Harmening et al., 2002).  
 
The oxygen transport function of haem is due to the fact that the haem portion 
of haemoglobin, which is formed in the nucleated red cell, combines four irons 
in the ferrous state, is surrounded by a porphyrin ring causing the haem to 
combine reversibly with O2 so that haemoglobin can function as an O2- 
transporting protein (Bunn, 1993).  
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The iron of haemoglobin is normally in the ferrous form (Fe2+) but the oxidation 
of iron to the ferric form (Fe3+) is poorly reversible, thus converting haem to 
haematin and haemoglobin to methaemoglobin, that cannot transport oxygen 
(Klug et al., 2000, Hoffbrand and Moss, 2010). The oxidation of haemoglobin 
to methaemoglobin and the enzymatic reconversion to haemoglobin can be 
determined by the Methaemoglobin Reductase Method for G6PD screening 
(Brewer et al., 1962; Bhasin and Chahal 1996). 
The globin portion of haemoglobin protects the haemoglobin from oxidation, 
renders the molecule soluble and permits variation in O2 affinity, by 2,3- 
diphosphoglycerate (2,3-DPG) (Hoffbrand et al., 2006). 
 
1.2.2 Molecular basis of haemoglobin synthesis 
The erythroid precursors, from the proerythroblast stage to the reticulocyte 
stage are the sites for haem synthesis (Ponka, 1997) with the various stages 
of haem synthesis taking place in the mitochondria or within the cytosol. Eight 
enzymatic reactions are involved, four in the mitochondrion (that is the first 
and the last three) and the four intermediate enzymatic reactions in the 
cytosol.  
Luvigsen, (1998) and Hoffbrand and Moss (2004) had described the first rate-
limiting step in haem synthesis as the formation of -aminolaevulinic acid (ALA) 
by condensation of glycine and succinyl CoA that is under the control of ALA-
synthase with pyridoxal-5I-phosphate as cofactor (Figure 1.2).  
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The availability of iron affects the rate of formation of ALA; thus, iron deficiency 
causes iron regulatory proteins to bind to iron-responsive elements in the 
messenger RNA (mRNA) for ALA-synthase resulting in repression of 
translation.  
 
Luvigsen, (1998) indicated that synthesis of ALA is followed by its entry into the 
cytosol with the formation of porphobilinogen and ALA-dehydrase influencing 
the coming together of the two molecules. The formation of uroporphyrinogen III 
is preceded by the combining effect of four molecules of porphobilinogen.  
Uroporphyrinogen III is then modified in two further steps to form 
coproporphyrinogen III. The entry into the mitochondria by coproporphyrinogen 
III is followed by its conversion to protoporphyrin IX. Under the influence of 
ferrochelatase is the combination of ferrous (Fe2+) iron with protoporphyrin IX 
to form haem (also referred to as ferroprotoporphyrin) Luvigsen, (1998). The 
release of iron from its carrier within the endocytotic vesicle is followed by the 
reduction to the ferrous form, transferred to the mitochondrion for haem 
synthesis or stored as ferritin within the cytoplasm (Hoffbrand et al., 2004). A 
negative feedback, control of haem synthesis by haem inhibits both 
ferrochelatase and the acquisition of iron from transferrin. ALA production is 
also inhibited by a reduced cellular uptake of iron whereas iron deficiency and 
erythropoietin enhance uptake of iron by erythroid cells (Klug et al., 2000) 
The iron-responsive element in the mRNA for the transferrin receptor protein is 
then protected from degradation, leading to increased expression of transferrin 
receptors on erythroid cell membranes and increased iron uptake.  
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The erythroid precursors, from the proerythroblast to the reticulocyte stage are 
sites for the synthesis of  and  globin (Steinberg and Adams 1991) whereas 
the  chain synthesis, which ceases before the reticulocyte stage, occurs in the 
cytoplasm, on ribosomes (Weatherall et al., 2001b).  
 
 
 
 
Figure 1. 2: Haemoglobin synthesis in the developing red cell. The 
mitochondria are the main sites of protoporphyrin synthesis, iron (Fe) is 
supplied from circulating transferrin; globin chains are synthesized on 
ribosomes. -ALA, -aminolaevulinic acid; CoA, coenzyme A (Courtesy of 
Hoffbrand and Moss, 2010)                                         
 
The genes for globin chain synthesis are located in two clusters on 
chromosomes 11 and 16, with the  gene cluster close to the telomere of 
chromosome 16, at 16p13.3 and the  gene at 11p15.5. Also in these clusters 
are non-functional ‗pseudo genes‘, which are homologues of globin genes that 
are not translated but are transcribed (Figure 1.3).  
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The  cluster of chromosome 16 extends over 28 kb and contains, in the 
following order,  gene (also referred to as 2), a pseudo  gene ( or 1), 
two pseudo  genes, (2 and 1) and two  genes, designated 2 and 1.  
The  cluster on chromosome 11 contains, in the following order, and  gene, 
two  genes, designated G and A, respectively, a pseudo  gene (), a  
gene, and a  gene. (Stamatoyannopoulos et al., 1994) 
 
Figure 1.3: Specific chromosomes relative to human haemoglobin formation. 
The  cluster is located on chromosome 16 and contains,  gene and 2 and 
1 gene. The  cluster on chromosome 11 contains the  gene, G and A,  
gene, and a  gene. Reduction in the synthesis of the alpha-globin chains of 
adult haemoglobin (HbA, α22) results in microcytosis and hypochromasia. Hb 
Portland is the only functional Hb and oxygen carrier in infants with Hb Bart‘s 
and Hb H (Adapted from Ciela Betty, 2007) 
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All human globin genes have three coding sequences (exons) and two 
intervening non-coding sequences (introns), which are flanked by 5‘, and 3‘ 
non-coding sequences (untranslated regions, UTRs) (Nagel and Jaffé 2001). 
Alpha-globin genes are duplicated haemoglobin-alpha locus 1 (HBA1) and 
haemoglobin-alpha locus 2 (HBA2). HBA1 is the gene encoding for 1-globin 
and HBA2 codes for 2. These two genes are associated with -thalassaemia. 
As normal allelic variants, both HBA1 and HBA2 have three coding exons. The 
mRNAs produced by HBA1 and HBA2 have identical coding regions and can be 
distinguished only by their 3‘ UTR, however as pathologic allelic variant, the 
deletion of one or both HBA1 and HBA2 is the most common cause of -
thalassaemia (Galanello et al., 1998).  The expression of HBA1 and HBA2 is 
regulated by a region known as the hypersensitivity site (HS–40) located 40kb 
upstream from the -globin cluster. The deletion of HS-40 results in an -
thalassaemia phenotype, inspite of the structural integrity of both -globin 
genes (Higgs, 2001). 
 
1.2.3 Normal haemoglobin 
Normal adult haemoglobin is made up of haemoglobin (Hb) A, HbA2 and F. Hb 
A2 comprises 2-3.5% of total haemoglobin with a rise in adult, but lower at birth 
(0.2-0.3%) (Serjeant et al., 1978). 
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 Its functional properties are similar to Hb A, but inhibit the polymerization of 
Hb S (sickle cell haemoglobin) by making the HbSS RBCs more deformable 
thus preventing microvascular occlusions and haemolytic anaemia 
characteristic of the disease, (Steinberg and Adams, 1991), and have higher 
affinity for oxygen and pan-cellular distribution.  
The slower rate of  chain synthesis compared to  chain is the result of 
reduced rate of synthesis of Hb A2.  
Absolute or functional iron deficiency anaemia (IDA), ,  and  thalassaemia 
trait cause a proportional reduction in Hb A2 (Nagel and Steinberg 2001), 
however the proportion of Hb A2 is increased in patients with  thalassaemia 
trait and some patients with unstable haemoglobin. 
Hb F is increased during intrauterine life with a very high oxygen affinity but 
weak affinity for 2,3-DPG, sex, inherited characteristics both linked and 
unlinked to the  gene clusters but vary from 60% to 90% at birth and appear 
slightly higher in women (Jane compared to Hb A. This is important in 
facilitating the transfer of oxygen from the mother to the foetus (Bunn and 
Forget, 1986). The percentage of HbF is determined by age and 
(Cunningham, 1998). 
 
1.2.4 Abnormalities of haemoglobin 
Normal adult haemoglobin (HbA) comprises 22 but also contains small 
quantities of HbF (22) and HbA2 (22).  
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Primarily, the function of normal haemoglobin is the carriage of oxygen from the 
lungs to the tissues (Hoffbrand et al., (2010). Because of the more stable 
protein of the normal haemoglobin it is able to convert to a coloured pigment 
called cyanmethaemoglobin, and this conversion forms the basis for most of the 
colorimetric procedure used to measure haemoglobin (Ceila, (2007).  However 
abnormal haemoglobins are toxic and have higher oxygen affinity. For example 
methaemoglobin oxidises iron to Fe
3+, which cannot bind oxygen and 
individuals become cyanotic, whilst carboxyhaemoglobin has affinity for carbon 
monoxide and causes carbon monoxide poisoning. The exposure to 
sulphonamides or sulfa-containing drugs results in the formation of 
sullfhaemoglobin (Bunn, 1993). In as much as abnormal haemoglobins could 
result from accidental or purposeful ingestion or absorption of substances and 
drugs they could also result from inherited defects.  
These abnormalities could be due to the synthesis of abnormal haemoglobin 
(haemoglobinopathies) and/ or reduced rate of synthesis of α or β - globin chain 
(thalassaemia) (Brown, 2003). A number of variant haemoglobins results from 
point mutations some of which the new codon does not code for amino acid 
(nonsense mutation); because of their termination of chain synthesis, their 
proximity to the 3/ end of the gene results in the production of an abnormal but 
functional globin chain. If proximal a short but unstable chain is produced 
leading to a beta thalassaemia phenotype (Nagel and Steinberg, 2001).  
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Hoffbrand et al., (2010), observed that most of the haemoglobinopathies are 
clinically silent; but sickle cell anaemia as well as thalassaemia major are the 
clinically most important abnormality. However, haemoglobin C, D and E are 
also common and, like Hb S occur as a result of substitutions in the β chain.  
According to Hoffbrand et al., (2010), unstable haemoglobins are rare and 
cause chronic haemolytic anaemia of varying severity with intravascular 
haemolysis; It has been observed that the genetic effects such as sickle cell 
offer protection against Plasmodium falciparum malaria in the heterozygotes 
(Aidoo et al., 2002) hence the high prevalence of the heterozygote in malaria 
endemic areas. 
1.3   THE THALASSAEMIAS 
The name thalassemia comes from the Greek words ―thalas‖ meaning sea and 
―emia‖ which stands for blood. Generally, thalassaemias are prevalent in 
populations that evolved in humid climates where malaria is endemic 
(Tassiopoulos et al., 2005).  
 
The thalassaemias are an increasing public health problem worldwide with over 
750 different mutations that can be identified, mostly affecting either alpha- 
chain (alpha thalassaemias) or β chain (beta thalassaemia) (Vichinsky, et al., 
2005). The frequency of the thalassaemias appears to be high in developing 
countries (Weatherall, 2008).  
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In many of these countries, however, facilities for the control of the disease are 
limited and the situation is compounded by the unwillingness of governments 
accepting that the thalassaemias present a diagnostic burden that may lead to 
inappropriate iron therapy (Weatherall, 2010).  
 
In most African countries, and for that matter Ghana, the more detailed 
frequency and economic data, which are required to provide solid evidence for 
the health burden posed by the thalassaemia, is non-existent. In addition many 
people may be carrying the disease but do not know they carry it.  
 
The thalassaemias are the most common single gene disorders in the world 
involving inherited disorders of haemoglobin synthesis that result from an 
alteration in the rate of globin chain production, (Murray, et al., 2003, Modell 
and Darlison, 2008, Colah et al., 2010). The disorder results in decrease and 
defective production of haemoglobin, with estimates of gene frequencies 
ranging from 2.5% to 15% in some areas of the tropics (Modell and Darlisson, 
2008). A reduction in the rate of production of certain of these globin 
chain/chains hinders the synthesis of haemoglobin and creates an imbalance 
with the other normally produced globin chains (Nagel and Steinberg, 2001). As 
a direct result of this imbalance between normally produced and the under-
produced globin chain, an excess of the normally produced type accumulates in 
the cells as an unstable product and begins reacting with cell membranes, 
hindering normal cellular processes and acting as foreign particles, leading to 
the destruction of red cells (Brown, 2003).  
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The degree of destruction or toxicity varies according to the type of excess 
chain involved with the type of thalassemia normally going by the name of the 
under-produced chain/chains (Yaish, 2005).    
 
The reduction in the chain production could vary from a slight decrease to a 
complete absence of production. A superscript symbol indicates whether a 
subunit is completely absent (α0 or β0) or whether its synthesis is reduced (α+ or 
β+) (Maggio et al., 2002). Of the four possible types of thalassaemias, alpha, 
and beta thalassemias are the most prevalent resulting from gene deletion or 
beta point mutations in the non-coding portion of the globin gene.  
Beta (β) thalassemia results when there is reduction in β-chains production (+) 
or when there is no production of -chain (0) and alpha (α) thalassemia refers 
to reduction in the production of α-chains but also due to the deletion of α-
chains of haemoglobin (Chui et al., 2006).  
 
Olivieri (1999) discussed the deficiency in these chains and indicated 
abnormalities in the formation, size, and shape of red blood cells (RBCs) 
resulting from ineffective production of RBCs and their destruction. The 
heterogeneity and complex nature of this inherited disease involves clinical 
manifestations such as ineffective haematopoiesis, and accelerated haemolysis 
due to abnormal haemoglobin synthesis (Haen, 1993).  
The severity of the above clinical manifestations is dependent on the number of 
globin chain(s) deleted.  
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As a result, people with thalassaemia often have a reduced number of RBCs, 
which can affect the transportation of oxygen to body tissues (Allen et al., 
1997). However in the carrier states a normal or increased number of RBC is 
observed due to compensated process. In addition, thalassaemia can cause 
RBCs to be smaller (microcytosis) resulting in reduced mean cell volume (MCV) 
As a result of the compensating increased RBC found in carriers of + and 
0 
thalassaemia alleles, they present with mild to no anaemia and therefore 
require no treatment. However, there appears to be no cure for Hb Bart‘s 
Hydrops Foetalis Syndrome and the HbH disease. (Harteveld and Higgs 2010) 
The best treatment available today consists of frequent blood transfusions 
(every two to three weeks) with iron chelation therapy (e.g. deferoxamine) 
administered subcutaneously (Allen et al., 1997). Bone marrow transplants 
(hematopoietic stem cell transplantations) and cord blood transplantation with 
pre-operative myeloablation are potentially curative (Tassiopoulos et al., 
2005). 
 1.3.1 Epidemiology 
The alpha thalassaemias also follow a pattern of distribution along the tropics 
where malaria is highly prevalent. The alpha thalassaemia afford their carriers 
some protection against death from Plasmodium falciparum infection by 
depriving the parasites of nutrients normally derived from digestion of 
haemoglobin (Cheesbrough, 2005).  
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Other researchers have also suggested that parasitized alpha thalassaemic 
cells bind more antibody than normal cells, thus facilitating the clearance of 
malaria parasites from the blood (Teo and Wong 1985; Luzzi et al., 1991).  
Mockenhaupt et al., (2000) reported that alpha thalassaemia and beta 
thalassaemia affect as many as 33% and 1% respectively, of the antenatal 
population in a Ghanaian community. The same study demonstrated that 
alpha thalassaemia trait protects the carriers from malaria. The prevalence of 
alpha
+
-thalassaemic trait in Tamale, Ghana and its surroundings was 
estimated to be 31.8% (Mockenhaupt et al., 2004a).  
The protective effect of thalassaemia trait against severe malaria was also 
demonstrated. The protection however, was shown to wane with age (>5 
years) with the explanation that innate resistance acts mainly before specific 
immunity has developed. However, studies in the Melanesia (William et al., 
1996) have shown that children homozygous for alpha
+
-thalassaemia who 
were less than 5 years had more than twice the incidence of severe malaria.   
In Tanzania, Enevold et al., (2008) observed reduced risk of Plasmodium 
falciparum in children older than 5 years and suggested that the increase 
susceptibility of subjects who were less than 5 years old might result in 
improve immunity to subsequent severe disease with an enhanced antigen 
expression on Plasmodium falciparum-infected alpha
+
-thalassaemia 
erythrocytes. 
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1.3.2 Beta (β)- Thalassaemia 
This group of inherited disorders is characterized by impaired synthesis of 
beta (β) - globins chain(s). Beta globin genes (located on chromosome 11), 
are inherited in pairs – one from each parent.  
The β thalassaemia is common in regions bordering the Mediterranean Sea 
(Southern Italy, Sardinia, Greece, Sicily, Turkey, Lebanon and Armania), Arab, 
African Americans, Asia and Africa (Haen, 1993).  
Affected individuals exhibit a variable reduction in  globins chain synthesis 
ranging from a minimal deficit (mild + thalassaemia alleles) to complete 
absence (° thalassaemia), which are caused by point mutations that affect the 
 globins gene locus and are extremely heterogeneous (Forget 2001) (Table 
1.1). The consequences of this mutation therefore are the reduction in total red 
cell haemoglobin in the -thalassemia major due to the precipitation of excess 
 chains in the erythroblast and in mature red blood cells leading to ineffective 
erythropoiesis and haemolysis (Hoffbrand et al., 2010) This damage to red 
blood cell precursors in the marrow and ineffective erythropoiesis caused by 
intracellular denaturation and precipitation of unmatched alpha chains results 
in the formation of inclusion bodies (Babior and Stossel, 1994). The reduction 
in total red cell is however corrected to some extent by mopping up of excess 
 chains by the production of  chains, the synthesis of haemoglobins 
containing other β - class chains (Hb F and Hb A2), but fail to compensate fully 
for the decreased quantity of Hb A in thalassaemia cells.  
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Pallister, (1994) described three groups of β thalassaemia as β thalassaemia 
minor (trait), β thalassaemia major and β thalassaemia intermedia of which the 
mildest form, β thalassaemia minor arises from the inheritance of a single 
abnormal β globin gene. Individuals who inherit this single β thalassaemia 
allele, either β° or β+ have thalassaemia trait.  
Moi et al., (2004) have described the β° or β+ thalassaemia trait as being 
clinically asymptomatic but with a mild anaemia and characteristic 
hypochromic microcytic red blood cells, elevated levels of Hb A2 (α2δ2) and 
variable increases of Hb F (α2γ2). Thein, (2004) describe β° thalassaemia as 
characterized by the complete absence of Hb A (α22) as no  chain or small 
amounts of β+ is synthesised and results from the inheritance of two β° 
thalassaemia alleles (homozygous or compound heterozygous states).  
This condition, β thalassaemia major will normally present with profound 
anaemia requiring regular blood transfusion without which the patient may die 
within the first 2 years of life. Inheritance of two β thalassaemia alleles, 
however, does not always lead to thalassaemia major and many patients with 
two β thalassaemia alleles have a milder disease, ranging from a condition that 
is slightly less severe than transfusion-dependence to one that is 
asymptomatic and often mistaken for β thalassaemia trait (Thein, 2001).  
The diverse collection of phenotypes between the two extremes of β 
thalassaemia major and β thalassaemia trait constitute the clinical syndrome of 
β thalassaemia intermedia (Moi, et al., 2004). 
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Table 1.1: Types of β- Thalassaemia 
Type Defect in Globin Chain 
Production 
β+ - thalassaemia Diminished β- chain 
β0 – thalassaemia No β- chain 
δβ- thalassaemia No β or δ- chain 
Hb Lepore No β- chains, δ- chain replaced by 
δβ- hybrid 
Hereditary persistence of 
foetal Hb 
No β- or δ- chain but increased γ- 
chain production 
(Adapted from Babior and Stossel 1994) 
1.3.3     Alpha (α)-Thalassaemias 
Normally four α globin genes of which two copies each located on chromosome 
16 regulate α globin synthesis. Each individual receives four α-globin genes 
from their parents – a maternal pair and a paternal pair (Hoffbrand et al., 2006). 
The production of alpha chains is divided among the four α-globin genes. Thus, 
each individual has four genes for the production of alpha chains (Ceila, 2007). 
The alpha globin chains produced by these four genes, along with the 
appropriate amount of beta globin chains then associate with the haem 
molecule to form the normal adult hemoglobin (Weatherall and Clegg, 2001b).  
Alpha thalassaemias refer to the under-production of α-globin chains. 
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Alpha thalassaemia results when one or more of these genes fails to function 
properly and with the amount of α-globin produced falling short of that required 
the normally produced beta globin chains will pair with the available, but limited, 
α-chains with leftover beta chains accumulating in the cellular environment (Old, 
2003). Though dysfunctional, rather than completely deleted genes are 
occasionally found, the defect in α-thalassaemia usually involves the total 
deletion of one or more of the genes due to deletion or mutation. Since the  
chain is a component of both foetal and adult haemoglobins, the -
thalassaemia is especially severe (Leung et al., 2005). In West Africa, the 
mutant genes responsible for alpha+ thalassaemia are reported to be 20 to 30% 
prevalent (Mockenhaupt et al., 1999a).  
Some works within the Sub-region are in agreement with this level of 
prevalence, though some figures seem to slightly exceed it (May et al., 2007; 
Mockenhaupt et al., 2004a; and Falusi et al., 1987). Apart from Africa, other 
regions of the world also have high prevalence and in Southeast Asia and 
Papua New Guinea, the prevalence is about 2 times that of Africa‘s. Alpha 
thalassaemia is known to equally affect both sexes. Ethnically, though, the 
disease is diverse, with different mutations (i.e. –α3.7 and –α4.2) being more 
prevalent in some regions than others, and at times even being unique to others 
(Yaish, 2005). 
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1.3.4    Types of alpha thalassaemia 
As indicated earlier, each individual inherits two sets of alpha globin genes 
from their parents. A normal individual is of the genotype (αα/αα), showing that 
all the α-globin genes are present and functioning properly.  
The types of alpha thalassaemias depend on how many of these genes are 
deleted or dysfunctional, and in rare cases, having a mutation (Ohene-
Frempong et al., 1980, Weatherall 2001a, Leung, et al., 2005). (Figure 1.5) 
1.3.5 The molecular basis of alpha+-thalassaemias  
The two main genes associated with alpha- thalassaemia are HBA2 (the gene 
encoding 2) globin and HBA1 (the gene encoding 1 globin). These regulate 
the normal individual alpha globin synthesis (Galanello et al., 1998).  However 
the expression of these genes is dependent on a Multispecies Conserved 
Sequences (MCS-R2) or the erythroid-specific DNAsel hypersensitivity sites 
(HS-40) located 40 kb upstream from the alpha globin clusters which have 
been shown to express alpha globin genotype (Harteveld and Higgs 2010) and 
appears to be the major regulator. The deletion of MCS-R2 (HS-40) therefore 
results in an alpha-thalassaemia phenotype.  
The molecular basis of alpha+ thalassaemia is the deletions that remove one 
of the linked pairs of α-globin genes, leaving the other one intact (–α/αα).  
However, there are situations where both α-globin genes are intact with one 
having a mutation that either partially or completely inactivates it (αTα/αα) 
(Weatherall 2001b).  
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1.3.6 Deletion of a single alpha globin gene (alpha+-thalassaemia 
mutation) 
Each α- globin gene lies within a boundary of homology of 4 kb long generated 
by duplication, subsequently subdivided by insertions and deletions, resulting 
in three homologous sub segments that are designated X, Y and Z (Pallister, 
1994) (Figure 1.4) 
 
Figure 1.4 Deletions resulting in alpha+- thalassaemia mutations 
(Adapted from Harteveld and Higgs 2010) 
 
The duplicated Z box homology is 3.7 kb apart and the X box homology is 4.2 
kb apart. Misalignment and unequal crossover between these segments at 
meiosis produces two chromosomes 16 with either a single (–α) or triplicated 
(ααα) α-globin genes.  
 
 
Chromosomes have 
only one functional  
gene that causes + 
thalassaemia. Also 
causes a triplication 
allele without 
thalassaemic effect 
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Chromosomes with three  genes represent the reciprocal  
anti 3.7
 and  
anti 4.2
 formed during the process of unequal crossing-over Pallister (1994). If the 
reciprocal recombination occurs between the Z boxes, which are 3.7 kb apart, a 
3.7 kb of DNA is lost, an event that is described as a rightward deletion (–α3.7).  
A crossover between the two X boxes which are 4.2 kb apart, results in the 
deletion of a 4.2 kb of DNA, and referred to as the leftward deletion (–α4.2) 
(Steinberg, 2001, Harteveld and Higgs 2010) 
1.3.6.1 Deletion of one gene on one or both chromosomes 
This type of alpha thalassaemia results from the deletion of all parts or part of 
the 2-globin gene. It is of genotype (-α/αα) is actually of no haematological 
consequence because the production of α-globin proteins is only slightly 
altered since only one gene is deleted (Bain, 2006, Hughes-Jones et al., 
2009)(Figure 1.5) 
It is so close to the normal condition that it is very difficult to detect without the 
use of specialized laboratory equipment and techniques. People with this 
condition are referred to as ‗silent carriers.‘ The condition is also termed as 
heterozygous alpha
+
-thalassaemia or alpha
+
-thalassaemia trait (Wintrobe and 
Lee, 1999) and the most common mutations causing this disease are the –α3.7 
and –α4.2. There is also the situation where there is the deletion or inactivation 
of two alpha-globin chains in trans configuration (-α/-α) (Figure 1.5). This is 
termed as homozygous alpha+ -thalassaemia (Higgs, 2001) 
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1.3.7 Deletion of both alpha globin genes on one chromosome (alpha
0
-
thalassaemia mutation) 
The deletions, which remove both alpha globin genes in cis renders these 
chromosomes unable to synthesize any alpha chains (Galanello et al., 1998). 
These mutations range from approximately 6 kb to more than 300 kb. The 
most common types of the alpha
0
-thalassaemia mutations are the Southeast 
Asian (- -SEA), Filipino (-- FIL), and Mediterranean (--MED) (Harteveld and Higgs 
2010) and in the homozygous state, neither the embryonic (22) nor the foetal 
(22) haemoglobins could be made with these mutations result in Hb Bart 
Hydrops Fetalis Syndrome. However, if any of the alleles occur in combination 
with another allele carrying a single deletion like the –α3.7, the outcome is Hb H 
disease (Higgs, 2001) 
1.3.7.1 Deletion of two genes 
The type of thalassaemia where there is the deletion of the two genes from 
one of the two chromosomes (--/αα) (Figure 1.5). (Chui et al., 2006) and is 
termed as heterozygous α0-thalassaemia. The heterozygous α0-thalassaemia 
genotype is a determinant of both haemoglobin H disease and haemoglobin 
Bart‘s disease (Johnston, 2005). The two-gene deletion alpha-thalassaemia, 
at times referred to as alpha-thalassaemia trait or mild alpha thalassaemia, is 
characterized by at most mild anaemia and small RBCs, though some other 
patients experience no symptoms.  
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Most heterozygous α0-thalassaemias do not present with any important clinical 
or haematological differences between the different mutations giving rise to α0-
thalassaemia genotype (Bain, 2006, Hughes-Jones et al., 2009). 
1.3.7.2 Deletion of three genes 
Three-gene deletion α-thalassaemias, with a genotype of (--/-α) (Figure 1.5), 
produce serious haematological problems. The most common causes are 
compound heterozygosity for α
+
-thalassaemia and α
0
-thalassaemia or 
alternatively compound heterozygosity for α
0
-thalassaemia and a non-
deletional α-thalassaemia (Bain, 2006, Hughes-Jones et al., 2009). Individuals 
with this form of α-thalassaemia suffer from severe anaemia, splenomegaly, 
bone deformities, and fatigue (Bain, 2006).  
Since only one of the alpha globin genes is producing alpha globin proteins, 
there are very few alpha proteins to pair with the beta proteins, which, are still 
being produced normally. Due to this imbalance, the surplus beta proteins 
begin to associate in groups of four (
4
), producing the abnormal haemoglobin 
referred to as haemoglobin H. (Johnston, 2005, Chui et al., 2006). There are 
two main problems with HbH. First, it is unable to carry oxygen properly, 
thereby rendering it useless to the cells. Second, Hb H proteins damage the 
red blood cell membrane, thereby speeding up cellular destruction (Weatherall 
2010). Because of the severe anaemia, patients with this disease usually 
require blood transfusions to survive. 
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1.3.7.3 Deletion of all four genes 
This form of alpha-thalassaemia, genotypically represented as (--/--),(Figure 
1.5), is the most deadly of all α-thalassemias. This condition is said to be 
‗incompatible‘ with life. The condition, also referred as Hydrops Fetalis 
Syndrome, is characterized by the deletion of all four of the α-globin genes, 
meaning that there is no production of alpha proteins (Harteveld and Higgs 
2010, Hughes-Jones et al., 2009 ). 
By extension, this means that absolutely no haemoglobin A (normal adult 
hemoglobin) or haemoglobin F (fetal hemoglobin) is produced (Chui et al., 
2006). Because of the lack of alpha proteins, the gamma proteins, which are 
produced during fetal life and under normal circumstances should have paired 
with the α-proteins, begin to associate in groups of four (4). This association 
forms the abnormal haemoglobin, called haemoglobin Bart‘s (Hb Bart‘s) 
(Johnston, 2005). Fetuses that are affected by Hydrops Fetalis Syndrome 
become anaemic early in pregnancy.  
Additionally, they become hydropic (retain fluids), frequently develop enlarged 
hearts and livers, and most are miscarried, stillborn, or die shortly after birth.  
However, there are reports that a few of such babies have survived, but only 
after intrauterine blood transfusion (Yaish, 2005). 
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Figure 1.5: Classification of the deletion of alpha globin gene and   
phenotypical expression     –Deletion of alpha globin gene 
 
1.3.8 Non deletional alpha-thalassaemia 
There are situations where both α-globin genes are intact but point mutation in 
the HBA2 (the gene encoding 2) globin (αTα) or the HBA1 (the gene 
encoding 1) globin (ααT) genes either partially or completely inactivates 
expression from a chromosome (Galanello et al., 1998). This results in non-
deletion forms of alpha thalassaemia. These non-deletional forms of alpha 
thalassaemia mainly occur in HBA2 
The non-deletional forms of α-thalassaemias have been described where these 
conditions have been observed to present with a more severe reduction in α 
chain synthesis than the deletional types (Harteveld and Higgs 2010).  
ξ       ψξ         αD      ψα1           α2       α1                      θ 
HBZ  HBZps    HBD   HBA1ps    HBA2      HBA1               HBQ 
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The most common ones are either due to polyadenylation site mutation, 
termination codon mutations or structural mutations resulting in -globin variant 
that is unstable (Table 1.2). Alpha0 thalassaemia is rare among people of 
African decent but alpha+ thalassaemia though of little clinical significance; 
homozygous for the more severe non-deletional α
+
-thalassaemias (αTα/ αTα) 
may have the clinical features of haemoglobin H disease (Bain, 2006). 
One of the most common forms of non-deletional alpha thalassaemia caused by 
a mutation of the termination codon of the 2-globin gene is Haemoglobin 
Constant Spring (-- SEA/ CS ). Impaired mRNA translation consequent on 
initiation codon of 2-globin gene produces non-deletional mutations among 
Africans (Table 1.2).  
Examples of such non-deletional mutations are haemoglobin Seal Rock and 
haemoglobin Evanston (Harteveld and Higgs 2010, Bain, 2006). Among 
Southeast Asians who are carriers of Haemoglobin Constant Spring, the 
prevalence is about 8% (Vichinsky, 2009). In the Middle East, the common 
alpha thalassaemia non-deletional mutation is Haemoglobin  TSaudi. It is a 
mutation of the polyadenylation signal sequence of the 2 gene, resulting in 
decrease expression of structurally normal  chains. Haemoglobin Koya Dora, 
another structural non-deletional mutation, is found in India. Other structural 
mutations such as haemoglobin Quong Sze found in Southeast Asia are highly 
unstable and result in defect in the haem pocket (Vichinsky, 2009). 
 
   Chapter 1. Literature Review 
 
 
 
 36 
1.3.9: Other forms of alpha+-thalassaemia deletions 
Some rare deletions affecting the α-globin genes have been associated with 
abnormalities usually affecting intellectual capabilities of the affected α-
thalassaemic patient (Higgs and Weatherall 2009). These are the α-
thalassaemia mental retardation syndrome on chromosome 16 (ATR16), the α-
thalassaemia mental retardation X-linked syndrome (ATR-X) and α-
thalassaemia myelodysplastic syndrome (ATMDS). In these conditions, 
deletions remove not only the  globin genes but also a number of other genes 
around them (Harteveld and Higgs 2010) 
 
Table 1.2 Classification of non-deletional mutations causing alpha-
thalassaemia in Africans 
Note- del-deletion; Cd-codon; term-termination codon; init-initiation codon; 
HGVS-Human genome variation society. (Adapted from Harteveld and Higgs 
(2010) 
Affected 
sequence 
Affected 
gene 
Mutation(s) HGVS Synonym 
Hb -name 
Distribution Phenotype 
mRNA translation 
 
Initiation 
codon  
- α3.7  init ATG>GTG  c.1A>G p.Met1Val  
 
African  α0  
 - α3.7 II init (-2 bp) 
c.-2_-3delAC 
 
N-African, 
Med 
α+ - α0 
Exon I α2  Cd22 (-C)  c.69delC p.Gly23fs   African   
 α2  Cd23 (G>T)  c.70G>T p.Glu24X   Tunesian   α0 
 - α  Cd30/31(-2 bp)  c.94_95delAG   African   α0 
Exon II α1  Cd62(-G)  c.187delG p.Val63fs   African   
Exon III α2  Cd116 G>T  c.349G>T p.Glu117X   African  + 
 
α2  
Term Cd 
TAA>GAA  
c.427T>G p.X143Glu  Seal Rock  African  α+  
Post translational 
 
Exon I - α Cd14 T>G c.43T>G p.Trp15Gly Evanston African α+ 
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1.4.0 Distribution of alpha+-thalassaemia 
Weatherall, (2001a) discussed the global distribution of α-thalassaemia and 
observed that the alpha+-thalassaemia provides a selective advantage in 
regions that are endemic for Plasmodium falciparum malaria. He further indicted 
that the protection might be due to thalassaemic red blood cells providing poor 
environment for the malaria parasite so that carriers are less likely to develop 
severe malaria and die from it (Weatherall, 2001a) 
Alpha+-thalassaemia is predominant in the tropics and sub-tropics, with its 
prevalence ranging between 1% and 98% (Higgs et al., 1989).  
However, in the wake of increase in global migration with consequent inter-
racial marriages, there has been a resultant upsurge in the worldwide 
occurrence of the disease (Liu et al., 1999). Alpha
+
-thalassemia occurs 
commonly across tropical Africa, the Middle East, certain regions of India, and 
throughout Southeast Asia. The highest frequencies occur in the Pacific Island 
populations (Vichinsky, 2000). 
With the advent of DNA technology, it has become possible to genotype α-
thalassemia, a previously difficult task (Weatherall and Clegg, 1999). The 
benefit of this breakthrough is that we now have an appreciable level of 
understanding as to which forms of α-thalassemia are most prevalent in which 
parts of the world. Though α-thalassemia has been found to occur in all races 
and ethnic groups, certain genotypes are more common in certain ethnic 
groups and regions than in others (Yaish, 2005, Leung et al., 2005) (Table 1.3)  
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For instance, α0-thalassemia is limited in its distribution to the Mediterranean 
regions and parts of South East Asia, especially Southern China, Thailand, 
and Vietnam (Weatherall and Clegg, 2001b). This explains why haemoglobin 
H disease and hydrops fetalis syndrome are most prevalent in Asia or people 
of Asian decent.  
In Africa, and in people of African descent around the world, the –α3.7 
deletional alpha+-thalassaemia is the most predominant (Kattamis et al., 1996, 
Old, 2003).  
In support of this, a study conducted in Nigeria, Africa‘s most populous nation, 
found a 27% prevalence of the –α3.7 alpha+ thalassemia in the South-western 
part of the country (Mockenhaupt et al., 1999b).  
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Table 1. 3 The prevalence of alpha
+
 and alpha
o
 thalassaemia in different ethnic groups and their clinical severity 
 
GENE  ETHNIC GROUP SEVERITY PREVALENCE 
Heterozygous alpha
+
-
thalassaemia. Silent 
carrier or mild alpha 
thalassaemia minor; 
alpha
+
-thalassaemia 
trait. (-α/αα) 
Africa Patients are asymptomatic but 
may be slightly anaemic. 
 
 
 
 
 
North Africa 5-8%(Egypt 8%); Gambia 8-55%; Togo 46%; Nigeria 8-
58%; Senegal 22%; Benin and Burkina Faso 29%; Ivory Coast 39%; 
Kenya 19-34%, Tanzania 2% CAR 39%(23% of pygmies); Republic 
of Congo 36-40% (29% of pygmies); Zambia 20-27%; Malawi 39%; 
Namibia 11.5%; South Africa (coloured-7%, black 12%-36%); 
Mozambique 5-6%, Madagascar<1-3%; Comoros 2%; Africans in UK 
25-30%; African-Americans 25%; Afro-Caribbeans 25% (Jamaica 
34%); Ghana 26-33% 
Homozygous alpha
+
-
thalassaemia (-α/-α)  
Africa,  
African American 
Melanesia, 
Polynesia 
No significant symptoms of 
disease. Mild microcytic 
hypochromic anaemia. 
Absence of splenomegaly 
 
Same as above 
Heterozygous alpha
0
-
thalassaemia(--/αα )    
Mediterranean, 
South-East Asia, 
Southern China, 
India, Vietnam, 
Thailand 
No significant symptoms of 
disease. Mild microcytic 
hypochromic anaemia 
Greece 1.5%; Cyprus 2%; 
Haemoglobin H Disease 
alpha
o
 alpha
+ 
double 
heterozygous (--/ -α)  
Mediterranean, 
South-East Asia, 
Southern China, 
Splenomegaly in most 
patients. Ineffective 
erythropoiesis. Defective Hb 
synthesis and haemolytic 
component. Ineffective O2 
transport by Hb H. Iron 
depletion. Marrow shows 
erythroid hyperplasia 
Rare 
Haemoglobin Bart‘s 
Hydrops fetalis or 
homozygous α
o
 
thalassaemia (--/--) 
South-East Asia, 
Mediterranean 
region  
No functional Hb formed. 
Intrauterine death followed by 
stillbirth usually occurs 
between 25 and 40 weeks of 
gestation, or the baby dies 
very shortly after birth. 
Rare 
 Adapted from Kattamis et al., (1996); Weatherall and Clegg, (2001); Yaish, (2005) 
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In Ghana, the picture reflects the general situation on the continent, especially the 
West African sub-region. The most prevalent form of α-thalassemia in Ghana is the 
alpha+-thalassemia trait, both the heterozygous (-α/αα) and the homozygous (-α/-α). 
According to Timmann et al., (2007), the Ashanti region of the country has a 
moderate prevalence of the –α3.7 deletional alpha thalassemia (Figure 1.6). A 
number of studies done in different parts of the country all seem to be in agreement 
with the 20 to 30% prevalence rate of alpha+-thalassemia in West Africa (Borges, et 
al, 2001), though there are some slight variations (Mockenhaupt et al., 2001; 
Mockenhaupt et al., 2004a; May et al., 2007). 
 
 
 
 
 
 
 
Figure 1.6: Allele Frequency of -α3.7
 
within Africa (Adapted from Wintrobe and 
Lee 1999).                                                                                                                                                                                                                                
Ghana–α3.7 gene 
frequency between 
.26- .33 
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1.4.1 Diagnosis of alpha-thalassaemia 
The International Committee for Standardization in Haematology expert panel on 
abnormal haemoglobins and thalassemias made diagnostic recommendations 
regarding laboratory investigation. Baseline tests that were recommended include a 
complete blood count (CBC), electrophoresis at alkaline pH, tests for solubility and 
sickling, and quantification of Hb A2 and Hb F (Clarke and Higgins, 2000). If an 
abnormal Hb is identified on the preliminary tests, then further techniques were 
recommended to identify the variants. These techniques include electrophoresis at 
pH 6.0–6.2, globin chain separation, and isoelectric focusing (IEF), HPLC and DNA 
analysis (Clarke and Higgins, 2000) 
Other information essential when diagnosing alpha+-thalassemia include race, 
ethnic background, family history, and age (Yaish, 2005). Trent, (2006) indicated a 
careful three tier approach involving: (1) full blood count (2) special haematological 
tests, followed by (3) DNA mutation analysis, which may provide the most effective 
way to detect primary gene mutations as well as gene-gene interactions that can 
influence the overall phenotype. For those with red cell microcytosis (MCV < 76 fL), 
a reliable measure of iron status is required (e.g. serum ferritin) to exclude iron 
deficiency (Vulliamy 2001).  
The production of alpha globin proteins starts early in foetal life, which therefore 
means that α-thalassaemia (Hb Bart‘s Hydrops Foetalis), can be diagnosed even at 
the earliest stages of human development.  
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Diagnostic tests at the foetal stage are either by chorionic villus sampling or amniotic 
fluid testing (Galanello et al., 1998 and Vijay et al., 2010). Some forms of the 
disease, like homozygous alpha
+
-thalassemia and heterozygous alpha0-thalassemia 
are of no serious haematological consequences, except during stressful events like 
illness or pregnancy when some sufferers have mild anaemia (Hoffbrand and Moss 
2010). Other more deadly forms of the disease like non-deletional Hb H disease or 
Hb Bart‘s disease result in life-threatening situations. Some signs and symptoms to 
look for in diagnosing α-thalassemia include slow growth, pallor, jaundice, and 
splenomegaly, hepatomegaly, and bone deformities.  
1.4.1.1 Complete Blood Count (CBC)  
The key components of the complete blood count (CBC) include: haemoglobin value 
(Hb), red blood cell (RBC) count, mean cell volume (MCV), mean corpuscular 
haemoglobin (MCH) and red cell distribution width (RDW) (Bertram 1991). Whilst red 
cell indices are observed as critical to the diagnosis of thalassemias, structural 
haemoglobinopathies may have an impact on the red cell indices (Lafferty et al., 
1996).  Rahim (2008) indicated that initial haematological data presents the key to 
successful detection and characterization of the haemoglobinopathies, particularly the 
thalassaemias. The red cell indices are important indicators in the assessment of 
thalassaemia trait, which is characterized by microcytosis (Bergstrome and Poon, 
2002).  
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MCV can be considered as a key diagnostic indicator. Low MCV (mean corpuscular 
volume) or MCH (mean corpuscular haemoglobin) might provide a clue for -
thalassaemia especially in regions at risk, and iron deficiency must be excluded as a 
first step (Wonke et al., 2007). However MCH value of < 26.5 pg have been 
suggested to be a sensitive indicator of thalassaemia trait (Savitree et al., 2009). The 
RBC count is useful as a differential tool because the thalassemias produce 
a microcytic anaemia that is associated with increased RBC count, while the other 
causes of microcytic anaemia, including iron deficiency and anaemia of chronic 
disease, are more associated with a decrease in the RBC count that is proportional to 
the degree of decrease in Hb concentration (Clarke and Higgins, 2000).  
The Hb concentration can provide complementary information since carriers of alpha 
thalassemia do not frequently have reduced Hb.  
 
1.4.1.2 Microcytosis 
When haemoglobin synthesis is retarded and an extra mitotic division occurs before 
the erythroblast dies mature red cell which are smaller than normal are formed which 
are known as microcytes. Microcytosis is a blood disorder characterized by the 
presence of microcytes; often associated with anaemia in which the average size of 
erythrocytes is smaller than normal (Pallister, 1994).  
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Microcytic anaemias are due to defects in haemoglobin biosynthesis resulting from 
reduced supply of iron (iron deficiency), inadequate delivery of iron (anaemia of 
chronic inflammation), impaired production of haem (sideroblastic anaemia), or 
defective synthesis of the globin component of haemoglobin (thalassaemia) (Old, 
2003). Microcytosis may be due to iron deficiency but also heterozygous or 
homozygous alpha
+
-thalassaemia or alpha0 thalassaemia trait and -thalassaemia 
(Figure 1.8) (Wonke et al., 2007; Eivazi-Ziaei et al., 2008). The presence of 
microcytosis in carriers for alpha thalassaemia or beta thalassaemia has been 
suggested as a reflection of an increased number of terminal cells divisions during 
erythropoiesis, due to the combination of defective haemoglobinization of the 
erythrocytes and a highly proliferative bone marrow (Fowkes et al., 2008). The 
general classification of thalassemias however, is hypochromic and 
microcytic anaemias (Figure 1.7). 
 
 
  
Figure 1.7 Red cell morphology showing normal red cells, microcytosis and 
hypochromasia x 40 
Normal red cell Microcytosis Hypochromasia 
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Figure 1.8: Red Blood Cell Morphology showing alpha thalassaemia (a), and iron 
deficiency (b) x 40 
 
1.4.1.3 Iron studies 
It is essential that iron deficiency be excluded before any further tests are undertaken 
in haemoglobinopathy workups. All samples that showed microcytosis are further 
evaluated for plasma or serum ferritin, serum iron, and iron binding capacity, 
percentage saturation levels and transferrin receptor levels (Table 1.4) to exclude iron 
deficiency, leaving probable alpha+ thalassaemia as causes of microcytosis in those 
with normal ferritin (Trent, 2006, Wonke et al., 2007). Iron deficiency (ID) and malaria 
are the major causes of anaemia in children in sub-Saharan Africa. Diagnosis of iron 
deficiency appears unreliable in the presence of malaria and other inflammatory 
conditions. This is because in areas of high malaria transmission and infection it is 
difficult to distinguish states when cellular iron delivery to the erythroblast is 
decreased even though iron stores are adequate (termed functional iron deficiency) 
from situations where limited amount of iron is due to lack of available iron in the 
reticular endothelial system (Phiri et al., 2009). However, plasma ferritin level at a 
cutoff of <273 g/L have been suggested to provide a 79% specificity and 79% 
sensitivity and best predicts iron deficiency anaemia (IDA) (Phiri et al., 2009).  
a b 
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Ong et al., (2008) had also indicated that in populations with a high prevalence of 
thalassaemia trait, the serum transferrin receptor (sTfR) level might not be useful in 
diagnosing iron deficiency unless the patient‘s thalassaemia status is known. 
He further explained that raised sTfR level is unaffected by inflammation and 
therefore useful as a marker of iron deficiency. However, diseases that cause an 
increase in erythropoietic activity can also result in a raised sTfR level.  
Thalassaemia trait is associated with ineffective erythropoiesis and therefore 
increases sTfR level (Ong et al., 2008) 
 
Table 1.4: Haematological parameters in alpha thalassaemia and other 
haematological conditions 
(MCV; mean corpuscular volume, MCH; mean corpuscular haemoglobin, TIBC; total 
iron- binding capacity Courtesy of Hoffbrand, et al, (2004) 
 
 
 Iron Deficiency Chronic 
Inflammation or 
Malignancy 
Alpha- 
Thalassaemia 
Sideroblastic 
Anaemia 
MCV, MCH Reduced in 
relation to 
severity of 
anaemia 
Normal or mild 
reduction 
Reduced; very 
low for degree of 
anaemia 
Usually low in 
congenital type 
but MCV often 
raised in 
acquired type 
Serum Iron Reduced Reduced Normal Raised 
 
TIBC Raised Reduced Normal Normal 
 
Serum Transferrin 
Receptor 
Raised Normal or low Variable Normal 
Serum Ferritin Reduced Normal or raised Normal Raised 
Bone Marrow Iron 
Stores 
Absent Present Present Present 
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1.4.1.4 Haemoglobinopathy evaluation 
1.4.1.4.1 Haemoglobin Electrophoresis 
This test measures the type and relative amounts of haemoglobins present in the red 
blood cells. It is the most common test for the initial detection and characterization of 
variant haemoglobin (Bain, 2006). In principle, haemoglobins are able to separate 
from each and the bands visualised when applied to a membrane and exposed to a 
charged gradient.  
 
The choice of methodology will usually depend on the volume of workload, whether 
sample is liquid blood or dried blood spots, the ease of handling, reproducibility, local 
availability of expertise and cost (Ryan et al., 2010).  
 
1.4.1.4.2 Cellulose acetate electrophoresis (CAE) at alkaline pH 
This method permits the initial identification of haemoglobins A, F, S/G/D/ Lepore, 
C/E/O-Arab, H at pH of 8.2 to 8.6. The consumable for CAE are less expensive 
however the method is time consuming and labour cost may be relatively high (Bryan 
et al., 2010). Cellulose acetate electrophoresis relies on charge change for separation 
and in general gives similar mobility to IEF, although IEF does show better resolution 
than CAE. Scanning densitometry or elution followed by spectrophotometry could be 
used to quantify normal or variant haemoglobin on cellulose acetate (Clarke and 
Higgins, 2000).  
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However because of the electrophoretic similarity of many structurally different types 
of haemoglobin, the evaluation must be supplemented by other procedures such as 
acid (agarose) gel, HPLC or IEF (Bain, 2006).   
In the presence of microcytosis, a single band may represent compound 
heterozygous for variant haemoglobin or 
0 thalassaemia (Ryan et al., 2010). 
A negative sickle-screening test in children less than six months of age should be 
viewed with caution. Alkaline or acid haemoglobin electrophoresis or high 
performance liquid chromatography (HPLC) or isoelectric focusing (IEF), or a 
combination of these, should be used to assess the sickle status in children less 
than six months of age. This is due partly to the smaller amount of Hb S present and 
partly to the larger amount of Hb F in newborns (Stephens, 2005) 
 
1.4.1.4.3 isoelectric focusing (IEF) 
Isoelectric focusing can be used as an alternative to CAE at alkaline pH, but not as an 
alternative to acid agarose or citrate agar. It can however be used to complement 
these tests (Stephens, 2005). Although time consuming and labour intensive, it has 
an excellent resolution than CAE and has been used to identify and quantify 
haemoglobins (Clarke and Higgins, 2000). Citrate agar (and acid agarose) relies not 
only on charge but also on solubility of the different haemoglobins in agar. It provides 
a good separation of Hb F from Hb A and haemoglobins S, C, D-Punjab, E and O-
Arab (Stephens, 2005). 
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1.4.1.4.4 High Performance Liquid Chromatography (HPLC) 
The Bio-Rad Variant quantifies HbA2, HbF, HbA, HbS and HbC. HPLC is suitable for 
use in the diagnosis of -thalassaemia trait because it provides an accurate 
quantification of HbA2. A greater percentage of HbA2 and/or HbF are usually seen in 
beta thalassaemia trait but are reduced in alpha thalassaemia (Clarke et al., 2000). In 
severe iron deficiency anaemia, Hb A2 may be lower  (by up to 0.5%) and if the Hb 
A2 is borderline, or 3.0–3.5%, the iron deficiency is corrected then repeating the Hb 
A2 before making a final decision about whether or not an individual is a carrier for ß-
thalassaemia (Stephens, 2005). Derivatives or post-translational adjuncts of HbS co-
elute with HbA2 and HbA0 rendering its quantification inaccurate. In the homozygous 
for HbS this can lead to falsely raised HbA2 and presence of HbA, that could result in 
patient wrongly diagnosed as HbS+thalassaemia (Stephens, 2005, Ryan et al., 
2010). 
A reduction in Hb A2 level is significant in patients with Hb H disease. However a 
more sensitive method is to identify inclusion bodies in the red blood cells by 
staining peripheral blood cell with 1% Brilliant Cresyl Blue (Harteveld and Higgs 
2010). These inclusion bodies may also be found in carriers of homozygous alpha
0
 
genotypes and carriers of non-deletional alpha+ -thalassaemias. 
In this study, the haemoglobinopathy evaluation was used to exclude HbAS trait and 
HbAC individuals, as they are known to protect from the effect of severe malaria. 
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They are serious confounders in epidemiological studies of alpha+-thalassaemia in 
Africa and needed to be excluded (William et al., 2005a, 2005c, Wambua et al., 2006)  
 
1.3.9.5 DNA analysis 
 DNA analysis of each deletion breakpoint is carried out using either Southern blot 
hybridization or single-tube-multiplex-Polymerase Chain Reactions (PCR) techniques. 
This method has been developed to detect the two most common deletional alpha+-
thalassaemia that is, -3.7 and -4.2 and the 5 alpha0 – thalassaemia deletions which 
are   the -20.5, Southeast Asian (- -SEA), Filipino (-- FIL), Mediterranean (--MED) and 
Thailand (--Thai). The -PCR-based testing is more rapid, less expensive, safer (no 
radioactivity involved), more sensitive, and easier to interpret than Southern blot 
analysis (Bowden et al., 1992, Dode et al., 1993, Baysal & Huisman, 1994, Oron-
Jarni et al., 1998). For various reasons, this test has not found its way into routine use 
but can be used to diagnose thalassaemia, and to determine carrier status. It is the 
only reliable way of diagnosing carriers who have only one of four alpha genes 
deleted or mutated. The single-tube multiplex PCR assay is used for the frequently 
observed determinants of alpha
+
–thalassemia that allows simple, high throughput 
genetic screening for these common haematological disorders (Chong et al., 2000). 
The PCR uses primers that anneal to the component single strands of the target DNA 
to amplify the DNA sequences for the investigation of deletions and mutations in the 
alpha and beta globins.  
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This is followed by enzymatic extension of the primers (from their 3‘ ends) using a 
thermostable DNA polymerase (Chong et al., 2000). PCR therefore selectively 
amplifies specific target genomic DNA and rapidly isolates DNA whose structure is 
already partly sequenced and detect small amounts of one specific type of DNA (Liu 
et al., 1999, 2000). Sequence analysis can be used to identify point mutations 
(including the rare termination codon mutations and hyperunstable -globin variants) 
in the coding regions of HBA1 (1) and HBA2 (2) when an alpha-globin deletion is 
not identified and alpha-thalassaemia is highly suspected (Traeger-Synodinos et al., 
2000) 
1.5 MALARIA 
 Malaria is a parasitic disease caused by five Plasmodium species – Plasmodium 
falciparum, Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae and 
Plasmodium knowlesi. Four of the about 170 Plasmodium species are known to 
cause malaria in humans (Mayo Foundation for Medical Education and Research, 
(MFMER), 2007). The most prevalent and by far the most virulent of the four is 
Plasmodium falciparum. The known vector of these parasites is the female 
Anopheles mosquito. The male however feeds on nectars (Kwiatkowski, 2005). The 
primary mode of infection is when a parasite-carrying mosquito bites an uninfected 
person and, in the process of taking its blood meal, injects the parasites into the 
person‘s blood (Snow et al., 2005).  
   Chapter 1. Literature Review 
 
 
 
 52 
Other modes of transmission include blood transfusion and from-mother-to-child 
transmission or congenital malaria (Cheesbrough, 2005).  
1.5.1 Life cycle of the Plasmodium falciparum parasite  
Infection of the human host occurs when a female Anopheles mosquito injects 
sporozoites during a blood meal into the dermis of the host. The major phases of the 
life cycle are: liver stage, blood stage, sexual stage, and sporogony (Snow et al., 
2005) (Figure 1.9). The sporozoites migrate to the liver, where they develop into 
thousands of merozoites. The matured merozoites enter the bloodstream invading 
the RBCs; develop into the ring stage trophozoite, followed by a mature trophozoite, 
and finally, the schizont (Miller et al., 2002). 
The mature schizont gives rise to approximately 16 daughter merozoites, which are 
released upon the rupture of the RBCs (Umar et al., 2007; Nyakeriga et al., 2004a) 
starting the clinical disease presentation of fever (>37.5oC), chills, headache, fatigue, 
seizures, and coma, primarily due to dysregulation of the cytokine response (Umar et 
al., 2007; Nyakeriga et al., 2004a,).  The sexual stage of the life cycle of the parasite 
commences when another female Anopheles mosquito ingests a gametocyte during a 
blood meal. Within the mosquito‘s gut where the temperature is lower, male and 
female gametocytes emerge from the ingested parasitized RBCs to produce a zygote 
also known as the ookinete. The ookinete forms an oocyte that contains immature 
sporozoites at mid-gut of the mosquito.  
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These sporozoites travel to the mosquitoes‘ salivary glands and are ingested into the 
human host to start a new life cycle (MRPMRC, 2005) 
1.5.2 Malaria Transmission 
Malaria transmission differs in strength and regularity depending on local factors 
such as rainfall patterns, proximity of mosquito breeding sites, and the mosquito 
species (WHO 2007). These factors combined, explain to a certain extent, why 
Africa, especially Sub-Saharan Africa, with its tropical and subtropical climate, is the 
most widely affected.  
 
Figure 1.9: Life Cycle of Plasmodium falciparum in Humans (Adapted from Snow et 
al., 2005) 
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Malaria has had far-reaching ramifications on the continent of Africa. Apart from the 
severe death toll, it also has serious economic implications for the continent‘s 
developing countries. Malaria is said to slow economic growth in affected countries by 
approximately 1.3% per year (WHO, 2007). The direct and indirect cost of malaria in 
Africa is estimated at $ 12 billion per year (Abdul-Aziz, 2006).  
 
The finding that malaria-affected families are able to harvest only 40% of their crops 
compared with healthy families (MRPMRC, 2005), gives meaning to this high 
economic cost, as farming/agriculture is one of the major sources of income for most 
African nations. Considering these harsh statistics, there appears to be a clear link 
between malaria and poverty. According to Abdul-Aziz (2006), approximately 60% of 
all malaria cases occur among the poorest 20% of the world‘s population. This 
apparent link establishes grounds for waging a concerted campaign against this 
disease, because this would not only halt the disease, but also ease, to a certain 
extent, the current economic problems.  
 
1.5.3 National Interventions 
Globally however, deaths from malaria have reduced from an estimated 350 million to 
250 million per year due to the Roll Back Malaria Programme under the Millennium 
Development Goals (MDGs).  
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For children under 5 years in Africa, malaria deaths dropped from an estimated 3000 
to 2000 children per day due to household distribution and ownership of insecticide-
treated bed nets (ITN), from 3% in 2000 to 42% in 2010 (Ministry of Health (MOH), 
Ghana 2011). It is estimated that malaria accounts for 22 % of under five years 
mortality and 9 percent of maternal deaths (Roll back malaria, 2005). 
In 1999, Ghana adopted the Roll Back Malaria initiative and has since been 
implementing a combination of curative and preventive interventions.  
Children less than five years of age and pregnant women are targeted for the 
distribution of ITNs (Ghana Demographic and Health Survey 2008) 
Some countries in Africa have achieved more than 50% reduction (Ghana has 
achieved about 37.5%) in either confirmed cases of malaria or malaria admissions 
and deaths over the past decade. 
In the past 10 years 736,700 children in 34 African countries have been saved from 
malaria through the use of ITN, indoor residual spraying (IRS), effective medicine, 
and preventive treatment during pregnancy. The Ghana Health Service provides 
sulphadoxine-pyrimethamine to pregnant women as intermittent preventive treatment 
(IPT) against malaria free of charge and as directly observed therapy (DOT) at both 
public and private antenatal services (Roll back malaria, 2005) 
The adoption of Artesunate-Amodiaquine, an Artemisinin-based Combination 
Therapy (ACT) as the drug of choice for the treatment of uncomplicated malaria was 
implemented across the country.  
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These include two alternative ACT drugs, namely Artemether-Lumefantrine and 
Dihydroartemisinin-Piperaquine for those who remain hypersensitive to Artesunate-
Amodiaquine (UNICEF, 2007). 
 The Ghana Health Service also conducts information, education, and communication 
(IEC) activities on these malaria control interventions, using a variety of 
communication media and strategies.  
None the less, malaria still remains hyper-endemic in Ghana accounting for about 
61 percent of hospital admissions of children under five years and 8 percent of 
admissions of pregnant women (UNDP 2000). About 3 to 3.5 million cases of 
suspected malaria are reported each year in public health facilities, representing 30-
40 % of outpatient attendance (Ministry of Health (MOH) Ghana 2011). Of this 
figure, over 900,000 are children under the age of five. 
1.5.4 Plasmodium falciparum malaria mortality in Ghana 
Present reports indicate that malaria incidence in urban areas is increasing rapidly. 
A study done in some communities of the two largest cities in Ghana, Accra and 
Kumasi, established a prevalence range for malaria at between 2% to 33% 
(Klinkenberg et al., 2006). One of such reports pointed out that malaria presently 
presents a leading cause of morbidity and mortality among urban African 
populations (Donnelly et al., 2005). Given the current rapid growth rate of 3.5% of 
urban populations in Africa, about 50% of the African population will live in urban 
areas by 2025 (UNPP, 2005).  
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The incidence of malaria cases in urban settlements could possibly increase 
proportionally in the absence of robust combative initiatives.  
Sadly, though, despite the concerted efforts, of local governments and international 
bodies, malaria still seems to be gaining ground.  
Some regions of the world, mostly within Africa, are still recording extremely high 
numbers of malaria cases (Asante et al., 2003). A study in 2001 involving 530 
pregnant women in Ghana revealed a 63% prevalence of Plasmodium falciparum 
alone, and a further 3.4% and 2.6% prevalence of Plasmodium malariae and 
Plasmodium ovale respectively (Mockenhaupt et al., 2001). It would be logical to 
think that, with the current degree of awareness, the situation should have improved, 
but that appears not to be the prevailing reality.  
In 2006, over 16 million people were infected with malaria in Tanzania, and about 
100,000 dying as a result, (Abdul-Aziz, 2006). Some of the reasons cited for this 
escalating number of cases include drug and insecticide resistance, climate change, 
failure of health delivery systems and armed conflicts 
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1.6 ERYTHROCYTE POLYMORPHISMS AND THE BASIS FOR MALARIA 
PROTECTIVE EFFECT 
It is recognised that some genetic factors, which could be lethal in their 
homozygous state, in their heterozygous state, may diminish the risk of an 
exposed person developing parasitaemia, the risk of a parasitaemic person of 
becoming ill with malaria fever, and the risk of a person with malaria fever 
developing severe malaria (Kwiatkowski, 2005). 
1.6.1 The Duffy antigen and protection from Plasmodium falciparum 
Innate resistance to malaria infection is conferred by some blood group 
polymorphism. The Duffy antigen encodes the Duffy Antigen Receptor Cytokine 
(DARC/Fy) chemokine receptor that is expressed on the erythrocyte, which the 
Plasmodium vivax merozoites require for erythrocyte invasion (Min-Oo and Gros 
2005). A large percentage of the African population, as well as many American 
blacks, are Duffy negative. These individuals lack the receptor on their red blood 
cells due to the polymorphism in the promoter gene GATA1 resulting in reduced 
receptor expression and therefore impair entry of Plasmodium vivax with the 
expression of the gene blocked in developing erythrocytes by a mutation of the 
erythroid transcription factor (Tournamille et al., 1995, Robert et al., 2004). 
However, some evidence of transmission of Plasmodium vivax among Duffy 
antigen negative individuals has been reported in Kenya (Ryan et al., 2006).  
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Other reported cases of individuals with the FYA/FYB genotypes showing higher 
susceptibility to malaria have also been observed in Brazil where the presence of 
FYB-33 allele is suggested to provide selective advantage in the population by 
reducing the rate of infection by Plasmodium vivax (Cavasini et al., 2007). 
1.6.2 Erythrocyte cytoskeleton and protection from Plasmodium falciparum 
Erythrocyte cytoskeleton changes can also affect the outcome of infection where 
ovalocytic erythrocytes for instance, are thought to have reduced susceptibility to 
parasite invasion (Genton et al., 1995; Mgone et al., 1996 and Allen et al., 1999). 
This may be due to altered binding of Southeast Asia Ovalocytosis (SAO) Band 3 
to parts of the cytoskeleton leading to decreased cell deformability or limited 
redistribution of the protein that is observed when the parasite tries to invade. 
(Evans and Wellems, 2002). 
1.6.3 Glucose-6-phosphate dehydrogenase (G6PD) and protection from 
Plasmodium falciparum 
G6PD deficiency, globally the most common human enzymeopathy, is present in 
nearly 400 million individuals, resulting in decreased activity of a metabolic 
pathway that protects the interior of the red blood cell from oxidant stress 
(Ruwende and Hill, 1998). Its distribution correlates with malaria endemicity in 
Africa, Asia, the Middle East, and the Mediterranean.  
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Mutations in the gene are varied between populations with epidemiological studies 
supporting associations between malaria resistance and deficiency of the enzyme 
(Mehta et al., 2000).  
Evidence from some studies has suggested protective effects from clinical malaria 
by G6PD deficiency (Aidoo et al., 2002).  
G6PD deficiency, notably the widespread form in Africa (G6PD A-) has been 
indicated to confer protection against malaria in male but not female children, who 
have just one abnormal gene (Guindo et al., 2007) but also provide protection in 
pregnancy of heterozygous deficient women (Mockenhaupt et al., 2003). Guindo 
and his co-workers further indicated that the protection was more evident against 
the life threatening cerebral malaria.  
However, reported work at the Kintampo Health Research Centre in Ghana, 
suggested that G6PD deficient children of less than 5 years were not protected 
against clinical malaria (Personal communication). The mechanism by which G6PD 
deficiency protects against malaria attracts varied opinions. Toxic oxidized 
substances in the red blood cell have been suggested to inhibit parasite 
multiplication or alternatively, infected red blood cells may be more susceptible to 
phagocytosis or haemolysis because of increased cytolytic compounds and 
membrane damage (Cappadoro et al., 1998).  
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Miller et al., (1984) and Golenser et al., (1988) reported that the growth of 
Plasmodium falciparum might be inhibited more consistently under conditions of 
oxidative stress resulting in extensive haemolysis in G6PD deficient individuals.  
However, Cappadoro et al., (1998) argued that the inhibition of parasite growth 
observed in G6PD-deficient individuals was a result of the susceptibility of their red 
blood cells to phagocytosis by peripheral blood monocytes, particularly at the ring-
stage of infection accompanying the increase binding of IgG and complement C3 
to infected red cells.  
Schwarzer et al., (1992) had reported that G6PD deficient cells were more prone to 
changes in the cell membrane because of low levels of reduced glutathione (GSH) 
and higher vulnerability to oxidants. 
1.6.4 Sickle cell trait (Hb AS) and protection from Plasmodium falciparum 
Of the 300,000 annual births of sickle cell disease (Hb SS) globally, about 70% 
occurs in sub- Saharan Africa where recent reports suggest that 50% to 80% of 
affected children die annually (Makani et al., 2010). Sickle cell disease has been 
described as a double–edged sword with evidence suggesting that those with the 
sickle cell trait (HbAS) are protected against malaria whilst those with HbSS not 
only suffer severe health problems but also generally die from malaria (McAuley et 
al., 2010).  
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Previous evidence from study by Aluoch (1997) supports the idea that individuals 
heterozygous for the sickle-cell allele (sickle-trait; HbAS) are protected against the 
severe effects of malaria due to an early and enhanced acquisition of protective 
immunity against malaria. Aidoo et al., (2002) also reported that the sickle cell trait 
provides significant protection against all-cause mortality, severe malarial anaemia 
and high-density parasitaemia.  
The homozygous sickle-cell condition (HbSS) is, however, reported to be responsible 
for the deadly effects of sickle-cell anaemia, whereas the heterozygous condition is 
usually asymptomatic. According to Ayi et al., (2004) the high frequency of the sickle 
cell haemoglobin (HbS) in populations where Plasmodium falciparum malaria is 
endemic is as a result of the reduced level of the malaria parasitaemia in the mutated 
allele (HbA / HbS). The protection has been attributed to defective parasite growth or 
to enhanced removal of the parasitized RBCs.  
Cheesbrough, (2005) described a ―balanced polymorphism‖ in which death caused by 
Plasmodium falciparum malaria to the homozygotes sickle cell individual is offset by 
the survival advantage of heterozygotes in malaria endemic areas.  
1.6.5 Haemoglobin C and protection from Plasmodium falciparum 
Another common erythrocyte variant found in the hyperendemic malaria region of 
West Africa is HbC (Hb C; 6GluLys), and the mutation presents with mild 
haematological symptoms in the homozygous (Robert et al., 2004).  
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The prevalence of HbC reaches 40-50 % in West Africa (Burkina Faso, Ivory Coast, 
Ghana, in Togo and Benin (20%), the Caribbean (3.5 %) in the USA (3 %), and in 
North Africa in Morocco and Algeria) (1 to 10 %) (Bachir and Galacteros, 2004). 
Recent studies in West Africa suggest that resistance to Plasmodium falciparum has 
maintained the relatively high frequencies of HbC with evidence suggesting both 
heterozygote and homozygote resistance to malaria (Weatherall and Clegg, 2002). 
HbC has been reported to protect from severe malaria but does not prevent 
infection. HbC occurs in polymorphic frequencies almost exclusively in the northern 
savannas of West Africa (Mockenhaupt et al., 2004b). Verra et al., (2009) indicated 
that HbC individuals have low Plasmodium falciparum invasion rate and parasite 
growth, reduced cytoadherence and red cell rosetting. Further indications from in 
vivo studies were that HbC individuals showed reduced uncomplicated and severe 
malaria. However, HbAC individuals in some ethnic groups did not show significant 
evidence of reduced rates of severe Plasmodium falciparum malaria compared to 
others (Agarwal et al., 2000).  
Whilst HbAC was observed to reduce the progression from uncomplicated malaria 
to severe malaria, HbC conferred protection from the severe manifestation of 
malaria, with a risk reduction of 80% of developing severe malaria observed 
amongst the Dogon people of Bandiagara, Mali, in West Africa, who were carrying 
HbC (Agarwal et al., 2000). 
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The situation was different in Burkinabes where HbAC and HbCC protect against 
clinical Plasmodium falciparum malaria (Modiano et al., 2001).  Hb C was 
associated with a 29% risk reduction in clinical malaria in HbAC and 93% in Hb CC 
(Modiano et al., 2001) suggesting therefore a protective effect against Plasmodium 
falciparum for heterozygous and homozygous HbC in certain populations of West 
Africa. The findings further suggested that HbC individuals were not protected from 
either infection or uncomplicated malaria, an observation that is corroborated by a 
recent study on the differing effect of HbC on uncomplicated Plasmodium 
falciparum malaria in Ghana which indicated children with HbC were not protected 
against malaria (Kreuels et al., 2010). However, Kreuels et al., (2010) observed 
that the clustering of erythrocyte band 3 protein and abnormal Plasmodium 
falciparum erythrocyte membrane protein 1 (PfEMP1), expression in HbAC 
erythrocytes, may prime recognition by antibodies and lead to reduced 
cytoadherence and enhanced elimination of parasitized red cells. This evidence for 
different protective effects from HbC suggests the possibility that population-
specific factors, including differences in genetic background, may have a strong 
influence on the distributions of haemoglobinopathies in malarious regions.  
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A case control study in the northern part of Ghana where this study was 
conducted, whilst suggesting a 47% reduction of acquiring severe malaria in HbAC 
individuals observed that the haemoglobin polymorphism did not only prevent 
infection but also reduced the odds of developing severe malaria (Mockenhaupt et 
al., 2004b). The geometric parasite density (GMPD) was lower in Hb AC than was 
observed in HbCC and HbSC. 
1.6.6 Haemoglobin E and protection from Plasmodium falciparum 
The most common form of the variant -globin gene (HBB; OMIM 141900) usually 
found in malaria endemic regions of Southeast Asia is haemoglobin E (HbE; 
26Glu->Lys), which causes the HbE disease and HbE trait (Naka et al., 2008). It is 
distributed throughout much of Southeast Asia and has gene frequencies of 
approximately between 13-50% in Thailand (Hutagalung, et al., 1999, Fucharoen et 
al., 1998). It has been suggested that the positive selection against Plasmodium 
falciparum has been responsible for the rather high population frequency of HbE in 
the region (Ohashi et al., 2004).  
Malaria complications are less severe in HbE trait, suggesting that the course of 
acute Plasmodium falciparum malaria is significantly ameliorated (Hutagalung et 
al., 1999) due to inhibition of parasite growth in HbE red cells (Chotivanich et al., 
2002).  
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1.7 ASSOCIATION BETWEEN ALPHA
+
- THALASSAEMIA AND PLASMODIUM 
FALCIPARUM MALARIA 
The severe manifestation of Plasmodium falciparum is a major cause of death 
amongst children in particularly Sub-Saharan Africa who are below the age of five 
years. Alpha
+
-thalassaemias are the commonest genetic disorders affecting humans, 
a reflection of the protection it confers against death from Plasmodium falciparum 
(Mockenhaupt et al., 2004a; and Williams et al., 2005b). The fact that red blood 
polymorphisms are evidently predominant in regions of the world where malaria 
reaches endemic proportions informed the suggestion by Haldane, (1949) that it was 
not a matter of coincidence, but rather a classic case of natural selection. The basic 
proposition of Haldane‘s hypothesis is that alpha+-thalassemia, is pronounced in 
malarious regions because it accords carriers a level of protection against death from 
malaria by assuaging the clinical course of the disease. What this means is that 
people who are not carriers or who have other forms of these conditions/disorders will 
most likely die, whereas carriers will survive and possibly produce more carriers, 
leading to a steady increase in the population of carriers in these regions. 
Since Haldane‘s proposition, the protective effect of some of these disorders has 
been well documented, whereas for others, there remains lack of empirical evidence 
(Table 1.5).  
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Table 1.5. Susceptibility of Heterozygous and Homozygous alpha+-thalassaemia 
to severe malaria and anaemia 
 
GENE PROTECTION FROM 
SEVERE MALARIA 
SEVERITY OF ANAEMIA 
Heterozygous alpha+-
thalassaemia. Silent 
carrier or mild alpha 
thalassaemia minor; 
alpha+ thalassaemia trait. 
(-α/αα) 
Protection from 
severe malaria 
No haematological abnormality. Hb is 
either normal or slightly reduced. 
Homozygous alpha+ 
thalassaemia (-α/-α)  
Protection from 
severe malaria 
May be slightly anaemic. 
About 15% show slight reduction in 
MCV and MCH  
Heterozygous αo (--/αα)  No protection Hb is either normal or slightly reduced. 
MCV and MCH are usually reduced. 
Haemoglobin H Disease 
αo α+ double heterozygous 
(--/ -α)  
No protection Chronic haemolytic anemia  
Shortened RBC life span. Hb con. is 
between 7g/dL and 11g/dL but may be 
as low as 3-4gldl.Red cells are 
hypochromic and show variation in size 
and shape  
MCV and MCH are reduced. 
Reticulocytosis is slight except during 
acute haemolysis. Fluctuation in Hb. 
Basophilic stippling always seen 
Haemoglobin Bart‘s 
Hydrops fetalis or 
homozygous αo 
thalassaemia (--/--) 
No protection Marked microcytic hypochromic cells, 
poikilocytosis, fragmented cells and 
numerous nucleated red blood cells 
Adapted from Weatherall and Clegg, (2001) 
 
Evidence for the protection has come principally from population studies, 
epidemiological and case control studies but the suggestion that alpha+-
thalassaemia has been selected by malaria is mainly based on epidemiological 
studies (Allen et al., 1997).  
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Min-Oo and Gros (2005) have indicated evidence from micro-epidemiological 
studies to suggest proportional thalassaemic prevalence with incidence of malaria 
amongst populations of South Pacific regions. In the view of Sakai et al., (2000), a 
micro epidemiological study conducted in Nepal indicated that the high frequency 
(63%) of the -α3.7 deletional alpha+-thalassaemia recorded might be due to the 
biological adaptation to the malaria environment.  
 
For instance, Sickle cell trait has been documented, with a high degree of certainty, to 
provide up to 90% protection against death due to malaria (Hill et al., 1991). 
Hemoglobin C was also reported to have reduced the risk of severe malaria in the 
Dongo people of Mali by about 80% (Agarwal et al., 2000). 
The same, however, cannot be said for alpha+-thalassemia, at least not with the 
same degree of certainty.  
 
1.7.1 Protection of alpha
+
- thalassaemia from severe malaria 
Previous studies have expressed varied opinion on the protection from severe 
Plasmodium falciparum malaria by alpha
+
-thalassaemia. Initially, not only was it 
suggested that alpha
+
-thalassaemia offered no protection against death from 
malaria, it was even reported that alpha
+
-thalassaemia predisposes children to 
contracting mild malaria.  
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Williams et al., (1996) indicated that both the incidence of uncomplicated Plasmodium 
falciparum malaria, Plasmodium vivax malaria and the prevalence of splenomegaly 
(an index of malaria infection) were higher in alpha
+
-thalassaemic children compared 
to their normal counterparts.  
In the view of Allen et al the incidence of contracting mild malaria among Papua New 
Guineans in the first two years of life was increased among alpha
+
-thalassaemic 
children (Allen et al., 1997). In a previous study, Allen et al., (1993) suggested that 
heterozygous alpha
+
-thalassaemic children from the Gambia showed no protection 
from either asymptomatic Plasmodium falciparum parasitaemia or clinical episodes of 
malaria. 
Alpha
+
-thalassaemia has not been found to reduce the incidence of uncomplicated 
malaria, does not protect from malaria infection but predisposes to mild clinical 
malaria. The disease has been observed to limits the progression to severe 
malaria anaemia (William et al., 1996, 2005). In support of this observation 
Wambua et al., (2006) reported no association between alpha
+
-thalassaemia and 
the incidence of uncomplicated Plasmodium falciparum parasitaemia or parasite 
densities during mild or severe anaemia episodes.  
 
Mockenhaupt et al., (2001) also suggested that alpha
+
-thalassaemia predisposed 
Ghanaian pregnant women to Plasmodium malariae infection.  
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They observed that the prevalence of Plasmodium falciparum infection and parasite 
densities did not show any significant correlation with alpha-thalassaemia genotypes 
and that Plasmodium malariae tended to be more frequent in alpha
+
-thalassaemic 
women. Furthermore, the alpha
+
-thalassaemia genotypes in general, did not 
influence Plasmodium falciparum malaria infection, febrile parasitaemia or parasite 
density (Mockenhaupt et al., 2004a).   
 
Currently, there appears to be a common understanding that alpha+ -thalassaemia 
has an ameliorating impact on malaria. However, a seemingly contentious point is 
whether the observed protective effect of alpha+-thalassemia impinges upon 
malaria in general or only on some forms of the disease.  
 
On this particular question, there appears to be a high degree of unanimity among 
the Papua New Guinean, Ghanaian, and Kenyan studies in that they all seem to 
suggest that the protective effect is across-the-board for all forms of malaria (Allen 
et al., 1997; Mockenhaupt et al., 2004a; and Williams et al., 2005b). Subsequent 
studies in Kenya clearly conflicted with the Ghanaian report but agreed with the 
findings from Papua New Guinea (Williams et al., 2005b). Another Ghanaian study, 
while agreeing with the protection against Plasmodium falciparum malaria by 
alpha
+
-thalassemia, concluded that the ‗impact‘ was specific and driven by 
protection from severe anaemia, the most prevalent malaria complication, whereas 
no effect was observed on the other forms of severe malaria (May et al., 2005).  
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The protection conferred by alpha+thalassaemia is however, observed to be limited 
to the severe manifestation of Plasmodium falciparum malaria (Veenemans et al., 
(2008).  
 
1.7.2 Homozygous and/or heterozygous alpha
+
- thalassaemia protection from 
severe malaria 
There is an apparent disagreement between researchers as to the type of alpha+-
thalassaemia genotype, which provides the ‗ameliorating effect‘.  
 
In Papua New Guinea where alpha+-thalassaemia genotype is almost at 90% 
fixation, Allen et al., (1997) observed protection from severe Plasmodium falciparum 
malaria with 60% and 34% risk reduction in homozygous and heterozygous children 
respectively.  
Findings from a case control study in children living on the coast of Kenya had 
concluded that both heterozygous and homozygous alpha
+
-thalassemia protect 
against the lethal effects of malaria, though the said protection was more evident in 
subjects with homozygous alpha+-thalassemia (William et al., 2005). The risk for 
hospital death among these children was 40% lower in the heterozygous compared to 
60% for the homozygous alpha
+
-thalassaemia than in healthy children (William et al., 
2005).  
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Similar studies in Tamale, the northern part of Ghana, indicated that alpha+-
thalassaemias are associated with a reduced risk for severe and fatal Plasmodium 
falciparum malaria; however, this was only true for heterozygous alpha+-
thalassaemia, which occurred less frequently in severe malaria children 
(Mockenhaupt et al., 2004a). Homozygous alpha
+
-thalassaemia did not reduce the 
odds of Plasmodium falciparum malaria. The inability to detect protection in the 
homozygous alpha
+
-thalassaemia against Plasmodium falciparum malaria, as 
explained might be due to their small number and statistical limitations (Mockenhaupt 
et al., 2004a).   
In a previous study, Allen et al., (1993) suggested that heterozygous alpha
+
-
thalassaemic children from the Gambia showed no protection from either 
asymptomatic Plasmodium falciparum parasitaemia or clinical episodes of malaria. 
 
A subsequent study in Tanzania also reported a reduced risk of uncomplicated 
malaria episodes in children homozygous and heterozygous for alpha+-thalassaemia, 
and the protective effect of alpha+-thalassaemia was most pronounced in children 
older than 5 years of age (Enevold et al., 2008).  
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1.7.3 Mechanisms of protection from severe Plasmodium falciparum by 
alpha
+
-thalassaemia 
Unlike the sickle cell trait, studies so far have not been able to provide plausible 
mechanisms for the protection (Pasvol, 2006, Harteveld and Higgs, 2010).  
The protective mechanism of alpha+-thalassaemia however remains unclear.  
Other reports have suggested various forms of mechanisms through which alpha
+
-
thalassaemia individuals confer protection against Plasmodium falciparum malaria.  
Luzzi, et al., (1991a), suggested that the protective effect of alpha+-thalassaemia is 
due to modified antigen recognition on the surface of the parasitized erythrocyte, with 
a proposal by Williams et al., (1996), that the alpha+-thalassaemia may be associated 
with higher levels of Plasmodium vivax infection early in life which may have heighten 
immunological defences and provide better protection from more dangerous and 
subsequent Plasmodium falciparum infections. 
 
In vitro flow-cytometry studies have indicated that erythrocytes of the alpha+-
thalassaemia phenotype show reduced parasite growth and/or invasion rate 
(Pattanapanyasat, et al., 1999) and increased binding of antibodies from malaria-
immune sera (Williams, et al., 2002) including enhanced splenic clearance of malaria-
infected cells. Additionally, alpha+-thalassaemia RBCs age more quickly, due to 
oxidative stress when parasites breaks-down erythrocytes leading to membrane 
damage, increased phagocytosis and decreased parasite invasion (Yuthavong et al., 
1988; Destro-Bisol et al., 1999a; 1999b; Senok et al., 2006).  
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Furthermore, surface antigens on the RBC undergo conformational changes when 
the parasite enters the thalassaemic red cells and appear to bind increased amounts 
of immunoglobulin, which might favour early removal of parasitized red blood cells 
(Luzzi et al., 1991a; Pattanapanyasat et al., 1999; Destro-Bisol et al., 1999a, Destro-
Bisol et al., 1999b).  
Severe malaria results from pathophysiological processes that include the local and 
systemic release of various cytokines, anaemia, decreased red cell deformability, and 
adhesion phenomena such as sequestration and rosetting, and the clinical features of 
severe malaria (such as coma, acidosis, and hypovolemic shock) (Marsh et al., 1995). 
That alpha+-thalassaemia protects against this range of clinical manifestations of 
severe malaria suggests it does so through a mechanism that is central to many of 
these processes (Clark, et al., 2003). Cockburn et al., (2004) proposed that, a 
promoter polymorphism of red cell complement receptor 1 (CR1), an important 
receptor for rosetting, is significantly associated with protection from severe 
falciparum malaria.  
Alpha+thalassaemia is independently associated with reduced expression of red cell 
CR1 suggesting that by reducing the ability of red cells to form rosettes, alpha+-
thalassaemia patients, (both heterozygous and homozygous) are protected against 
severe malaria (Clark, et al., 2003, Williams, et al., 2005a). 
Imrie et al., (2004) suggested that the higher levels of haptoglobin in the homozygous 
individuals were toxic to Plasmodium falciparum in vitro.  
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Further studies by Imrie et al., (2006) indicated that the higher level of haptoglobin 
(Hp), in homozygous alpha+-thalassaemic individuals confers protection by removing 
free haemoglobin released during haemolysis. In providing an explanation to the 
unusually high level of haptoglobin in homozygous alpha+-thalassaemia, Imrie and 
colleagues indicated that these individuals experience fewer Plasmodium falciparum 
infections than the heterozygotes thus reducing the haemolysis and increasing the 
haptoglobin levels.  
Homozygous but not heterozygous alpha+-thalassaemia has been suggested to 
confer protection against the severe manifestation of Plasmodium falciparum 
parasitaemia (Fowkes et al., 2008). This observation was the outcome of a study 
conducted in Papua New Guinea, which indicated that the increased number of 
abnormally small erythrocytes (microcytosis) were associated with homozygous 
alpha+-thalassaemia that might be responsible for the protection against severe 
malarial anaemia (Fowkes et al., 2008). 
 
1.7.4 Alpha
+
 -thalassaemia, microcytosis, and Plasmodium falciparum malaria 
Alpha
+
-thalassaemia is characterized by hypochromic microcytic anaemia, occurs 
when there is a reduction in the synthesis of the alpha-globin chains of adult 
haemoglobin (HbA, α22) relative to -globin synthesis;
 excess -chains then form 
homotetramers (HbH, 4) (Higgs et al., 2001).  
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Microcytosis and hypochromia result from deficient haemoglobin (Hb) synthesis in 
erythroid cells, causing a reduction in both mean corpuscular volume (MCV) and 
mean corpuscular haemoglobin (MCH) of red blood cells.  
Compared to non-thalassaemias, heterozygote alpha
+
-thalassaemias do not present 
any clinical symptoms, whereas homozygote alpha
+
-thalassaemias are characterized 
by mild hypochromic microcytic anaemia (Imrie, 2006).  
 
The microcytic hypochromic anaemia observed in alpha
+
-thalassaemia could be due 
to iron deficiency resulting from an increased rate of haemolysis leading to a fall in 
plasma haptoglobin levels and the excretion of free haemoglobin in urine thereby 
reducing the body‘s iron stores (Imrie et al., 2006). 
 
Both iron deficiency and alpha
+
-thalassaemia can therefore cause microcytosis 
(Colah et al., 2010) however, iron deficiency remains the first cause of microcytosis 
whilst deletional αlpha
+
-thalassemia, the most frequent haemoglobinopathy 
throughout the world, represents the second most frequent cause of microcytosis 
followed by β-thalassemia heterozygous state. Without an increase in Hb A2 levels, 
these haematological alterations may be due to α-thalassaemia or iron deficiency 
(Borges, et al., 2001).  
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Ronald (2006) had suggested a careful three tier approach involving: (1) Full blood 
count (2) Special haematological tests and biochemical iron markers, followed by (3) 
DNA mutation analysis, that may provide the most effective way in which to detect 
primary gene mutations. For those with red cell microcytosis, a reliable measure of 
iron status is required (e.g. serum ferritin) to exclude iron deficiency (Vulliamy 2001). 
The red cell indices are suggested to be important indicators in the assessment of 
thalassaemia trait, which is characterized by microcytosis (Howard, 2005; Modell and 
Darlison, 2008). This is because microcytosis may be due to iron deficiency but also 
heterozygous or homozygous alpha
+
 -thalassaemia or alpha
0
-thalassaemia trait  
(Wonke et al., 2007, Eivazi-Ziaei et al., 2008). Low MCV (mean corpuscular volume) 
or MCH (mean corpuscular haemoglobin) might provide a clue for thalassaemia 
especially in regions at risk, and iron deficiency must be excluded as a first step 
(Bergstrome and Poon, 2002). 
 
Though the subject of alpha+-thalassaemia and anaemia in Africa is still to be fully 
understood, a study carried out in southwest Nigeria reported that alpha
+
-thalassemia 
contributes essentially to mild anaemia, microcytosis and hypochromasia 
(Mockenhaupt et al., 1999a). In another study, Rahim, (2008), found a considerable 
(20%) prevalence of alpha+-thalassaemia in microcytic hypochromic anaemic 
patients.  
Luzzi et al., (1990) indicated an unrestricted growth of Plasmodium falciparum in 
microcytic erythrocytes in alpha thalassaemia.  
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They explained that whilst morphological abnormalities may be detected in 
parasitized thalassaemic erythrocytes, development of Plasmodium falciparum in the 
condition is not limited by microcytic red blood cells.  
Later, Mockenhaupt et al., (1999b) observed that microcytosis was significantly 
associated with protection from haemoglobin decrease due to Plasmodium falciparum 
and that the rate of infection was lower in microcytic than in normocytic anaemia. 
Microcytosis has therefore been suggested to be responsible for the protection 
against severe malarial anaemia (Mockenhaupt et al., 1999b). 
Fowkes et al., (2008) corroborated this finding by indicating that the protection against 
severe malarial anaemia in homozygous alpha+-thalassaemia was driven by red cell 
microcytosis.  
 
 1.7.5   Iron deficiency and malaria in children 
Both iron deficiency and malaria are common in much of sub-Saharan Africa, and 
the interaction between these conditions is complex (Nyakeriga et al., 2004b).  
Iron-deficiency anaemia is also a major threat to maternal and child health. Overall, 
78 percent of Ghanaian children ages 6-59 months have some level of anaemia, 
including 23% of children who are mildly anaemic, 48% who are moderately 
anaemic, and 7% who are severely anaemic (Ghana Demographic Health Survey, 
2008). 
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Earlier reports by Hendrickse et al., (1989) on the effects on malaria of treating 
iron-deficiency anaemia with oral iron in Gambian children suggested that there 
was a significantly increased risk of fever associated with severe malarial 
parasitaemia for children with iron-deficiency anaemia when given iron. Iron 
chelators were suggested to inhibit malarial growth in vitro as well as in vivo 
(Hershko et al., 1988), and later reported cases of an in vitro study indicated that a 
small labile pool of iron in red cells (crucially smaller in iron deficiency) provided the 
iron the malaria parasite requires (Loyevsky et al., 1999).  
Cheesbrough (1999) then suggested iron as essential for the growth of 
Plasmodium falciparum and that higher levels in serum following treatment with 
iron were shown to increase the incidence of malaria  
In contrast, Tsedal et al., (2004) observed that low dose daily iron supplementation 
did not increase the prevalence of malaria infection or density of parasites in young 
Zanzibari children.  
However, recent observations from a study in Zanzibar, Tanzania (Sazawal et al., 
2006) indicated that oral iron-folic acid supplements might increase the risk of 
morbidity from malaria and/or the bacterial infections that complicate malaria in 
children below 3 years of age.  
The administration of iron parenterally or orally without food may increase plasma 
iron concentrations and transferrin saturation resulting in plasma iron exceeding 
the binding capacity of transferrin leading to the appearance of non transferrin-
bound iron (NTBI).  
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This is potentially toxic in promoting free radical formation and becoming readily 
available to pathogens (WHO, 2006). A further explanation by WHO is that iron 
deficiency may impair the immune response while an iron bolus increases the risk 
of forming potentially toxic NTBI.  
Iron-deficient children may then be protected from toxic effect of NTBI because iron 
is removed more rapidly from the plasma due to their higher tissue requirements 
for iron.  
Increase exposure to phosphatidylserine in individuals who were iron deficient and 
infected with Plasmodium falciparum have resulted in red cell death in humans 
(Koka et al., 2007).  With the reported in vitro impairment of intraerythrocytic growth 
and infection of erythrocytes, Koka et al., (2007), using mice models reported that 
iron deficiency influences the course of malaria in Plasmodium falciparum berghei 
infected mice by a decrease in parasitaemia and accelerated clearance of 
parasitized red cells. However in a cohort of children in coastal Kenya Nyakeriga et 
al., (2004b) had earlier reported that iron deficiency was associated with protection 
from mild clinical malaria. This they explained might be due to a complex 
interaction exists between the parasite, iron status and immune system of the 
individual.  
The immune response to malaria, as suggested by Sazawal et al., (2005), does not 
solely depend on access of the parasite to free plasma iron in the intraerythrocytic 
phase of infection.  
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In malaria-endemic areas, there is also some evidence that an elevated plasma 
zinc protoporphyrin/haem (ZPP/H) ratio may identify iron-deficient children (Labbe, 
1992) who will benefit from iron supplementation.  
This is due to the fact that there is incorporation of zinc into protoporphyrin instead 
of iron in iron deficiency.  
Iron deficiency, which results in decreased production of red blood cells, can 
therefore be said to offer some protection to the host against malaria (Rodak 2002, 
Cromer et al., 2009) 
 
1.8 Aims of the research 
The aim of this study was to test the hypothesis that the protective effect of alpha+-
thalassaemia against Plasmodium falciparum parasitaemia is driven by microcytosis 
and hypochromasia that might result in reduced parasites density.  
1.8.1 Specific aim 1 
This study would attempt to establish whether the heterozygous, homozygous or both 
alpha+ globin genotypes confer protection from severe malarial parasitaemia 
 1.8.2 Hypothesis 1 
That both homozygous and heterozygous alpha+-thalassaemia genotypes   
are protected from Plasmodium falciparum parasitaemia.  
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1.8.3 Specific aim 2 
To determine the effects of microcytosis and hypochromasia in protecting alpha+-
thalassaemia and non thalassaemia patients from severe Plasmodium falciparum 
malaria and the relationship between MCV and geometric mean parasite 
density (GMPD) 
 
1.8.4 Hypothesis 2 
That microcytosis and hypochromasia are responsible for protection from severe 
malaria amongst alpha+ thalassaemia and non-alpha thalassaemias 
 
1.9 Objectives 
 To estimate G6PD deficiency, HbC and HbAS frequency in subjects, in order to 
exclude them from the analysis, as these confounding factors protect against 
Plasmodium falciparum malaria  
 To estimate the mean parasite density in subjects and compare with microcytic 
and normocytic, and hypochromic and normochromic children 
 Characterise the genotype specific protection from severe Plasmodium falciparum 
malaria 
 Determine whether the protective effect of alpha+thalassaemia from Plasmodium 
falciparum wane with age 
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2.0 Materials, subjects, and methods 
2.1 Location of Project and Subject Population 
Subjects were patients already attending the polyclinic out patient department at 
Komfo Anokye Teaching Hospital (KATH) as well as the children hospital at 
Manhyia where their blood samples were already being collected for medical 
care. Samples were analyzed at the KATH and the Kumasi Center for 
Collaborative Research in Tropical Medicine (KCCR). Both institutions are located 
in Kumasi – the second largest and fastest growing city in Ghana, with a 
projected population of about 645,100 (Ghana Statistical Service, 2010). KATH is 
a major tertiary referral Hospital in Ashanti region, while KCCR is a major 
research facility within the College of Health Science of the Kwame Nkrumah 
University of Science and Technology. In Kumasi ethnic Akans, make up 77.7% 
of the population, while other smaller groups, including, but not limited to, the 
Mole-Dagbon (9.1%), Ewe (2.9%), and Grusi (2.9%), account for the rest. One 
thousand six hundred and seventy-two (1672) children, aged ≤10 years, were 
recruited as subjects for this study. Seven hundred and thirty-two (732) cases that 
tested positive to Plasmodium falciparum malaria were enrolled.  
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2.2 Study Management 
The Investigator, Clement Opoku-Okrah, managed the study locally with Prof. Tsiri 
Agbenyega the local supervisor who constituted the Local Steering Committee that 
oversaw the day-to-day conduct of the study, whilst Dr. Caroline Smith, Dr., Mike 
Gordge, and Dr. Martin Parry constituted the external supervisors. Dr. Caroline 
Smith however visited Ghana to monitor the progress of the project. The Local 
Steering Committee met monthly  
 
2.3 Ethical Consent 
Ethical clearance was obtained, from the Committee on Human Research 
Publication and Ethics, School of Medical Sciences, Kwame Nkrumah University 
of Science and Technology, Kumasi, Ghana (Approval letter: 
CHRPE/KNUST/KATH/12_03_09), Approval was given by the University of 
Westminster-Ethical Committee (Application number- 08/09/14) for all 
experimental works (refer to appendix 5). Subjects were patients already attending 
the polyclinic out patient department of the Komfo Anokye Teaching Hospital 
(KATH) as well as the children hospital at Manhyia, all in Kumasi, Ghana, at where 
their blood samples were already being collected for medical care. Blood samples 
were collected from the subjects only after an informed consent was given by their 
parents/guardians.  
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2.4 Informed consent 
 Parents were duly informed about the research and their involvement in the study 
was purely voluntary. Informed consent were sought from mothers before samples 
were taken. 
 
2.5 Inclusion Criteria   
Children with proven malaria within the specified age group, and whose parents 
had consented, were included in the study. Subjects were not more than 10 years 
of age at enrolment. The problem of malaria infection is most critical for children 
less than five years of age.  
 
2.6 Exclusion Criteria 
Children with other serious chronic disease were excluded because their illness 
may confound the results obtained for this study. Those whose parents did not 
consent, or those older than 10 years old, were not included either. In addition, 
children that were known to have HIV/AIDS and whose clinical conditions 
(HIV/AIDS and Hepatitis B) were indicated on their request form were exempted 
before sampling, although their HIV/AIDS could not possibly have influenced 
tests.  
2.7 Risk 
There is no inherent major risk to the subjects. Blood sampling by venepuncture for 
tests may cause bruising, infection, fainting, pain, or discomfort.  
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The pain of blood sampling by venepuncture is minimal but is real and 
unfortunately an unavoidable part of health care.  
All normal precautions were taken to keep these side effects from happening. 4mls 
of blood was taken from each child. 
 
2.8 Sample collection and experimental approach 
Haematological and parasitological tests were performed within 24 hours of 
collecting blood sample for malaria parasite density, complete blood count, 
Glucose-6-phosphate dehydrogenase (G6PD) screening and Hb electrophoresis. 
The rest of the sample was stored at -20 oC for the determination of alpha globin 
genotype.  
Samples were collected between May 2009 and July 2011. The nature of the study 
was explained to the parents/guardians of the sequential patients and their 
child/ward‘s participation enlisted. With informed consent, 4 ml of blood was 
collected into ethylenediamine tetra-acetic acid (EDTA) through venipuncture.  
Three milliliters of blood was put into the one tube for the purpose of the malaria 
parasite test, complete blood count (CBC), and the ferritin tests, while the remaining 
1 ml was placed into a second tube to be used exclusively for the polymerase chain 
reaction (PCR). After the blood was collected, details like the age, sex, and location 
were also recorded to help with the analysis of the data. Blood samples were placed 
in an ice-chest and taken to the main haematology laboratory at KATH for 
immediate testing. The tests done at KATH include malaria parasite test, CBC, and 
the ferritin test.  
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The samples that were set-aside for the PCR were then transported to the Kumasi 
Center for Collaborative Research in tropical Medicine, where DNA was extracted 
and genotypes determined by Single-Tube Multiplex PCR method (Chong et al., 
2000) 
2.81. Parasitological studies 
2.8.1.1 Experimental approach by Giemsa staining technique for Plasmodium 
falciparum parasitaemia 
The asexual form of Plasmodium falciparum, which is the predominant 
Plasmodium species, found in Ghana was tested. The malaria parasite test was 
carried out within 45 minutes of sample collection. Thick and thin blood films were 
prepared for all the 1672 samples, using clean and grease-free slides and labelled 
in accordance with the recommendations of Agomo et al., (2001).  
Both films were stained with 10% Giemsa (pH 7.2) and read for malaria parasites 
following standard, quality-controlled procedures (WHO, 2009) where thin and thick 
blood films of each sample were applied on a single pre-cleaned slide. Fixation of 
thin blood films was done with methanol and thin and thick blood films were stained 
with 10% Giemsa at pH 7.2 .The stained slides were examined using a light 
microscope with x100 oil immersion objective for Plasmodium falciparum 
trophozoites (Figure 2.1) 
The results were initially recorded as either positive (+ve) or negative (-ve). Malaria 
parasites density was determined on all positive cases.  
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Using thick film, 200 WBC were counted and the number (N), of parasite seen 
noted. Two hundred (200) WBC then divides the N and then the value multiplied by 
the WBC count of the subject or WHO standard for WBC, which is 8000/µL.  
In this study the RBC count or the total WBC count of the subjects was used to 
calculate the parasite density. The WHO standard for WBC was not used as it is 
meant for facilities that did not have equipment for estimating the total WBC count. 
 
Using the thin film, 1000 RBC‘s were counted and the number of parasitized RBC‘s 
counted along side simultaneously. The total number of parasitized red cells is 
then divided by 1000 and the value multiplied by the RBC count of the subject to 
get the parasite density. 
Parasitaemia was expressed as the number of asexual forms of the malaria 
parasites per microliter. It was graded as low (1-999/μL), moderate (1000-
9999/μL), high (10000-99999/μL) and severe (≥ 10000/μL). 
An independent parasitologist at the Malaria Research Laboratory at KATH further 
read malaria slides that were initially negative for malaria parasites. Twelve of the 
slides with no malaria parasites seen were however reported as positive by the 
independent parasitologist. No positive slides were sent for independent 
confirmation, as these were very clear on both the thin or thick film. 
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Figure 2.1 Trophozoite of Plasmodium falciparum in affected red blood cell in A-thin film 
and B-thick film x100 
 
 
 
 
 
 
 
Ring form of 
Plasmodium 
falciparum 
Gametocyte 
  Chapter 2 Materials and Methods 
 
 
 90 
2.8.2 Haematological studies 
2.8.2.1 Experimental approach for glucose-6-phospate dehydrogenase 
(G6PD) screening by methaemoglobin reductase method 
The oxidation of haemoglobin to methaemoglobin by sodium nitrite and the 
subsequent enzymatic reconversion to haemoglobin in the presence of methylene 
blue was determined by the Methaemoglobin Reductase Method for G6PD 
screening (Brewer et al., 1962; Bhasin and Chahal 1996).  
The test was set up within 30 minutes after blood sample has been taken. Samples 
that could not be worked on were kept at 4OC but were tested within 6 hours. Two 
millilitres of blood sample was placed in a test tube and 0.1 ml of 0.18 M sodium 
nitrite solution added followed by 0.1 ml of 0.0004 M methylene blue chloride 
solution.  
The test was controlled for full defect, partial defect and no defect using known 
samples. Both test and control were incubated at 37oC for 3 hours. Aeration was 
ensured at 60, 120 and 180 minutes during incubation.  
After incubation, 0.1 ml each of the test sample and the controls were pipetted into 
10 ml distilled water in separate clean glass test tubes of identical diameter. The 
contents were mixed gently and the colours observed and compared (Figure 2.2) 
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Figure 2.2 Glucose-6-phosphate dehydrogenase (G6PD) deficient testing by 
methaemoglobin reductase method. 
A- Positive control; B-full defect; C-partial defect and D- no defect 
 
No defect or normal sample was clear red 
Heterozygous female was light dark grey or light brown.  
Hemizygous males or homozygous female was dark grey or brown. 
 
 
 
A B 
C 
D 
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2.8.2.2 Experimental approach for the determination of -globin genotypes by 
alkaline cellulose acetate Hb electrophoresis  
Haemoglobin AS (HbAS) and haemoglobin AC (HbAC) trait individuals are 
protected from the effect of severe malaria. They are serious confounders in 
epidemiological studies of αlpha+-thalassaemia in Africa, and needed to be 
excluded (William et al., 2005c, Wambua et al., 2006). Beta thalassaemia was 
excluded because facility for identifying the disease was not available at the time of 
this study. 
The phenotypes were determined using the cellulose acetate method (Kohn et al., 
1969) by alkaline haemoglobin electrophoresis (Helena, Sunderland, and Tyne & 
Wear). The Titan

 Cellulose Acetate membrane (76 mm x 60 mm) was soaked in 
distilled water, blotted then soaked in the Tris-EDTA-borate. Haemolysate was 
prepared by adding 0.005M EDTA in deionized water with 0.07% potassium 
cyanide to whole blood, and was applied to the Titan III

 Cellulose Acetate Plate. 
The haemoglobin electrophoresis was performed at 350 volts for 25 minutes using 
an alkaline buffer (pH 8.2-8.6) and were stained with (0.5% (w/v) Ponceau S in an 
aqueous solution of 10% (w/v) sulfosalicylic acid and the migration of the 
haemoglobin noted. Control sample containing haemoglobins A, F, S and C were 
included with each electrophoresis run (Figure 2.3) 
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Figure 2.3: Haemoglobin electrophoresis by cellulose acetate method at pH 8.6 
showing haemoglobin A, haemoglobin AS (sickle cell trait), haemoglobin S, 
haemoglobin C and haemoglobin F. Haemoglobins AFSC were pooled together 
and used as control. The arrow shows the migration of negatively charged 
haemoglobins from the cathode to the positively charged anode. 
 
 
2.8.2.3 Experimental approach for complete blood count (CBC) 
To determine the level of anaemia, haemoglobin (Hb), mean cell volume (MCV), 
mean cell haemoglobin (MCH), and red cell count (RBC) counts were estimated 
using Cell-Dyn® 3500 (Abbott Diagnostics, USA). Samples with Hb level ≤5.0g/dL 
were considered as severe anaemia cases.  
Microcytosis is defined in this study as MCV ≤ 76 fL and hypochromasia as MCH ≤ 
25 pg were used to exclude microcytosis and hypochromasia. These values are 
established cut-off values in use for children at the Komfo Anokye Teaching 
Hospital of Kumasi, Ghana. 
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2.8.3 Alpha globin genotyping 
2.8.3.1 Experimental approach for alpha globin genotyping by polymerase 
chain reaction (PCR) 
The characterization of the -α 3.7 kb deletional α+- thalassaemia (heterozygous, 
homozygous and wild type) were determined by DNA analysis of each deletion 
breakpoint using the single-tube -PCR assay that allowed a high throughput 
genetic screening for these common haematological disorders (Chong et al., 2000.  
Genomic DNA was extracted strictly in compliance with the protocol described in 
the QIAamp DNA Blood Mini kit Handbook (2003). Sample was incubated at room 
temperature and 20 µL of Proteinase K (a lysis enzyme) added, followed by the 
addition of 200 μL of blood sample and 200 µL of Lysing buffer (buffer AL) then, 
200 μL of ethanol (96-100%). 500 μL Residual washing buffer 1 (Buffer AW1) was 
added followed by 500 μL Residual washing buffer 2 (Buffer AW2) and finally 200 
μL Elution buffer (Buffer AE) added, and an elute of genomic DNA collected and 
stored at -20 OC. 
Following the extraction of the DNA, each DNA sample was amplified using a 
Thermal Cycler (Eppendorf, Germany). Along with the test sample, each PCR run 
included three positive control DNAs, Homozygous (mutant) DNA (64 ng/µL), 
normal genotype (wild type) DNA (71 ng/µL), and heterozygote DNA (105 ng/µL)) 
and a negative control of aqua ad injectabilia. The total reaction volume was 50 μL 
in adherence to the protocol of Chong et al., (2000).  
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The primers used in the PCR to amplify the 1800bp and the 2000bp for the 
heterozygous, homozygous and normal genotypes are the α
2
/3.7-F 5‘ 
CCCCTCGCCAAGTCCACCC 3‘, 3.7-R 5‘ CCCCTCGCCAAGTCCACCC 3‘ and 
α2-R 5‘ AGACCAGGAAGGGCCGGTG 3‘ 
Each 50-µl-reaction master mix tube contained 5 μL 10 x PCR buffer (QIAGEN), 10 
μL of Q-solution 5 x (QIAGEN), 1 μL of 1 forward primer 
2
/3.7-F (10 pmol/µL), 2 
μL of 1 reverse primer 
3.7
-R (10 pmol/μL) (MWG-Biotech AG),1 μL of 2 reverse 
primer 
2
-R (10 pmol/μL) (MWG-Biotech AG), 1 μL of dNTPs (10 mM each), 0.25 
μL of Taq polymerase (5 U/μL) (QIAGEN), 1 μL of DNA template, and 28.75 μL of 
aqua ad injectabilia. The amplification conditions were as follows: 5 minutes of 
initial denaturation at   95 oC, followed by 40 cycles of 45 seconds denaturation at 
95 oC, 1 minute 15 seconds annealing at 57 oC and 2 minutes 30 seconds of 
extension at 72 oC, and a 10 minutes final extension at 72 oC. It was then held at   
8 oC. Following amplification 10 µL of each amplicon and 10 μL of the 100 bp 
ladder were electrophoresed through 1.5% agarose gel 1x TBE gel at 80 volts for 
about 45 minutes, stained in ethidium bromide, visualized using an ultraviolet 
transilluminator (KW 245) attached to a monitor. The images were then printed out 
on a black and white Polaroid film (Figure 2.4). The individual bands were then 
compared with the positive controls, and the different genotypes determined. The 
extent of deletion was confirmed by comparing the bands with the 100 base pair 
(bp) DNA ladder.  
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Along the 100 bp DNA ladder, the 1800 bp point was the normal genotype (wild 
type), the 2000 bp was the homozygous (mutant) type, while the heterozygote form 
was comprised of two strands, one of the 1800 bp, while the other was of the 2000 
bp. The results were thus reported as Normal genotype (αα/αα), Homozygous (-α/-
α), and Heterozygote (-α/αα). 
 
Figure 2.4: Ethidium bromide-stained gels showing results from multiplex PCR for 
the 3.7 thalassaemia. Sizes of the amplified fragments are given in base pair (bp). 
Lane L is the 100 bp DNA; M- Mutant (2000 bp); H – Heterozygote (1800 bp and 
2000 bp); W- Wildtype or normal genotype (1800 bp); N- Negative 
 
 
 
 
 
        
    2000 bp      
    1800 bp 
L      W       M      H       N       W     N       H      W      M     M 
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2.9 Statistical analysis  
All data were entered in Microsoft excel and were analysed using SPSS 17 (IBM 
Corporation, New York, USA). Statistical analyses for variables that were not 
normally distributed were handled by the Shapiro Wilks W test to identify those with 
skewness after which they were log transformed to better meet the assumptions of 
hypothesis testing. The prevalence and frequency distribution of the haemoglobin 
phenotypes, G6PD deficiency and alpha+ thalassaemia for gender and malaria 
parasitaemia were summarized by descriptive analysis.  
Geometric Mean Parasite Density (GMPD) was determined after the log 
transformation of the mean malaria parasite density.  
The differences between haemoglobin, RBC, MCV, MCH and GMPD by 
normocytic and microcytic, hypochromic and normochromic and the alpha+ 
thalassaemia genotype children were determined by one-way ANOVA. Post-hoc 
test were performed using the Tukey for multiple comparisons. The strength in the 
relationship between GMPD and MCV, MCH, RBC and haemoglobin levels was 
determined by Pearson correlation coefficient. Significance was estimated by 95% 
confidence interval (p< 0.05) 
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Chapter 3 
 
3.0 Baseline characteristics of study population 
 
3.1 Introduction 
 
Some red blood group polymorphisms are known to confer resistance against severe 
malaria infection. However, the theory of balance selection for the sickle cell trait, 
Glucose-6-phosphate dehydrogenase (G6PD), haemoglobin AC (HbAC), and other 
blood group genotypes appear to be substantiated, there is still the need to determine 
the prevalence of these RBC polymorphisms to Plasmodium falciparum malaria. 
 G6PD deficiency is the most common human enzymeopathy in the world (Ruwende 
and Hill, 1998) and mutations in the gene are varied between populations with 
epidemiological studies supporting associations between malaria resistance and 
deficiency of the enzyme (Mehta et al., 2000; Aidoo et al., 2002).  
The Africa type (G6PD A-) has however been indicated to confer protection against 
malaria in male but not female children who have just one abnormal G6PD gene, and 
against cerebral malaria (Guindo et al., 2007) as well as providing protection in 
pregnancy of heterozygous deficient women (Mockenhaupt et al., 2003). Some 
mechanisms have been suggested to drive this protection, which includes inhibition of 
parasite multiplication by oxidized toxic substances in infected red blood cells that 
make them susceptible to phagocytosis or haemolysis (Cappadoro, et al., 1998; Miller 
et al., 1984; Golenser et al., 1988).  
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The susceptibility of the G6PD patient red blood cells to phagocytosis by peripheral 
blood monocytes and the increased binding of IgG and complement C3 to infected red 
cells have been suggested to confer protection against severe malaria (Schwarzer et 
al., 1992). A few studies in Ghana have reported various rates of prevalence of G6PD 
deficiency (Allison et al., 1961, Lewis et al., 1965, Acquaye et al., 1973, Burchard et 
al., 2001, Baird et al., 2002). Current studies have suggested prevalence rates of 
8.33% in the northern part of Ghana (Baird et al., 2002), 19.0% in the middle belt of 
Ghana (Amoako et al., 2010, personal communication) and 30.4% and 2.6% 
heterozygous and homozygous G6PD deficient pregnant women in the Ashanti region 
of Ghana respectively (Mockenhaupt et al., 2003). 
Africa‘s burden of sickle cell disease is about 200,000 out of a projected annual world 
population of about 300,000 (WHO 2006). About 70% of the sickle cell anaemia (SCA) 
occurs in sub- Saharan Africa where recent reports suggest that 50% to 80% of 
affected children die annually (Makani et al., 2009).  
Current estimates suggest that the frequency of the sickle-cell trait (HbAS) in Ghana 
and Nigeria is 15% and 30% respectively (WHO 2006).  
In Ghana, the newborn screening for sickle-cell disease, which started in February 
1995 in the Ashanti region of Ghana, had by December 2011 screened 345,861 
infants. Prevalence for sickle cell disease (SCD) was 1.9%, haemoglobin FS (HbFS), 
1.0%, haemoglobin FSC (HbFSC), 0.8% and 0.008% for haemoglobin SA (HbFSA). 
Prevalence for haemoglobin FAS (HbFAS) was 13.3%, haemoglobin FA (HbFA), 
75.6% and haemoglobin FAC (HbFAC), 8.9% (Ohene-Frempong 2012, Unpublished 
data).  
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Mockenhaupt et al., (2000) observed a 14% prevalence of HbAS, 7% of HbAC and 1% 
of HbSS in pregnant Ghanaian women. Amoako et al., (2010) (personal 
communication) had reported a 9.2% prevalence of HbAS amongst children in the 
Kintampo North Municipality of Ghana.  A recent study involving a cohort of children in 
the Ashanti region of Ghana however, reported a 10.9% prevalence of HbAS (Kreuels 
et al., 2010). Sickle cell disease has been described as a double–edged sword with 
evidence suggesting that those with the sickle cell trait (HbAS) are protected against 
malaria whilst those with HbSS not only suffer severe health problems but also 
generally die from malaria (McAuley et al., 2010). HbAS individuals are not only 
protected against the severe effects of malaria due to an early and enhanced 
acquisition of protective immunity (Aluoch 1997), they also enjoy significant protection 
against severe malarial anaemia, and high-density parasitaemia (Aidoo et al., 2002). 
Contrary to other observations the homozygous sickle-cell state (HbSS) and the sickle 
cell trait (HbAS) were significantly associated with reduced risks of high-density 
parasitaemia (>10,000 parasite/µL) Aidoo et al., (2002) and lower parasite rate than 
compared to Hb AA.  
This observation by Aidoo and his co-workers did not support earlier suggestions by 
Mockenhaupt et al., (2000) who reported a higher malaria parasite density in pregnant 
Ghanaian women with HbAS than those with Hb AA.  
HbC is commonly found in the hyperendemic malaria region of West Africa and the 
mutation presents with mild haematological symptoms in the homozygous state 
(Robert et al., 2004).  
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Very few studies have reported the prevalence of HbAC in Ghana. Kreuels et al., 
(2010) reported a 10.5% prevalence of HbAC in a cohort of children in the Ashanti 
region of Ghana.  
HbC has been suggested to reduce the risk of developing severe Plasmodium 
falciparum by 80% in the Dogon people of Mali (Agarwal, et al., 2000) and 29% and 
93% reduction among Burkinabe population who were HbAC and HbCC respectively 
(Modiano et al., 2001). In Ghana, a risk reduction of 47% had been reported 
(Mockenhaupt et al., 2004 a) among the people of Tamale. These findings therefore 
suggest a protective effect against Plasmodium falciparum for heterozygous and 
homozygous HbC in certain populations of West Africa. 
However, among the people of Agogo in the Ashanti region of Ghana, (Kreuels et al., 
2010) did not observed protective effect against uncomplicated Plasmodium 
falciparum malaria in HbC children suggesting that population-specific factors, 
including differences in genetic background, may have a strong influence on the 
distributions of haemoglobinopathies in malarious regions.  
The objectives of this study were: 
 To estimate in a cohort of children from Kumasi metropolitan area   
o The prevalence of erythrocyte polymorphisms  
o The prevalence of G6PD  
o The prevalence of alpha+ thalassaemia   
o The prevalence of Plasmodium falciparum parasitaemia  
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3.2 Subject populations and experimental approach  
Participant recruitment and blood sample collection followed the procedure described in 
section 2.1 of chapter 2  
Enrolled Subjects     
Mps +ve and non- 
confounders (n=732) 
Screened Subjects (n=1672) 
Mps+ve	(904);	 Mps +ve (n=904)  Mps –ve (n=768) 
Mps-ve and Mps +ve, confounders (n=940) 
 
Hb AS (n=123) 
Mps-ve (79) 
Mps +ve (44) 
 
HbAC (n=147) 
Mps –ve (68) 
Mps +ve (79) 
G6PD 
deficiency         
n=102)              
Mps –ve (40)   
Mps	+ve	(62) 
No Mps (n=768).   
Some already 
included in Hb 
AS, Hb AC and 
G6PD deficiency Mean																																								
Hb														RBC        MCV																																									
MCH         GMPD 
Normal Genotype (αα/αα)  
(n=358) 
Alpha+ thalassaemia 
(n=175) 
Homozygous (-α/-α) 
(n=49) 
Heterozygous (-α/αα) 
(n=126) 
PCR 
 
Microcytic																
(MCV	£	76	fL)	
Hypochromic										
(MCH	£	25	pg)  (n=	238) 
Normocytic 														
(MCV	>	76	fL)	
Normochromic										
(MCH	>	25	pg) (n=114) 
Microcytic																
(MCV	£	76	fL)	
Normochromic										
(MCH	>	25	pg)  (n=	351) 
Normocytic 															
(MCV	>	76	fL)	
Hypochromic 									
(MCH	£	25	pg) (n=	29) 
No	Amplifica on 
(n=56).		
 
Study 
Population 
Study population 
 
Figure 3.1: Flow diagram of study population, eligibility, confounders and tests used. Hb-
haemoglobin, RBC- red blood cell, MCV- mean cell volume, MCH-Mean haemoglobin 
concentration, HbAS-haemoglobin AS, HbAC- haemoglobin AC, GMPD-geometric mean 
parasite density; α/αα, heterozygous alpha +- thalassaemia; -α/-α, homozygous alpha+-
thalassaemia; αα/αα, normal or wild type alpha +- thalassaemia. n is number of subjects. 
Mps refer to malaria parasite (+ve is positive and –ve is negative). PCR is polymerase 
chain reaction. Only children who were microcytic were tested for alpha 
thalassaemia 
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3.3 Experimental protocol 
3.3.1 Assessment of Plasmodium falciparum malaria  
Malaria parasite density was determined using the thick and thin blood films by the 
microscopic method. This followed the experimental procedure as describe in section 
2.8.1.1 
 
 
3.3.2 Evaluation of G6PD activity by the Methaemoglobin Reductase Method 
G6PD deficient individuals are also protected from the effect of severe malaria, and could 
be a serious confounder and therefore need to be excluded. Tests were performed within 
30 minutes after sample collection as indicated in the experimental procedures in section 
2.8.2.1 
   
3.3.3 Determination of -globin phenotypes by Alkaline Cellulose Acetate Hb 
Electrophoresis  
The phenotypes were determined using the cellulose acetate method at pH 8.6 (Kohn et 
al., 1969) by alkaline haemoglobin electrophoresis (Helena, Sunderland, and Tyne & 
Wear). The subjects‘ red cell haemolysate were prepared and haemoglobin 
electrophoresis done as indicated in the experimental procedure in section 2.8.2.2.  
3.3.4 Polymerase chain reaction (PCR) 
Genomic DNA was extracted strictly in compliance with the protocol described in the 
QIAamp DNA Blood Mini kit Handbook (2003). The characterization of the α 3.7 kb α+- 
thalassaemia (heterozygous, homozygous and wild type) was determined by DNA 
analysis (Chong et al., 2000) as explained in section 2.8.3.1 of the experimental protocol.  
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3.4 Statistical analysis  
All data were entered in Microsoft excel and were analysed using SPSS 17 (IBM 
Corporation, New York, USA)..  
The prevalence and frequency distribution of the haemoglobin phenotypes, G6PD 
deficiency and alpha+ thalassaemia for gender and malaria parasitaemia were 
summarized by descriptive analysis. All confounders based on haemoglobin genotypes, 
G6PD deficiency and malaria parasite negative were analysed and excluded from further 
analysis. 
 
 
3.5 RESULTS 
 
One thousand six hundred and seventy-two (1672) children of mean age 51.2 months 
(range, 1-120 months) were screened. Initial screening of subjects was performed to 
exclude G6PD deficiency (Table 3.1), Hb AS and Hb AC (Table 3.2) individuals who are 
known to be protected from the effect of severe malaria and are serious confounders in 
epidemiological studies of alpha+-thalassaemia in Africa and therefore were not enrolled 
into the study. Plasmodium falciparum parasitaemia was not seen in 768 (45.9%) of the 
children tested, whilst 904 (54.I %) of the children tested positive for Plasmodium 
falciparum parasitaemia out of which 732 were enrolled. These excluded confounders 
who were also positive for parasitaemia. All malaria positive children were tested for 
haemoglobin level; RBC count, MCV, MCH and geometric mean parasite density 
(GMPD) was determined.  
MCV (cut-off ≤ 76 fL) was used to discriminate microcytic (589/732) from normocytic 
(143/732) subjects and MCH (cut-off ≤ 25 pg) used to distinguish hypochromic (267/732) 
from normochromic (465/732) children (Figure 3.1). 
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All microcytic children were subjected to -globin genotyping by PCR of which 358 were 
normal genotypes, 49 homozygous alpha+-thalassaemia and 126 heterozygous alpha+-
thalassaemia. Fifty-six of the subjects did not show any amplification for PCR (Figure 3.1) 
and were therefore excluded from further analysis. 
 
3.5.1 Frequency distribution of erythrocyte polymorphisms 
 
Glucose-6-phosphate dehydrogenase (G6PD) deficiency was present in 6.1% of the 
children (Table 3.1).  
The frequency of Hb AS (sickle-cell trait) was 7.4 % and the homozygous for HbS was 
4.9%. Hb AA also recorded a frequency of 74.4%, whilst the frequency for HbAC was 
8.8% (Table 3.2). Alpha+-thalassaemia recorded a frequency of 21.0% for the 
heterozygous (-α/αα), 8.3% for the homozygous (mutant -α/-α), resulting in a carriage 
rate (α/αα & -α/-α) of 29.3% (Table 3.3; Figure 3.6). The frequency of Plasmodium 
falciparum parasitaemia was 54.1%. 
 
Table 3.1 Baseline characteristics of G6PD deficiency  
  
Number 
 
% 
Gender 
(n, % whole sample) 
Malaria Parasite  
 (n, % whole sample) 
Male  Female  +ve -ve 
G6PD       
        Normal 1570 93.9 53.7 40.2 842 (50.4) 728 (43.5) 
 
       Full Defect 92  5.5 3.3 2.2 56 (3.3) 36 (2.2) 
 
      Partial Defect 10 0.6 0.2 0.4 6 (0.4) 4 (0.2) 
 
G6PD is glucose-6-phosphate dehydrogenase. Mps +ve is malaria parasite positive and 
mps-ve is malaria parasite negative 
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Table 3.2:  Baseline characteristics of β-globin polymorphism 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Hb AA-homozygous wild type genotype for -globin; HbAC- heterozygous 
haemoglobin C; HbAS- heterozygous sickle cell haemoglobin; HbCC- homozygous 
haemoglobin C; HbSC- haemoglobin C disease; Hb SS- homozygous for sickle cell 
disease; G-6-PD- Glucose-6-phosphate dehydrogenase. Mps +ve is malaria parasite 
positive and mps-ve is malaria parasite negative. Haemoglobinopathies other than 
HbAS and HbAC were included in the study because they are not known to protect 
against severe malaria. 
 Number (%) Gender 
(n, % whole sample) 
Malaria Parasite 
(n, % whole sample) 
Male Female  +ve       -ve 
Hb AA 1247 
 
74.6  42.8 31.8 716 (42.8) 531(31.8) 
Hb AS 123 
 
7.4 4.7 2.7 43(2.5) 80(4.8) 
Hb AC 147 
 
8.8 5.3 3.5 79(4.7) 68(4.1) 
Hb SS 82 
 
4.9 2.6 2.3 38(2.3) 44(2.6) 
Hb SC 20 
 
1.2 0.7 0.5 7(0.4) 13(0.8) 
Hb CC 1 
 
0.1 0.1 0 0 1(0.1) 
Hb AF 44 
 
2.6 0.9 1.7 21(1.3) 23(1.4) 
Hb SF 4 
 
0.2 0.1 0.2 1(0.1) 3(0.2) 
Hb AD 2 
 
0.1 0 0.1 0 2(0.1) 
Hb AFC 2 
 
0.1 0.1 0 0 1(0.1) 
Hb ASF 3 
 
0.2 0.2 0 0 3(0.2) 
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Table 3.3 Baseline characteristics of α-globin polymorphism 
 
Alpha+-
thalassaemia 
 
Numb
er 
Gender Malaria Parasite  
 (n, % mps+ve sample) (n, % mps+ve sample) 
Male     Female +ve -ve 
      αα/αα 358  34.6       25.7 60.8 - 
 
      -α/αα 126  11.2       9.8 21.4 - 
 
      -α/-α 49   3.7       4.6 8.3 - 
 
No amplification  56      9.5 - 
 
Note: -α/αα is heterozygous alpha +- thalassaemia; -α/-α is homozygous alpha+-
thalassaemia. Mps +ve is malaria parasite positive and mps-ve is malaria parasite 
negative 
 
Figure 3.6: Distribution of Plasmodium falciparum malaria in alpha+- thalassaemia 
 
 
 
  Count 
(mps/µL) 
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3.6 DISCUSSION 
 
The results from this study show that the incidence of malaria infection in the subject 
population of 1672 children of mean age 51.2 months (range, 1-120 months) is 54.1% 
indicating that malaria is hyper-endemic in Ghana.  
Hitherto, the malaria disease had been considered primarily as a disease of the rural 
settings, and report by Abdul-Aziz (2006) suggesting approximately 60% of all malaria 
cases occur among the poorest 20% of the world‘s population. 
Kumasi, however, is an urban settlement in Ghana, and the prevalence rate recorded in 
this study lends credence to the assertion by Donnelly et al., (2005) that malaria 
currently presents a leading cause of morbidity and mortality among urban African 
populations and as indicated by the UNDP report the current rapid growth rate of 3.5% 
of urban populations in Africa could result in about 50% of African population migrating 
to urban areas by 2025 (UNPP, 2005).  
Previous studies have recorded a prevalence of 8.6% in Accra, the national capital 
(Klinkenberg et al., 2006), and 13.65% in the Kumasi Metropolis (Asante 2003). Higher 
incidence rates of 66.90% were reported in northern Ghana by Mockenhaupt et al., 
(2004a, 2004b), 40% by Amoako et al., (2010, personal communication) in the Kintampo 
North Municipality of Ghana and 25.30% in Kumasi (Ronald et al., (2006). 
 
According to Ronald et al., (2006) the socio-economic status of the residents of the 
Moshie-Zongo and Manhyia communities of Kumasi, Ghana reflected greater exposure 
to infected mosquitoes through poor quality housing and overcrowding in the 
communities.  
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Haemoglobinopathies other than Hb AS, AC trait including G6PD deficient individuals 
who are known to protect against the severe manifestation of Plasmodium falciparum 
malaria and represent serious confounders in epidemiological studies of alpha+-
thalassaemia in Africa, and were excluded from the study (William et al., 2005, Wambua 
et al., 2006). As a baseline to this study, the frequencies of these erythrocyte 
polymorphisms and their susceptibility to Plasmodium falciparum malaria parasitaemia 
was determined.  
 
This study recorded prevalence of 6.1%, 74.4%, 8.8%, and 7.4% for G6PD deficiency, 
HbAA, HbAC, and HbAS respectively. These compare favourably with HbAS prevalence 
of 10.9% reported by Kreuels et al., (2010), 9.2% by Amoako et al., (2010) and 7% by 
Mockenhaupt et al., (2002).  
On the contrary, the World Health Organization had reported 15% prevalence for HbAS 
(WHO (2006). Kreuels et al., (2010) had also reported 10.5% prevalence for HbAC. 
 
The frequency recorded for alpha+-thalassaemia in this study was 21.0% for the 
heterozygous (-α/αα), 8.3% for the homozygous or mutant (-α/-α), resulting in a carriage 
rate (α/αα & -α/-α) of 29.3%. All α-globin genotypes were positive for Plasmodium 
falciparum malaria, however the prevalence of malaria was in the order of αα/αα >α/αα >-
α/-α.  
This result appears to support the basic proposition of Haldane‘s hypothesis that alpha+-
thalassemia is pronounced in malarious regions because it accords carriers a level of 
protection against death from malaria by assuaging the clinical course of the disease. 
(Hendricks 2003).  
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3.7 CONCLUSION 
This study has provided the prevalence for the -globin genotypes, G6PD deficiency and 
alpha+-thalassaemia among children of the Kumasi metropolitan area. The frequency of 
Plasmodium falciparum malaria was 54.1% indicating that malaria is hyperendemic in 
Kumasi, an urban population inspite of governmental interventions against mortality due 
to malaria. The alpha+-thalassaemia also recorded a frequency of 29.3%. Even though 
alpha thalassaemia does not exclude the presence of iron deficiency, the high 
prevalence of alpha+-thalassaemia also informs the need to appropriately discriminate 
iron deficiency from alpha+-thalassaemia to avoid the unnecessary administration of iron 
therapy. 
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Chapter 4 
 
4.0 Does microcytosis protect against Plasmodium falciparum malaria in 
alpha+-thalassaemia?  
 
4.1 Introduction 
The protective mechanism of alpha+-thalassaemia thus remains unclear with 
various suggested mechanisms through which alpha+-thalassaemic individuals 
could confer protection against Plasmodium falciparum malaria.  
 
In vitro flow-cytometry studies have shown that erythrocytes of the alpha+ 
thalassaemia phenotype have reduced parasite growth and/or invasion rate 
(Pattanapanyasat, et al., 1999) as well as increased binding of antibodies from 
malaria-immune sera (Williams, et al., 2002) and enhanced splenic clearance of 
malaria-infected cells. Additionally, thalassaemic RBCs were said to age more 
quickly due to oxidative stress leading to membrane damage and subsequent 
increased phagocytosis and an eventual decreased parasite load (Yuthavong et 
al., 1988; Destro-Bisol et al., 1999 b; Senok et al., 2006).  
Red cell rosetting and the sequestration of schizont-infected red cell have been 
observed in alpha+-thalassaemia individuals in protecting from severe Plasmodium 
falciparum parasitaemia (Carlson et al., 1994). The role of the red cell complement 
receptor 1 (CR1) associated with rosetting and its reduced expression in alpha+-
thalassaemia (both heterozygous and homozygous) allowing protection against 
severe malaria was observed by Clark, et al., (2003), Cockburn et al., (2004) and 
Williams, et al., (2005b). 
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The protective effect by alpha+-thalassaemia against Plasmodium falciparum has 
been suggested to result from modified antigen recognition on the surface of the 
parasitized erythrocyte and the binding of thalassaemic red cells to increased 
amounts of immunoglobin and complement (Luzzi et al., 1991a; Luzzi et al., 1991b; 
Pattanapanyasat et al., 1999; Destro-Bisol et al., 1999a, Destro-Bisol et al., 1999b, 
Cockburn et al., 2004).  
Further indications were that these events resulted in the early removal of 
parasitized cells by the immunoglobin and the sparing of those cells with reduced 
complement (Cockburn et al., 2004). 
Williams et al., (1996), observed that alpha+-thalassaemia is associated with 
higher levels of P. vivax infection early in life which may heighten immunological 
defences and provided a better protection from subsequent Plasmodium 
falciparum infections.  
Higher levels of haptoglobin in the homozygous alpha+-thalassaemic individuals 
were suggested as toxic to Plasmodium falciparum in vitro (Imrie et al., 2004), thus 
conferring protection by removing free haemoglobin released during haemolysis 
This might explain why alpha+- thalassaemia red cells are apparently less 
hospitable to parasite growth and multiplication (Imrie et al., 2006).   
Researchers appear to agree that iron deficiency that results in microcytosis and 
hypochromasia confers protection from severe manifestation of Plasmodium 
falciparum and that iron is essential for the growth of the parasite (Cheesbrough 
1999).  
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Administration of oral iron-folic acid supplements might therefore increase the 
risk of morbidity from malaria and/or the bacterial infections that complicate 
malaria in children (Sazawal et al., 2006; WHO, 2006).  
 
Iron deficiency therefore is regarded to influence the course of malaria in 
Plasmodium falciparum infected individuals by offering some protection to the 
host (Koka et al., 2007; Rodak 2002, Cromer et al., 2009), via a complex 
interaction between the parasite, iron status and immune system of the 
individual Nyakeriga et al., (2004b; Sazawal et al., 2005).  
However, there is still a gap of knowledge regarding the role played by 
microcytosis in driving protection from the severe manifestations of Plasmodium 
falciparum parasitaemia in alpha+-thalassaemia. 
Microcytosis has been shown to be significantly associated with protection from 
haemoglobin decrease due to Plasmodium falciparum and the rate of infection was 
lower in microcytic than in normocytic anaemia (Mockenhaupt et al., 1999b). 
Fowkes et al., (2008) corroborated this finding by indicating that red cell 
microcytosis was associated with homozygous alpha+-thalassaemia and might be 
responsible for the protection against severe malarial anaemia.  
Recent observation by Vafa et al., (2008) indicated that the altered red cell 
membrane of alpha+-thalassaemia might affect erythrocyte invasion by 
Plasmodium falciparum with merozoites surface protein (msp2) antigen.  
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This results in lower susceptibility to infection by certain strains of parasite and 
reduces the parasite density in these alpha+-thalassaemia individuals with multiple 
infection.  
There are also disagreements between researchers as to the type of alpha+-
thalassaemia genotype that confers protection against Plasmodium falciparum.  
Findings from studies in Papua New Guinea concluded that both heterozygous and 
homozygous alpha+-thalassaemia protect against severe malaria parasitaemia, 
though protection was more evident in subjects with homozygous alpha+-
thalassaemia (Allen et al., 1997). This observation is supported by Williams et al., 
(2005b) who indicated in a Kenya study that both the heterozygous and 
homozygous alpha+-thalassaemia were protected from severe malaria. In contrast, 
reports from Tamale, the northern part of Ghana, indicated that alpha+-
thalassaemia does protect against death from malaria, however this was only true 
for heterozygous alpha+-thalassaemia (Mockenhaupt et al., 2004a, 2004b). 
The inability to detect protection in the homozygous alpha
+
-thalassaemia might be 
due to their small number and statistical limitations (Mockenhaupt et al., 2004a).   
 Another Ghanaian study, while agreeing with the ameliorating impact of alpha+-
thalassaemia on malaria, concluded that the ‗impact‘ was specific and driven by 
protection from severe anaemia, the most prevalent malaria complication (May et 
al., 2005). This concept of alpha+-thalassaemia malarial anaemia specificity is 
supported by another study from Kenya (Wambua et al., 2006).  
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The aims of this study therefore were to test the hypothesis that the protective 
effect of alpha+-thalassaemia against malarial parasitaemia can be demonstrated 
in both the heterozygous and homozygous states.  
We will also establish whether microcytosis might be responsible for protection 
from severe malaria parasitaemia amongst alpha+ thalassaemia individuals 
 
4.2 OBJECTIVES      
 To compare the geometric mean parasite density between normocytic (control), 
microcytic, normal genotype (presumed iron deficiency (PID)), homozygous, 
and heterozygous alpha+-thalassaemia 
 Determine the prevalence of different degrees of malaria among normocytic, 
microcytic, normal genotype (presumed ID) homozygous and heterozygous 
alpha+-thalassaemia. 
 
4.3 Participants 
Seven hundred and thirty-two children in whom Plasmodium falciparum malaria 
were detected (see flow chart, figure 3.1) and who had no confounding factors 
were tested for haemoglobin (Hb) levels, red blood cell (RBC) count, mean cell 
volume (MCV), and malaria parasite density. The subjects were then categorised 
into microcytic and normocytic using an MCV cut-off of 76 fL.  Polymerase chain 
reaction (PCR) for the -3.7 thalassaemia mutation was exclusively done on those 
subjects that were microcytic (MCV<76 fL).  
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4.4 Experimental approach 
 
4.4.1 Complete Blood Count (CBC) 
Hb, MCV, and RBC counts were estimated following the experimental procedure 
indicated in section 2.8.2. 3. Microcytosis was defined as MCV (<76 fL).  
 
4.4.2 Polymerase chain reaction (PCR) 
The experimental procedures for the extraction of DNA, the polymerase chain 
reaction and agarose gel electrophoresis are explained in 2.8.3.1  
 
 
4.4.3 Plasmodium falciparum malaria density                                                                                                    
Malaria parasite density was determined using the thick and thin blood films by the 
microscopic method. This followed the experimental procedure as described in 
section 2.8.1.1  
 
4.5 Statistical analysis 
All data were entered in Microsoft excel and analysed using SPSS 17 (IBM 
Corporation, New York, USA). Statistical analyses were performed as indicated in 
section 2.9 
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4.6 RESULTS 
Cases were grouped into normocytic (these were control groups whose MCV was 
>76fL), microcytic (these were children whose MCV was 76fL and were not 
alpha+- thalassaemic and therefore presumed to be iron deficient), homozygous 
and heterozygous alpha+-thalassaemia based on MCV measurements and PCR.  
Microcytosis defined as MCV ≤76 fL was initially used to distinguish between 
normocytic and microcytic children (Menendez et al., 2001). PCR was used to 
discriminate between alpha+-thalassaemia and presumed iron deficient (PID) after 
excluding confounding factors.  
We were unsuccessful in using plasma ferritin at a cut-off of ≤273 g/L as 
suggested by Phiri et al., (2009) to provide a 79% specificity and 79% sensitivity in 
predicting iron deficiency (ID) (Table 4.1). Children who had ferritin levels of ≤273 
g/L were considered as iron deficient whilst those with levels >273 g/L were 
regarded as alpha thalassaemic. Contrary to our expectations, we observed that 
59/197 of the iron deficient children were alpha thalassaemic suggesting that the 
ferritin cut off used in this study could not successfully discriminate iron deficiency 
from alpha thalassaemia. It does also suggest that some of the alpha thalassaemic 
children were iron deficient, thus corroborating earlier suggestions that iron 
deficiency might be found among alpha thalassaemias (Imrie et al., 2006). This 
might result from an increased rate of haemolysis in the children leading to a fall in 
plasma haptoglobin levels and the excretion of free haemoglobin in urine thereby 
reducing the body‘s iron stores (Imrie et al., 2006). 
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We performed PCR on the microcytic subjects for the -3.7 deletional type of 
alpha+-thalassaemia that is mostly found in sub-Saharan Africa and those that 
were not positive for alpha+ thalassaemias were presumed to be iron deficient. 
The association between haematological and parasitological parameters for 
microcytic, normocytic and alpha+-thalassaemia children as well as the severity of 
malaria were assessed. The frequency of Plasmodium falciparum malaria in the 
studied population of children who visited the clinic was 54.1%. 
 
4.6.1 Comparism between microcytic and normocytic children in terms of red 
cell indices and GMPD  
There were 589 (80.5%) microcytic children and 143 (19.5%) normocytic children 
in the study group; MCV (76fL) was significantly different between normocytic 
(MCV, 85.77 ±8.49) and microcytic children (MCV, 70.09 ±5.67) (p<0.001). (Table 
4.2) Among microcytic children, a significant correlation was observed between 
MCV and geometric mean parasite density (GMPD) (r= 0.124, p=0.01, n=589) 
(Figure 4.1). The GMPD however was lower (p=0.004) in the normocytic children 
compared to the microcytic children (Table 4.2).  
Haemoglobin concentration was not significantly different between the microcytic 
and normocytic groups (p=0.616), Table 4.2 
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Table 4.1 Discriminating iron deficiencies from alpha
+ 
-thalassaemia amongst 
microcytic children  
 
  Microcytic children (MCV ≤76 fL) on 
which ferritin was done (n= 586) 
  
 
                                Plasma Ferritin  
 
  
                     273 g/L 
 
    >273 g/L  Total  
 N, %  197 (33.62%)     389 (66.38%)   
 
Alpha
+
 -
thalassaemia  
-α/αα   19       30    49  
  -α/-α    40       86   126  
 
  αα/αα  117      241   358  
 
 TOTAL  176      357   533  
 
MCV (mean cell volume); α/αα, heterozygous alpha+- thalassaemia; -α/-α, 
homozygous alpha+-thalassaemia; αα/αα, normal alpha+- thalassaemia. Children 
(n=59/197) whose plasma ferritin were 273 g/L were also alpha+-thalassaemic. 
 
 
 
Table 4.2 Haematological indices and Plasmodium falciparum malaria 
characterized by microcytosis and normocytic  
 
                                             Mean (SD) 
 Normocytic  
(n=143) 
 
Microcytic 
 (n=589) 
P-value 
Hb (g/dl) 9.01 (3.02) 8.87(2.48) 0.616 
 
RBC (106/L) 3.31(1.14) 3.74(1.06) <0.001 
 
MCV (fL) 85.77 (8.49) 70.09(5.67) <0.001 
 
GMPD/µL 13156(1.31) 29087(1.13) 0.004 
 
Independent t-test assessed the differences in the mean values for 
Hb-haemoglobin, RBC- red blood cell, MCV- mean cell volume, GMPD-
geometric mean parasite density. Figures shown are mean and SD 
W 
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4.6.2 Comparism between alpha globin genotypes in terms of red cell indices 
and GMPD 
Amongst the microcytic population, the - 3.7 deletional type of alpha+-
thalassaemia recorded a frequency of 21.0% for the heterozygous (-α/αα), 8.3% for 
the homozygous (-α/-α), resulting in a carriage rate (-α/αα & -α/-α) of 29.3%.  
Fifty-six of the subjects did not show any amplification for PCR and were excluded 
from the analysis.  
Microcytosis (MCV 76fL) 
 
Figure 4.1: Correlation between mean cell volume (MCV) and 
log malaria parasite density/L amongst the microcytic 
population (r=0.124, p=0.01, n=589) 
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Both the homozygous and heterozygous alpha+-thalassaemia showed significantly 
reduced (p <0.001) GMPD compared to normal genotype (presumed iron 
deficiency-PID) (Table 4.3) 
The mean Hb, RBC and MCV significantly differed between the alpha+ 
thalassaemia genotypes (Tables 4.3). The homozygous alpha+-thalassaemia 
recorded the lowest haemoglobin concentration 
We observe a trend in the association between MCV and GMPD among alpha+-
thalassaemia genotypes in the sequence of αα/αα > -α/αα > -α/-α- (Table 4.3). The 
GMPD values between the alpha+-thalassaemia groups and the normocytic and 
PID differed significantly (p<0.05) (Table 4.4) 
 
 
Table 4.3 Haematological indices and Plasmodium falciparum malaria 
characterized by alpha+-thalassaemia genotypes  
 
                                                        Mean (SD) 
 -α/-α 
(n=49) 
-α/αα 
(n=126) 
αα/αα (PID) 
(n=358) 
P-value 
     
Hb (g/dl) 7.50(2.19) 9.28(2.09) 8.9(2.57) <0.001 
 
RBC (106/L) 
 
3.39(1.16) 
 
3.97(1.00) 
 
3.65(1.04) 
 
<0.001 
 
MCV (fL) 
 
68.71(8.31) 
 
69.54(5.08) 
 
70.88(4.76) 
 
0.004 
 
GMPD/µL 
 
6852(1.02) 
 
9015(0.98) 
 
51794(1.10) 
 
<0.001 
 
Analysis of variance (ANOVA) assessed the differences in the mean values 
Hb-haemoglobin, RBC- red blood cell, MCV- mean cell volume, GMPD-geometric 
mean parasite density; α/αα, heterozygous alpha +- thalassaemia; -α/-α, 
homozygous alpha+-thalassaemia; αα/αα, normal or wild type alpha +- 
thalassaemia; PID=presume iron deficiency. Fifty-six of the samples did not show 
amplification. Data shown represent mean and SD 
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Table 4.4: Post-hoc Tukey analysis of means of haematological 
parameters and malaria parasitaemia by microcytosis 
 -α/αα 
Vrs 
-α/-α 
-α/-α 
Vrs 
αα/αα 
(PID) 
-α/αα 
Vrs 
αα/αα 
(PID) 
Normocytic 
Vrs 
-α/-α 
Normocytic 
Vrs 
-α/αα 
Normocytic 
Vrs 
αα/αα (PID) 
Hb (g/dL) <0.05 <0.05 NS >0.05 NS NS 
RBC (106/L) NS NS <0.05 NS <0.05 NS 
MCV (fL) NS <0.05 <0.05 <0.05 <0.05 <0.05 
GMPD/µL <0.05 <0.05 <0.05 <0.05 <0.05 <0.05 
 
NS-not significant; Hb-haemoglobin, RBC- red blood cell, MCV- mean cell volume, 
GMPD-geometric mean parasite density; -α/αα, heterozygous alpha +- 
thalassaemia; -α/-α, homozygous alpha+-thalassaemia; αα/αα, normal or wild type 
alpha +- thalassaemia. PID- presumed iron deficient. 
 
4.6.3 The influence of alpha+-thalassaemia on levels of malaria severity in 
microcytosis 
Parasitaemia was expressed as the number of asexual forms of the malaria 
parasites per microliter and graded as low (1-999/μL) moderate (1000-9999/μL), 
high (≥ 10000/μL), or severe (100000/L) (Barbara et al., 1994). The proportion of 
patients with severe malaria was reduced in both the homozygous and 
heterozygous alpha+-thalassaemia groups compared to those with normal 
genotype (Figure 4.3).  Similarly, the proportion of patients with severe malaria was 
reduced in the alpha+-thalassaemia genotype groups compared to the normocytic, 
all microcytic and PID groups (Table 4.5) 
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Table 4.5: Incidence of Plasmodium falciparum malaria density amongst       
alpha+-thalassaemia children attending clinic      
 
 PID=presume iron deficiency; MPD =mean parasite density; α/αα, heterozygous 
alpha +- thalassaemia; -α/-α, homozygous alpha+-thalassaemia; αα/αα, normal or 
wild type alpha +- thalassaemia; Parasitaemia was expressed as the number of 
asexual forms of the malaria parasites per microlitre graded as low (1-999/μL), 
moderate (1000-9999/μL), high (10000-99999/μL) and severe (100000) n is 
number of children with various degree of parasitaemia (%). Data shown 
represents number and percentage of individuals in each group. * p<0.03 by Fisher 
exact test 
 
  Malaria status (n, %)        
  
  
 
Malaria 
Parasitaemia/μL 
Normocytic 
(n=143) 
All Microcytic  
(n=589) 
-/- 
(n=49) 
-/ 
(n=126) 
/(PID)  
(n=358) 
1-999 33 (23.1) 74 (12.6) 12 (24.5) 21 (16.7) 31 (8.7) 
 
1000-9999 40 (28.0) 131 (22.2) 16 (32.7) 39 (31.0) 66 (18.4) 
 
10000-99999 23 (16.1) 140 (23.8) 13 (26.5) 51 (40.5) 69 (19.3) 
 
100000 47 (32.9) 244 (41.4) 8 (16.3) 15 (11.9) 192(53.6)* 
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4.7 Discussion 
The results from this study show that the incidence of malaria infection in the 
subject population of 1672 children (mean age 51.2 month) is 54.1%. This is 
slightly lower than incidence rates of 66.90%, reported in Tamale, Northern Ghana 
(Mockenhaupt et al., 2004c), and 77.80% recorded in Southwest Nigeria 
(Mockenhaupt et al., 1999), which are both areas of intense malaria transmission. 
The observed incidence of malaria in this study is higher than the 13.65% (range, 
2% to 33%) reported by Asante (2003) in a study conducted in the Kumasi 
Metropolis of Ghana, and the 16.1% incidence rate reported in Ouagadougou, the 
capital city of Burkina Faso, Sabatinelli et al., (1986). 
 According to the World Health Organisation (WHO) report of 2010, the incidence 
of malaria in 2005 to 2009 was 26% -35% in Africa with some countries achieving 
less than 20% rates.  
The prevalence of the -3.7kb type of alpha+-thalassaemia as reported in this study 
was 21.0% for the heterozygous (-α/αα), 8.3% for the homozygous or mutant     
(-α/-α), resulting in a carriage rate (α/αα & -α/-α) of 29.3%.  This rate is slightly 
within the 20% to 30% prevalence range in West Africa reported by Yaish (2005). It 
is, also similar to the 33% (29% Heterozygotes; 4% Homozygotes) prevalence 
reported by Mockenhaupt et al., (2001) in Agogo, the Ashanti region of Ghana but 
lower than the 45% reported by Mockenhaupt et al., (1999 b) in Nigeria, or the 
53.7% reported by Wambua et al., (2006) on the Coast of Kenya.  
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Compared to other parts of the world, like the North Coast of Papua New Guinea 
where the prevalence of the -3.7 deletional alpha+-thalassemia reaches more than 
90% (Allen et al., 1997) the prevalence rate of alpha+-thalassemia in Ghana, as 
found in this study, is relatively moderate. 
We estimated the prevalence of microcytosis to be 80.5% (mean MCV< 72.6 ±8.86 
fL) in the subject population (n=732). Three hundred and fifty eight (48.90%) of the 
microcytic cases were presumed to be iron deficient, contrary to the 83.5% 
reported in pre-school children in Ghana (Stanley et al., 2001). The high incidence 
of alpha+thalassaemia amongst the microcytic children does suggest that alpha+-
thalassaemia is a key contributor to microcytosis. This finding corroborates reports 
from Brazil (Borges et al., 2001) and Iran (Rahim, 2008) suggesting that the 
practice of considering iron deficiency as the most common cause of microcytic 
hypochromic anaemia could prove problematic. 
Plasmodium falciparum malaria is the single biggest cause of death in children in 
Africa and various haemoglobinopathies have been proposed to protect against the 
severe manifestation of malaria. Severe malarial anaemia (SMA) a complicated 
form of severe anaemia is the leading cause of mortality in malaria-affected 
children under the age of five years (WHO 2000). One suggestion is that increased 
microcytosis associated with homozygous alpha
+
-thalassaemia might be 
responsible for the protection against severe Plasmodium falciparum malarial 
anaemia (Fowkes et al., 2008; Mockenhaupt et al., 1999 b).  
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However, contrary to suggestions by Mockenhaupt et al., (1999 b), Fowkes et al., 
(2008) did not observe any association between parasite load and alpha
+
- 
genotype. Some studies have indicated that microcytosis confers protection from 
malaria in both alpha+-thalassaemia and iron deficiency (Nyakeriga et al., 2004b) 
and that the mechanism of the protection might be linked to a reduction in the 
parasite density. Pattanapanyasat et al., (1999) in an in vitro study showed that, 
though normal RBCs and alpha+-thalassaemic RBCs were both susceptible to 
Plasmodium falciparum invasion, the parasite multiplication rates were significantly 
reduced in the thalassaemic RBC population. 
In the opinion of Luzzi et al., (1990), red cell disorders in which microcytosis is a 
characteristic feature contributes to Plasmodium falciparum malaria resistance. 
We tested the hypothesis that microcytosis might be responsible for protection 
from severe malaria amongst phenotypically determined alpha
+
-thalassaemia and 
non-alpha+ thalassaemia children.  
 
We observed a reduction in the GMPD in normocytic children compared to 
microcytic children (p<0.004, Table 4.2). This is in contrast to observations by 
Luzzi et al., 1990, Mockenhaupt et al., (1999 b), and Fowkes et al., (2008) who 
indicated protection from severe malaria and malarial anaemia in microcytic 
children who were alpha+-thalassaemia. In this study the microcytic children were  
heterozygous, homozygous alpha+-thalassaemia and normal genotypes. 
 
Chapter 4. Microcytosis protects against Plasmodium falciparum in α+-thalassaemia 
 
 
 127 
 
However, among the microcytic patients GMPD values were lower in the presence 
of an alpha-thalassaemia genotype (p<0.001, Table 4.2), suggesting that the 
severity of Plasmodium falciparum parasitaemia were significantly lower in both 
homozygous and heterozygous alpha+-thalassaemia genotypes compared to 
microcytic children with normal genotype. The protective effect observed in this 
study was for both heterozygous and homozygous alpha+-thalassaemia but most 
evident with homozygotes that recorded a significantly lower GMPD compared to 
both the heterozygotes and normal genotypes (p< 0.001).  
Our finding conflict with results of a study conducted in Ghana by Mockenhaupt et 
al., (2004c), which reported that the observed protective effect from Plasmodium 
falciparum malaria was attributable only to the heterozygous form of alpha+-
thalassemia. Our finding is however, consistent with Allen et al., (1997) and 
Williams et al., (2005b) that the protective effect is visible in both genotypes, but 
most evident in homozygotes. 
Severe malaria (defined as MPD >100000/L) was less prevalent in microcytic 
patients with an alpha+-thalassaemia genotype (-α/αα 11.9% and -α/-α 16.3%) 
than either normocytic patients or microcytic patients with a normal genotype 
(32.9% and 53.6% respectively) (p<0.03 by Fisher‘s exact test). suggesting that 
both alpha+-thalassaemia genotype were less susceptible to the severe 
manifestation of malaria and that it is the alpha+-thalassaemia state that confers 
protection. 
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 Microcytosis (MCV 76fL) itself did not influence the incidence of malaria parasite 
infection as reflected in the proportion of patients in whom parasites were seen, 
however in the presumed iron deficiency and heterozygous and homozygous 
alpha+ thalassaemia groups there appeared to be a connection between a 
progressive decrease in MCV (increased microcytosis) and decrease in parasite 
density.  Both MCV and GMPD were significantly different among these groups 
(Table 4.3). We also observed a positive correlation among microcytic patients 
between MCV (Figure 4.1) and malaria parasitaemia and therefore suggest that 
red cell microcytosis might be associated with a reduction in parasite burden in 
alpha+ -thalassaemia a view that has been observed by Fowkes et al., (2008).  
A reduction in parasite density has been indicated in the multiplicity of Plasmodium 
falciparum infection among Senegalese children (Vafa et al., 2008) who observed 
a correlation between multiple parasite strains and parasite density. They 
explained, this may be due to the altered membrane of alpha+-thalassaemia red 
blood cells, which prevented the invasion of Plasmodium falciparum with 
merozoites, surface protein (msp2) and thus reduce the parasite density in these 
individuals. This study however did not find any evidence of multiple infections 
among our subject population. 
 
In the current study, we observed in alpha+-thalassaemia children a reduced 
parasite density, an observation, contrary to the views of (Mockenhaupt et al., 
(2004a) and Williams et al., (2006) who indicated that the protection by alpha+-
thalassaemia did not lower parasite densities.  
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The present findings are also supported by the suggestion that red blood cells of 
more severe alpha+thalassaemia genotypes are less hospitable to parasite growth 
and multiplication (Ifediba et al., 1985). By implication the homozygous alpha+-
thalassaemia is more protected from severe Plasmodium falciparum malaria than 
the heterozygous alpha+-thalassaemia. 
 
4.8 Summary, limitations and further works  
Our study observed a weak but significant correlation between MCV and GMPD 
among microcytic children. We have also found reduced mean parasite density in 
both the heterozygous and homozygous alpha+-thalassemia compared to normal 
genotypes. Alpha+-thalassemia is a key contributor to microcytosis among the 
study population, accounting for 29.3% in children with microcytosis who might 
otherwise be regarded as iron deficient. In conclusion, therefore, the severity of 
Plasmodium falciparum parasitaemia measured, as either GMPD or prevalence of 
severe parasitaemia was significantly lower in both the -α/αα and -α/-α- groups 
compared to microcytic individuals with normal genotype 
Our inability to successfully use ferritin measurements to discriminate microcytosis 
due to iron deficiency from microcytosis due to alpha+-thalassaemia has been to 
us a limitation. This would have enabled us to evaluate better the relationship 
between microcytosis and iron deficiency in protecting against malaria. 
 
Further research might consider enrolling both symptomatic and asymptomatic 
children for future study. It might also be possible to investigate the epistasis 
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relationship between some of the haemoglobinopathies and alpha+-thalassaemia 
in protecting against malaria. The exclusion of subjects with possible inflammation 
and haemolysis caused by worm infestation other than malaria may address 
confounding factor issues.  
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Chapter 5 
 
5.0 Does hypochromasia protect against Plasmodium falciparum malaria in 
alpha
+
-thalassaemias?  
 
5.1 Introduction 
Hypochromasia is a red cell abnormality that results in the decrease in 
haemoglobin concentration in erythrocytes rendering them pale staining and less 
intensely than normal. Hypochromasia causes reduction in mean corpuscular 
haemoglobin (MCH) of red blood cells (Hoffbrand and Moss 2010). 
Anaemia and hypochromasia have been observed to be significantly more frequent 
in alpha+-thalassaemic than in non alpha+-thalassaemic children.  
 
Though the degree to which alpha+-thalassemia contributes to the prevalence of 
hypochromic anaemia in Africa has not yet been convincingly established, some 
studies from other parts of the world report that alpha+-thalassemia is a significant 
contributor to hypochromic anaemia (Rahim, 2008; Borges et al., 2001; Sankar et 
al., 2006). 
 
One of the features of alpha+-thalassaemia is haemolysis. Generally, both 
heterozygous and homozygous alpha+-thalassaemia have lower levels of total Hb, 
mean cell haemoglobin concentration, mean corpuscular volume, and mean cell 
haemoglobin concentration than normal alpha
+
-thalassaemias (αα / αα).  
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However, there is a greater difference between heterozygotes and homozygotes 
than between heterozygotes and normal alpha
+
-thalassaemias (Imrie et al., 2006).  
Therefore, compared to normal alpha
+
-thalassaemias, heterozygotes do not 
present any clinical symptoms, whereas homozygotes are characterized by mild 
hypochromic and microcytic anaemia (Imrie et al., 2004).  
 
Reports that Hb levels are further lowered in iron depleted alpha+-thalassaemic 
children suggest that inhibition of -globin synthesis might be responsible 
(Mockenhaupt et al., 1999). 
  
Malaria associated anaemia was observed to be less pronounced among 
homozygous alpha
+
- thalassaemia children than in the normal genotype. However, 
observations by Veenemans et al.,(2008) showed that alpha+-thalassaemia 
actually limits the decline in haemoglobin concentration associated with afebrile 
Plasmodium falciparum infection. The effect of alpha
+
-thalassaemia on 
haemoglobin level was observed among Tanzanian children with uncomplicated 
malaria (Enevold et al., 2008) where alpha
+
-thalassaemias were found to be 
associated with reduced haemoglobin levels. In the opinion of Pasvol, (2006) whilst 
haemoglobin concentrations were lower among alpha
+
-thalassaemia children in 
steady state and during mild Plasmodium falciparum attack, haemoglobin 
concentrations were relatively higher in children with severe malaria.  
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A similar observation has been made in Kenyan children who were both 
heterozygous and homozygous for alpha
+
-thalassaemia (Wambua et al., 2006) 
suggesting that alpha+-thalassemia may protect against the progression of 
anaemia during the course of severe manifestation of Plasmodium falciparum 
parasitaemia. Among children with acute Plasmodium falciparum malaria 
haemoglobin concentrations were lower in normal alpha+-thalassemia genotypes 
than were found in both the heterozygous and homozygous alpha+-thalassemia 
(Fowkes et al., 2008). However, Hb concentrations were higher in the homozygous 
than in the heterozygous alpha+-thalassemia.  
 
5.2 OBJECTIVES      
 To compare the geometric mean parasite density (GMPD) between 
normochromic (control), hypochromic, normal genotype (presumed iron 
deficiency (PID), homozygous and heterozygous alpha+-thalassaemia 
 Determine the prevalence of different degrees of malaria among normochromic, 
hypochromic, normal genotype, (presumed ID) and homozygous and 
heterozygous alpha+-thalassaemia. 
 
5.3 Participants 
Refer to section 2.1 and flow chart, figure 3.2 of chapter 3  
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5.4 Experimental approach 
5.4.1 Complete Blood Count (CBC) 
Hb, MCH, and RBC counts were estimated following the experimental procedure 
indicated in section 2.8.2.3.  
 
5.4.2 Polymerase chain reaction (PCR) 
The experimental procedures for the extraction of DNA, the polymerase chain 
reaction and agarose gel electrophoresis are explained in 2.8.3.1  
 
5.4.3 Plasmodium falciparum malaria density                                                                                                    
Malaria parasite density was determined following experimental procedure as 
describe in section 2.8.1.1 
 
5.5 Statistical analysis 
All data were entered in Microsoft excel and were analysed using SPSS 17 (IBM 
Corporation, New York, USA) as indicated in section 2.9.  
 
5.6 RESULTS 
There were 267 (36.5%) hypochromic children and 465(63.5%) normochromic 
children in the study group. Cases were grouped into normochromic (control), 
hypochromic, with normal genotype (presumed iron deficiency (PID), and 
homozygous and heterozygous alpha+-thalassaemia based on PCR. MCH cut-off 
of 25 pg was used to discriminate normochromic from hypochromic children.  
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The association between haematological and parasitological parameters for 
hypochromic children as well as the severity of malaria were assessed. 
 
5.6.1 Comparism between hypochromic and normochromic children in terms 
of red cell indices and GMPD 
Haemoglobin concentration was not significantly different between normochromic 
and hypochromic children (p=0.481, Table 5.1) however the difference in the red 
blood cell count values was significant (p<0.001).  
The GMPD in the hypochromasia was significantly higher than that in 
normochromic children (p<0.001) suggesting that hypochromic children were more 
susceptible to Plasmodium falciparum infection than the normocytic children (Table 
5.1). The correlations of Plasmodium falciparum parasite density with haemoglobin 
and MCH concentrations were not significant among the hypochromic children 
(r=0.21, p=0.653, n=267, and r=0.053, p=0.474, n=267, respectively (Figures 5.1 
and 5.2), as well as normochromasia group (r=0.030, p=0.623, n=465).  
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Table 5.1: Haematological indices and Plasmodium falciparum malaria 
characterized by hypochromasia and normochromasia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Independent t-test assessed the differences in the mean values 
Hb-haemoglobin, RBC- red blood cell, MCH- mean corpuscular haemoglobin, 
GMPD-geometric mean parasite density  
 
 
 
 
 
 
 
 
                                                Mean (SD) 
 Normochromic 
N=465 
Hypochromic  
N=267 
P-value 
Hb (g/dl) 8.95(2.67) 8.81(2.44) 0.481 
 
RBC (106/L) 3.51 (1.07) 3.91(1.78) <0.001 
 
MCH  (pg) 25.76(3.86) 22.70(2.30) <0.001 
 
GMPD/µL 22134(1.20) 30603(1.14) <0.001 
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5.6.2: Comparism between alpha globin genotypes in terms of red cell 
indices and GMPD 
In all the haematological and parasitological tests, comparisons between the alpha 
+-thalassaemia genotypes, showed significant differences for only MCH and 
GMPD. GMPD was comparatively low in the homozygous compared to the 
heterozygous alpha+-thalassaemia genotypes, and the normal or presumed iron 
deficiency (Table 5.2). Haemoglobin values were largely depended on genotype 
(normal, 8.78 g/dL; heterozygous, 9.17 g/dL; and homozygous, 8.06 g/dL). Mean 
haemoglobin concentration was not significantly different amongst all α-globin 
genotypes (Table 5.2).  
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Haemoglobin value did not correlate with mean parasite density (MPD) (r=0.21, 
p=0.653 Figure 5.1) and does not appear influence parasitaemia in alpha 
+thalassaemia. 
 
 
 
 
 
Table 5.2: Hypochromasia and Plasmodium falciparum malaria characterized 
by alpha+-thalassaemia genotypes  
 
                                    Mean (SD)  
 -α/-α 
(n=23) 
-α/αα 
(n=44) 
αα/αα (PID) 
(n=141) 
P-value 
Hb  (g/dl) 8.06(2.22) 9.17(1.89) 8.78(2.53) 0.075 
 
RBC (106/L) 3.77(1.03) 4.08(0.95) 3.89(1.10) <0.458 
 
MCH (pg) 21.45(2.94) 22.55(2.08) 22.81(2.20) <0.029 
 
GMPD/µL 7160(1.00) 17280(0.89) 48997(1.09) <0.001 
 
Analysis of variance (ANOVA) assessed the differences in the mean values 
Hb-haemoglobin, RBC- red blood cell, MCH- mean corpuscular haemoglobin, 
GMPD-geometric mean parasite density; α/αα, heterozygous alpha +- 
thalassaemia; -α/-α, homozygous alpha+-thalassaemia; αα/αα, normal or wild type 
alpha +- thalassaemia; PID=presume iron deficiency. Data represents mean and 
SD 
 
 
 
 
 
 
 
 
            Chapter 5. Hypochromasia protect against Plasmodium falciparum in α+thalassaemia 
 
 
 139 
Table 5.3: Post-hoc Tukey analysis of means of haematological parameters 
and malaria parasitaemia by hypochromasia 
 -α/αα 
Vs. 
-α/-α 
-α/-α 
Vs. 
αα/αα 
(PID) 
-α/αα 
Vs. 
αα/αα 
(PID) 
Normochromic 
Vs. 
-α/-α 
Normochromic 
Vs. 
-α/αα 
Normochromic 
Vs. 
αα/αα (PID) 
Hb (g/dL)   NS NS NS NS NS NS 
RBC 
(106/L) 
  NS NS NS NS <0.05 <0.05 
MCH 
(pg)  
  NS <0.05 NS NS <0.05 <0.05 
GMPD/µL   <0.05 <0.05 <0.05 <0.05 <0.05 <0.05 
 
Hb-haemoglobin, RBC- red blood cell, MCH- mean corpuscular haemoglobin, 
GMPD-geometric mean parasite density, α/αα, heterozygous alpha +- 
thalassaemia; -α/-α, homozygous alpha+-thalassaemia; αα/αα, normal or wild type 
alpha +- thalassaemia. NS-not significant; PID-presumed iron deficiency 
 
 
 
 
5.7: Discussion 
 
 
 The primary objective of this study was to determine whether hypochromic red 
blood cells (MCH 25 pg) are responsible for conferring protection from the severe 
manifestation of Plasmodium falciparum malaria in alpha+ thalassaemias. Of 
particular interest to us is whether the said protection might result in reducing the 
parasite density in the alpha+ -thalassaemic patients.  
Very little is however known of the role of hypochromasia, which is the decrease in 
haemoglobin concentration in erythrocytes in conferring protection from severe 
Plasmodium falciparum malaria in alpha+ thalassaemias. 
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The scarcity of haemoglobin has been suggested to provide a non-conducive 
nutrient-deficient environment for Plasmodium falciparum growth (Nyakeriga et al., 
2004 b).  
 In the hypochromic children, the haemoglobin level did not differ significantly 
(p=0.481) from the normocytic children even though the level in normocytic 
children appeared slightly higher compared to haemoglobin level in the 
hypochromic children. This might explain the significantly high (p<0.001) GMPD 
observed in the hypochromic children compared to the normocytic children due to 
haemoglobin decline. This not withstanding, we did not find any evidence to 
suggest a relationship between Plasmodium falciparum parasitaemia and 
haemoglobin (Figure 5.1) 
  
Both heterozygous and homozygous alpha+-thalassaemia have been implicated in 
preventing the decline in haemoglobin concentration in children with clinical 
malaria (Wambua et al., 2006). We observed haemoglobin levels to be 
independent of heterozygous, homozygous and normal alpha+-thalassaemia 
genotypes however children heterozygous for alpha+-thalassaemia had higher 
mean haemoglobin concentration than did children with normal genotype. This 
suggests that alpha+-thalassaemia might prevent the decline in haemoglobin 
concentration in the heterozygous for alpha+-thalassaemia.  
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This compares to other works that have suggested that alpha+ thalassaemia might 
limit the decline in haemoglobin that is not only confined to severe malaria cases 
but even so the protective effect might be evident when the Plasmodium falciparum 
infection is accompanied by inflammation (Veenemans et al., 2008).  
But the fact that GMPD in the hypochromic differed significantly from the 
normochromic group (p<0.001), recording an increase in the density of parasite 
compared to the normocytic group suggests that hypochromic alpha+ 
thalassaemia were not biologically advantageous in terms of protection from 
parasitaemia over their normochromic counterparts. Hypochromic patients were 
therefore more susceptible to Plasmodium falciparum parasitaemia than the 
normochromic counterparts. This is however in contrast to suggestions that the 
scarcity in haemoglobin might provide an environment conducive for the 
Plasmodium falciparum malaria to thrive. Relative to children with normal alpha
+
-
thalassaemia genotype, GMPD differed significantly (p<0.001) compared to both 
the heterozygous and homozygous alpha
+
-thalassaemias suggesting that 
protection from the severe manifestation of Plasmodium falciparum parasitaemia 
might not be due hypochromic red cells per se but rather alpha+-thalassaemia 
genotypes who are hypochromic. 
In addition we observed a progressive decrease in MCH compared to GMPD 
(Table 5.2) in the order of homozygous <heterozygous <normal alpha
+
-
thalassaemias, a trend that was observed among the microcytic children with 
alpha
+
-thalassaemia.  
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This trend might explain the fact that both microcytic and hypochromic are inherited 
together in either iron deficiency anaemia or the thalassaemias and that the 
protection against severe malaria in heterozygous and homozygous alpha
+
-
thalassaemias who are microcytic might be implicated in hypochromic alpha+-
thalassaemias. 
 
5.8: Summary, limitations and further works  
Even though GMPD and MCH differed significantly among all alpha
+
-thalassaemia 
genotypes, our data did not observe any significant correlation between 
hypochromasia and Plasmodium falciparum parasitaemia. Hypochromasia 
therefore might not confer protection from the severe manifestation of Plasmodium 
falciparum parasitaemia in alpha+-thalassaemia genotypes and did not prevent 
infection.  
The study also found that haemoglobin levels were independent of GMPD and that 
alpha
+
-thalassaemia genotype did not influence a decline in haemoglobin 
concentration.  
Further works might have to discriminate other causes of hypochromic and 
microcytic anaemia like worm infestation which is common among the population 
and the possible interaction between other haemoglobinopathies like HbSC and 
HbSS that causes haemoglobin reduction and therefore hypochromasia.
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Chapter 6 
 
6.0 Does severe malarial anaemia protect against Plasmodium falciparum 
malaria in alpha
+
-thalassaemias?  
 
6.1 Introduction 
Severe malarial anaemia (SMA) is the leading cause of mortality in malaria-
affected children under the age of five years (WHO 2000). In acute childhood 
malaria, suppression of bone marrow responsiveness and the increased 
phagocytosis of parasitized red blood cells (pRBC) and non-parasitized red blood 
cells (n-pRBC) play a major role in SMA (Ekvall, 2003).  Both haemolysis and 
suppression of normal erythropoiesis have been indicated to cause SMA in 
children with severe Plasmodium falciparum parasitaemia (Menendez et al., 
2000). 
 
Indications from a Ghanaian study were that the protection against malaria death 
in alpha+-thalassaemia was specific and driven by protection from severe 
anaemia, the most prevalent malaria complication (May et al., 2005). Among a 
cohort of Gambian children heterozygous and homozygous for alpha+-
thalassaemia, Allen et al., (1997) observed protection against SMA. 
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This concept of alpha+-thalassemia‘s anaemia dependent protection against 
malarial complications is supported by another study from Kenya (Wambua et al., 
2006) where it is suggested that the protection might be as a result of a promoter 
polymorphism of red cell complement receptor 1 (CR1), for red cell rosetting. 
Alpha
+
-thalassaemia has been implicated to independently associate with reduced 
expression of red cell CR1 and thus reduce the ability of red cells to form rosettes, 
(Clark, et al., 2003, Williams, et al., 2005a) leading to protection against malarial 
complications 
 
In the opinion of Veenemans et al., (2008) alpha
+
-thalassaemia confers protection 
against SMA in children by preventing a gradual decline in haemoglobin 
concentration during repeated or chronic infection. 
 
It has been suggested that not only did homozygous alpha
+
-thalassaemia protect 
from severe forms of Plasmodium falciparum malaria but also protect against SMA 
(Wambua et al., 2006, William et al., 2005, Mockenhaupt et al., 2004, May et al., 
2007); that the mechanism for this protection against SMA might be an increased 
in erythrocyte count and microcytosis thus maintaining the Hb concentration above 
5.0g/dL (Fowkes et al., 2008). Evidence of this protection has been observed 
among Papua New Guinean children who were homozygous for alpha+-
thalassaemia (Fowkes et al., 2008). 
Chapter 6. Does severe malarial anaemia protect against Plasmodium falciparum malaria in 
alpha
+
-thalassaemias?  
 
 
 
 145 
This notwithstanding, there is still a gap of knowledge regarding the mechanism by 
which alpha
+
-thalassaemia confer protection from SMA.  
 
However, with reports that microcytosis and hypochromic erythrocytes reduce the 
decline in haemoglobin concentration, Danquah and Mockenhaupt (2008) have 
suggested that alpha
+
-thalassaemia might protect against SMA during acute and 
chronic Plasmodium falciparum parasitaemia and thus reduce the risk of anaemia. 
 
6.2 OBJECTIVES      
 To determine the prevalence of severe anaemia (Hb<5 g/dL) in hypochromic, 
normal genotype (presumed ID) homozygous and heterozygous alpha+-
thalassaemia 
 Determine whether severe malarial anaemia drives protection from 
Plasmodium falciparum parasitaemia 
 
6.3 Participants 
Refer to section 2.1 and flow chart, figure 3.2 of chapter 3  
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6.4 Experimental approach 
6.4.1 Complete Blood Count (CBC) 
Hb, MCH, and RBC counts were estimated following the experimental procedure 
indicated in section 2.8.2.3.  
 
6.4.2 Polymerase chain reaction (PCR) 
The experimental procedures for the extraction of DNA, the polymerase chain 
reaction and agarose gel electrophoresis are explained in 2.8.3.1  
 
6.4.3 Plasmodium falciparum malaria density                                                                                                    
Malaria parasite density was determined following experimental procedure as 
describe in section 2.8.1.1 
 
6.5 Statistical analysis 
All data were entered in Microsoft excel and were analysed using SPSS 17 (IBM 
Corporation, New York, USA) as indicated in section 2.9 
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6.6 RESULT 
 
6.6.1 Severe malarial anaemia in alpha+ thalassaemia genotypes 
Severe anaemia was defined as Hb<5 g/dL (WHO, 2000).  
Severe malarial anaemia was associated with higher parasite density in 
heterozygous and homozygous alpha+ thalassaemia as children with severe 
anaemia had higher GMPD compared to those whose haemoglobin values were 
more than 5 g/dL (Table 6.1). The proportions of severe anaemia cases 
associated with Plasmodium falciparum malaria infection were largely independent 
of all alpha+ thalassaemia genotypes (Table 6.1).  
 
 
Table 6.1: Prevalence of severe malarial anaemia and MPD among alpha+- 
thalassaemia genotypes 
 Severe malarial anaemia (n,%) GMPD (SD) 
 
-/- ≤ 5 g/dL  
 
9 (18.0) 17725(5.37)* 
>5 g/dL 40 (82.0) 5387(5.08) 
-/ ≤ 5 g/dL 7 (5.6) 12040(5.51)* 
>5 g/dL 119 (94.4) 8863(4.95) 
 
/ 
(PID) 
≤ 5 g/dL 32 (8.9) 32732(5.76)* 
 
>5 g/dL 325 (90.5) 55552(5.59) 
 
PID=presumed iron deficiency; GMPD = geometric mean parasite density; -α/αα, 
heterozygous alpha
+
-thalassaemia; -α/-α, homozygous alpha
+
-thalassaemia; 
αα/αα, normal or wild type alpha
+
- thalassaemia; Severe malarial anaemia is 
defined as haemoglobin concentration ≤ 5 g/dL. *The comparism between the 
GMPD of severe anaemia and non-severe anaemia is significant at p<0.001 
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6.7 Discussion 
 
 
We determined the influence of SMA on Plasmodium falciparum parasitaemia. Of 
particular interest to us is whether SMA might result in reducing the parasite 
density in the alpha
+
-thalassaemic patients.  
Some of the mechanisms that have been suggested to protect from the severe 
manifestation of Plasmodium falciparum malaria have been the protection from 
severe anaemia (May et al., 2005). Malaria generally causes haemolysis and 
therefore a reduction in the haemoglobin concentration. However, among alpha
+
-
thalassaemic patients is a gradual decline in the haemoglobin concentration 
(Veenemans et al., 2008) thus conferring protection against SMA in children.  
 
Our finding suggests that children with SMA were not advantageous in protecting 
from severe malaria but rather had increase Plasmodium falciparum parasitaemia 
as shown in table 6.1. Our data therefore suggests that the protection conferred 
by alpha
+
-thalassaemias is confined to children that had no SMA and whose 
haemoglobin concentration was ≤ 5 g/dL  
 
The observation that alpha
+
-thalassaemias were protected from severe malaria 
only when there was severe anaemia (Pasvol, 2006) was not evident in our study. 
We defined SMA as Hb 5 g/dL in association with parasite density ≥100000/µL.   
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Amongst the homozygous and heterozygous alpha+-thalassaemia, children with 
SMA had a significantly high GMPD than their counterparts who were not severely 
anaemic (p<0.001, Table 6.1).  
 
Our finding is however consistent with previous observation by May et al., (2005) 
who indicated that the protection from malaria by alpha
+
-thalassaemia was driven 
by protection from severe anaemia. In other words severe anaemia did not offer 
any protection against Plasmodium falciparum parasitaemia in alpha
+
-
thalassaemia genotypes.  
 
The proportion of SMA in the homozygous and heterozygous alpha
+
-thalassaemia 
groups was less compared to the normal genotype and this might explain the limit 
in the decline of haemoglobin concentration in alpha
+
-thalassaemia associated 
with malaria (Veenemans et al., 2008). We are therefore of the opinion that 
alpha
+
-thalassaemia genotypes might protect from Hb decline, however this 
protection could wane should the Hb concentration fall below 5 g/dL. This is 
because in children with severe Plasmodium falciparum parasitaemia, 
phagocytosis of both parasitized and non-parasitized red blood cells as well as 
haemolysis are increased resulting in SMA (Ekvall, 2003).  
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6.8: Summary, limitations and further works  
A major outcome of this study is the observed relationship between SMA and 
GMPD in the alpha+-thalassaemia genotypes where SMA might be implicated in 
increased GMPD among heterozygous and homozygous alpha
+
-thalassemia. We 
were unable to determine the reason for the loss of protection from severe 
Plasmodium falciparum parasitaemia in children who were severely anaemic and 
future works might examine the mechanism responsible for protecting alpha
+
-
thalassemia children who were not severely anaemic from severe Plasmodium 
falciparum parasitaemia. 
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Chapter 7 
 
7.0 The waning of protection from Plasmodium falciparum in alpha
+
-
thalassaemia  
 
 
7.1 Introduction 
The prevalence of alpha
+
-thalassaemia trait in Tamale, Ghana and its 
surroundings was estimated to be 31.8% with the homozygous alpha+-
thalassaemia recording prevalence rate of between 2-3% (Hendricks 2003, 
Mockenhaupt et al., 2004c). The protective effects of alpha+-thalassaemia trait 
against severe malaria have been demonstrated mostly amongst children 10 
years (Mockenhaupt et al., 2004c) 
The protective effects of the sickle cell trait (HbAS) against severe and 
uncomplicated Plasmodium falciparum malarial infection have been reported in 
Kenya (Aidoo et al., 2002) where they are restricted to younger children below 5 
years. William et al.,(1996) suggested that the incidence of uncomplicated 
malaria (of Plasmodium vivax) amongst alpha
+
-thalassaemia children was 
significantly higher in younger children than in older children. Similarly, the 
protective effect from malaria-associated mortality in heterozygous alpha
+
-
thalassaemia is said to be strongest in younger children (Mockenhaupt et al., 
2004c) with the explanation that innate resistance will normally act at an early 
age before specific immunity develops at a later age.  
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Luzzi and his colleagues have also indicated that the incidence of Plasmodium 
vivax infection was increased in children aged less than 30 months (Luzzi et al., 
1997). In the opinion of Allen et al., (1997), homozygous alpha
+
-thalassaemia 
children of a median age of 3.6 years had a tendency towards reduced malaria; 
he further explained that the exposure to malaria infection and subsequently the 
intensity of the malaria parasitaemia determines the age at which clinical 
immunity develops. However, reports from Melanesia have indicated that 
homozygous alpha
+
-thalassaemia children of less than 5 years old had twice the 
incidence of Plasmodium falciparum or Plasmodium vivax (William et al., 1996) 
with the suggestion that an increased susceptibility to malaria in infancy might 
result in improved immunity to subsequent severe parasitaemia by enhanced 
antigen expression on Plasmodium falciparum–infected alpha
+
-thalassaemic 
erythrocytes. In support of this observation, Enevold et al., (2008), who also 
investigated the risk of uncomplicated malaria in alpha+ thalassaemia children 
observed that the protective effect was prominent in both heterozygous and 
homozygous alpha
+-thalassaemia who were older than 5 years old.  
Thus there is still a gap of knowledge as to whether the protection conferred by 
alpha
+
-thalassaemia wanes with age. The aim of this study is to determine 
whether the protective effect conferred by alpha+-thalassaemia against 
Plasmodium falciparum parasitaemia wanes with age 
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7.2 Objectives 
 To compare the proportion of patients with various levels of Plasmodium 
falciparum (1-9999, 10000-99999 and 100000) parasitaemia in children >60 
months and 60 months age groups for the alpha
+
-thalassaemia genotypes 
 To compare the mean parasite density in various alpha
+
-thalassaemia 
genotype groups for children 60 months and >60 months of age. 
 
7.3 Participants 
Participants were five hundred and thirty-three children who were positive for 
Plasmodium falciparum malaria and were 120 months and below. They constitute, 
heterozygous (n=126), homozygous (n=49) alpha
+
-thalassaemia and normal 
genotypes (n=358). The children were grouped into two age categories of  60 
months and >60 months.  
 
7.4 Experimental approach 
7.4.1 Polymerase chain reaction (PCR) 
The experimental procedures for the extraction of DNA, the polymerase chain 
reaction and agarose gel electrophoresis are explained in 2.8.3.1  
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7.4.2 Plasmodium falciparum Malaria Density                                                                                                    
Malaria parasite density was determined using the thick and thin blood films by the 
microscopic method. This followed the experimental procedure as described in 
section 2.8.1.1  
 
7.5 Statistical analysis 
The proportion of severe malaria (defined as parasite density 100000 
parasite/L) in the age group  60 months amongst the alpha globin genotypes 
was determined and compared with the age group  >60 months using the Fisher‘s 
exact test. Geometric Mean Parasite Density (GMPD) was determined after the 
log transformation of the values malaria parasite density.  
 
7.6 Results 
Cases were grouped into ages  60 months and >60 months. The mean age 
overall was 51.2 months (range 1-120 months). A total of 215 cases of severe 
malaria (100000 parasite/L) were recorded in the alpha+-thalassaemia 
genotypes (homozygous-8, heterozygous-15 and normal genotype-193) (Table 
7.1). All children had Plasmodium falciparum malaria.  
The distribution of severe malaria parasitaemia amongst the various age groups 
was determined. The density of parasitaemia in the age groups for alpha+-
thalassaemia genotypes was also assessed. 
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7.6.1: Comparism of Plasmodium falciparum parasitaemia between age 
group 60 months and >60 months amongst the alpha+-thalassaemia 
genotypes.  
The proportion of severe malaria cases amongst children 60 months and >60 
months who were either homozygous or heterozygous for alpha+-thalassaemia 
was assessed. This study found that whilst there were more severe malaria 
cases in children 60 months compared to the children >60 months who were 
homozygous and heterozygous for alpha+-thalassaemia (Table 7.1), there were 
no statistical difference between these groups (p=0.8281 and p=0.7412 
respectively). The differences in the mean parasite densities between the two 
age groups for homozygous and heterozygous alpha+-thalassaemia were not 
significant for the various degree of parasitaemia (1-9999, p=0.502; 10000-
99999, p=0.428; 100000, p=0.399, Table 7.1). Even though the geometric mean 
parasite density (GMPD) of both the homozygous and heterozygous alpha+-
thalassaemia were significantly different (p<0.001) within the individual age 
groups of 60 months and >60 months  (Table 7.2), the differences in the GMPD 
between the two age groups for both the homozygous and heterozygous alpha+-
thalassaemia were not significant (p=0.207, Figure 7.2). 
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Table 7.1: Percentage distribution of Plasmodium falciparum parasitaemia 
amongst age groups of alpha+ thalassaemia children 
Age 
Group 
(month) 
 alpha+ 
thalassaemia 
Mean parasite density/L, n (%) Total 
1-9999 10000-99999 100000 
0-12  -/- 3(75.0) 1(25.0) 0 4 
  -/ 10(50.0) 7(35.0) 3(15.0) 20 
  / 10(23.8) 9(21.4) 23(54.8) 42 
 Total  23 17 26 66 
13-24  -/- 7(50.0) 3(21.4) 4(28.6) 14 
  -/ 16(59.3) 9(33.3) 2(7.4) 27 
  / 28(35.4) 10(12.7) 41(51.9) 79 
 Total  51 22 47 120 
25-36  -/- 10(76.9) 2(15.4) 1(7.7) 13 
  -/ 12(48.0) 10(40.0) 3(12.0) 25 
  / 10(16.7) 17(28.3) 33(55.0) 60 
 Total  32 29 37 98 
37-48  -/- 1(20.0) 2(40.0) 2(40.0) 5 
  -/ 6(35.3) 10(58.8) 1(5.9) 17 
  / 15(29.4) 8(15.7) 28(54.9) 51 
 Total  22 20 31 73 
49-60  -/- 1(33.3) 2(66.7) 0 3 
  -/ 3(27.3) 4(36.4) 4(36.4) 11 
  / 5(19.2) 3(11.5) 18(69.2) 26 
 Total  9 9 22 40 
61-72  -/- 2(50.0) 1(25.0) 1(25.0) 4 
  -/ 4(66.7) 1(16.7) 1(16.7) 6 
  / 6(19.4) 8(25.8) 17(54.8) 31 
 Total  12 10 19 41 
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Table 7.1 continued 
Age 
Group 
(month) 
 alpha+ 
thalassaemia 
Mean parasite density/L, n (%)  
1-9999 10000-99999 100000 Total 
73-84  -/- 1(50.0) 1(50.0) 0 2 
  -/ 0 3(100) 0 3 
  / 8(40.0) 3(15.0) 9(45.0) 20 
 Total  9 7 9 25 
85-96  -/- 1(100) 0 0 1 
  -/ 4(50.0) 4(50.0) 0 8 
  / 10(40.0) 5(20.0) 10(40.0) 25 
 Total  15 9 10 34 
97-108  -/- 2(100) 0 0 2 
  -/ 3(50.0) 2(33.3) 1(16.7) 6 
  / 1(12.5) 2(25.0) 5(62.5) 8 
 Total  6 4 6 16 
109-120  -/- 1(50.0) 1(50.0) 0 2 
  -/ 2(66.7) 1(33.3) 0 3 
  / 4(23.5) 4(23.5) 9(52.9) 17 
 Total  7 6 9 22 
 
Severe malaria is parasite density ≥ 100000/μL. n is number of children with 
severe Plasmodium falciparum parasitaemia. Homozygous alpha+-thalassaemia 
(-/-), Heterozygous alpha+-thalassaemia (-/), Normal genotype (/) 
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Figure 7.1: Distribution of patients in each category of Plasmodium falciparum 
malaria parasite density of the various age groups of alpha+- thalassaemia 
(n=533; homozygous, n=49; heterozygous, n=126; normal genotype, n=358). The 
differences within age group >60 and  60 months was significant, p<0.001. The 
differences between the age group >60 and  60 months for homozygous and 
heterozygous alpha+-thalassaemia were not significant (p=0.8281, p=0.7412)  
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Table 7.2 Plasmodium falciparum malaria in terms of alpha+-thalassaemia 
genotypes among children of 60 months and >60 months age group  
                                                        Mean (SD) 
 -α/-α 
(n=49) 
-α/αα 
(n=126) 
αα/αα (PID) 
(n=358) 
       P-value 
     
  GMPD/µL   
 
    >60 months 3545(1.01) 10034(0.88)   4171(1.05)          <0.001 
  
 
    60 months  
 
 7980(1.02) 
 
9015(1.00) 
 
51794(1.11) 
 
         <0.001 
Analysis of variance (ANOVA) assessed the differences in the mean values 
GMPD-geometric mean parasite density; α/αα, heterozygous alpha +- 
thalassaemia; -α/-α, homozygous alpha+-thalassaemia; αα/αα, normal or wild type 
alpha +- thalassaemia; Data shown represent mean and SD 
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7.7 Discussion 
We have discussed that alpha+-thalassaemias were protected from the severe 
manifestation of Plasmodium falciparum, and that the GMPD were lower 
amongst the homozygous and heterozygous alpha+ thalassaemia compared to 
the normal genotype (PID-presumed iron deficiency). However, researchers have 
agued whether this protective effect is directly linked to the alpha+--thalassaemia 
genotype or that the protection wanes once the patient grows out of the high-risk 
zone of 60 months. We grouped our subjects into children 60 months and those 
>60 months. Even though the age-group 60 months recorded a higher 
proportion of severe malaria compared to age group >60 months, the difference 
between the two age groups, was not significantly differently (p=0.8281 and 
p=0.7412) contrary to observation by Mockenhaupt et al., (1999a, 2004a) who 
reported that the protective effect of heterozygous alpha+- thalassaemia from 
severe Plasmodium falciparum parasitaemia was strongest in youngest children 
during which time that malaria-associated mortality is highest. In order words 
older children might be more susceptible to Plasmodium falciparum and therefore 
have less protection. However our observation supports findings by Allen et al., 
(1997) that greater frequency of malaria were seen in alpha thalassaemia 
children with a median age of <3.6 years and Veenemans et al., (2008) who 
reported more protective immunity in older children with alpha+-thalassaemia.    
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The higher proportion of severe malaria in the age-group 60 months may have 
provided immunity in the older age hence the degree of parasitaemia between 
the age groups was also not significant (p=0.207, Figure 7.2); the lower GMPD in 
the homozygous alpha+-thalassaemia notwithstanding. The proportion of children 
with severe Plasmodium falciparum malaria in both heterozygous and 
homozygous alpha+-thalassaemia was significantly different compared to normal 
genotype within the age groups (p<0.001, Figure 7.1). This finding suggests that 
children irrespective of age group were protected from the severe manifestation 
of Plasmodium falciparum parasitaemia. 
The number of alpha+-thalassaemias who had severe Plasmodium falciparum 
were very few and this might have affected the results. This shortfall was evident 
amongst children >60 and who were homozygous alpha+thalassaemia. The 
prevalence of the homozygous alpha+-thalassaemia in Ghana is 2-3% hence the 
shortfall. We observed that this age–specific risk reduction involving Plasmodium 
falciparum and infected alpha+-thalassaemic red blood cells might be an 
interaction between maternal immunity and the innate mechanism of alpha+-
thalassaemia. The age group that children acquire immunity as observed by 
Aidoo et al., (2002) is 2-16 months. In other words increased susceptibility to 
malaria in infancy might result in improved immunity to subsequent severe 
parasitaemia by enhanced antigen expression on Plasmodium falciparum–
infected alpha+-thalassaemic erythrocytes (William et al., 1996).  
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The fact that malaria-associated mortality is strongest in younger children less 
than 60 months suggests that innate resistance might probably act before 
specific immunity develops.  
This study found protection from Plasmodium falciparum in both heterozygous 
and homozygous alpha+-thalassaemia who were either less than or more than 60 
months, an observation that contrast findings by Enevold et al., (2008), who 
investigated the risk of uncomplicated malaria in alpha+-thalassaemia children 
and observed that the protective effect was prominent in both heterozygous and 
homozygous who were older than 60 month.  
We are however of the opinion that the lower proportion of severe Plasmodium 
falciparum cases recorded in the age group >60 months might suggest an 
enhanced protection from severe malaria in both the homozygous and 
heterozygous alpha+ -thalassaemia in this age group. 
7.8: Summary, limitations and further works  
We observed that the proportion of Plasmodium falciparum parasitaemia 
amongst children >60 months were fewer compared to children 60 months. 
Similarly parasite count and GMPD were lower in children >60 months compared 
to children 60 months.  
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Statistically there was no significant difference between the two age groups; the 
implication is that the protection conferred by alpha+ thalassaemia on 
Plasmodium falciparum parasitaemia might not wane with age. Future study 
might have to consider increasing the sample size in order to enrol more 
homozygous alpha+ thalassaemia, which has been the limitation to these studies
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Chapter 8 
8.0: Final discussion 
The basic proposition of Haldane‘s hypothesis that alpha
+
-thalassemia is 
pronounced in malarious regions is because it accords carriers a level of protection 
against death from the severe manifestation of Plasmodium falciparum 
parasitaemia by assuaging the clinical course of the disease. (Hendricks 2003).  
Evidence suggests that alpha
+
-thalassaemia ameliorates the severity of malaria, 
but does not reduce initial infection rates. However, current studies have not been 
able to provide plausible mechanisms for the protection of alpha
+
-thalassaemia 
against the severe manifestation of Plasmodium falciparum (Pasvol, 2006, 
Harteveld and Higgs, 2010). 
 
The prevalence of Plasmodium falciparum malaria as provided in this study was 
54.1% among children of the Kumasi metropolitan area. This is in contrast to 
previous observations by Asante, (2003) and Ronald et al., (2006) who found 
respectively a 13.65% and 25.30% prevalence of Plasmodium falciparum malaria 
among children in the Kumasi metropolitan area. Our finding therefore suggests 
that malaria is hyperendemic in Kumasi, an urban population inspite of 
governmental interventions against mortality due to malaria.  
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The prevalence of -
3.7
 type of alpha+-thalassaemia was 29.3%. This compared 
favourably with the 20% to 30% prevalence reported by Borges et al., (2001) for 
the West African sub-region and 26%- 33% prevalence reported by Mockenhaupt 
et al., 2001; Mockenhaupt et al., 2004a and May et al., 2007). Alpha thalassaemia 
does not exclude the presence of iron deficiency, and however, the high 
prevalence of alpha
+
-thalassaemia does suggests that alpha
+
-thalassaemia is a 
key contributor to microcytosis and therefore informs the need to appropriately 
discriminate iron deficiency from alpha
+
-thalassaemia to avoid the unnecessary 
administration of iron therapy. The high prevalence of alpha
+
-thalassaemia might 
be the as a result of the protection of these children from the severe manifestation 
of Plasmodium falciparum parasitaemia (Hendricks 2003). 
 
In the normal genotype, heterozygous and homozygous alpha
+
-thalassaemia 
groups we observed a connection between a progressive decrease in MCV 
(increased microcytosis) and decrease in parasite density suggesting microcytosis 
might be associated with a reduction in parasite burden in alpha+-thalassaemia 
(Fowkes et al., 2008). However, we found that both alpha+-thalassaemia 
genotypes were less susceptible to the severe manifestation of malaria as 
expressed by the low prevalence of parasitaemia in microcytic patients with an 
alpha+-thalassaemia genotype (-α/αα 11.9% and -α/-α 16.3%) compared to either 
normocytic patients or microcytic patients with a normal genotype (32.9% and 
53.6% respectively) (p<0.03). 
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Similarly, geometric mean parasite density (GMPD) values were lower in the 
presence of an alpha-thalassaemia genotype (-α/αα GMPD 9015, n=126 and -α/-α 
GMPD 6852, n=49) compared to normal genotype (αα/αα GMPD 51794, n=358) 
(p<0.001). These findings whilst indicating that the severity of Plasmodium 
falciparum parasitaemia was significantly lower in both homozygous and 
heterozygous alpha+-thalassaemia genotypes compared to microcytic children with 
normal genotype also suggests the protection from severe malaria might be due to 
the alpha+-thalassaemia state.  
The protective effect was observed in both the heterozygous and homozygous 
alpha+-thalassaemia but was more evident with homozygous genotype in contrast 
to findings by Mockenhaupt et al., (2004c), who observed protective effect from 
Plasmodium falciparum malaria in only to the heterozygous form of alpha+-
thalassemia. Their inability to observe protection in the homozygous alpha+-
thalassemia was attributable to the small number of the genotype in the study 
population, statistical consideration and differences in the design and conduct of 
these studies. Our finding is however, consistent with suggestions by Allen et al., 
(1997) and Williams et al., (2005b) that the protective effect is visible in both 
genotypes, but most evident in homozygotes. 
We observed reduced parasite density in alpha+-thalassaemia children, contrary to 
findings (Mockenhaupt et al., (2004a) and Williams et al., (2006) who indicated that 
the protection by alpha+-thalassaemia did not lower parasite densities.  
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Our finding however is in support of previous suggestion that red blood cells of 
more severe alpha+thalassaemia genotypes are less hospitable to parasite growth 
and multiplication (Ifediba et al., 1985).  
 
The scarcity of haemoglobin has been suggested to provide a non-conducive 
nutrient-deficient environment for Plasmodium falciparum growth (Nyakeriga et al., 
2004b). Relative to children with normal genotype haemoglobin concentrations 
were not significantly different suggesting that alpha+-thalassaemia might limit the 
decline in haemoglobin concentration in these children. This observation compares 
to suggestions by Veenemans et al., (2008) that alpha+ thalassaemia might limit 
the decline in haemoglobin that is not only confined to severe malaria cases but 
even so the protective effect might be evident when the Plasmodium falciparum 
infection is accompanied by inflammation. Both heterozygous and homozygous 
alpha+-thalassaemia have been implicated in preventing the decline in 
haemoglobin concentration in children with clinical malaria (Wambua et al., 2006).  
In this study however, only children heterozygous for alpha+-thalassaemia had 
higher mean haemoglobin concentration than did children with normal genotype. 
This not withstanding we suggest that the protection conferred by alpha+-
thalassaemia might prevent the decline in haemoglobin concentration in the severe 
forms of Plasmodium falciparum malaria.  
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Our data did not observe any significant correlation between hypochromasia and 
Plasmodium falciparum parasitaemia. The GMPD in the hypochromic however 
differed significantly from the normochromic group (p<0.001), recording an 
increase in the density of parasite compared to the normocytic group. This 
suggests that hypochromic alpha+ thalassaemia were not biologically 
advantageous in terms of protection from parasitaemia over their normochromic 
counterparts and did not prevent infection. 
  
In addition we observed a progressive decrease in MCH compared to GMPD in the 
order of homozygous <heterozygous <normal alpha
+
-thalassaemias, a trend that 
was observed among the microcytic children with alpha
+
-thalassaemia.  
This trend might explain the fact that both microcytic and hypochromic are inherited 
together in either iron deficiency anaemia or the thalassaemias and that microcytic 
hypochromic alpha
+
-thalassaemia genotype confer protection from the severe 
forms of Plasmodium falciparum malaria.  
 
Severe malarial anaemia (SMA) is the leading cause of mortality in malaria-
affected children under the age of five years (WHO 2000).  
In the opinion of May et al., (2005), protection against malaria mortality among 
Ghanaian children who were alpha+-thalassaemic was specific and driven by 
protection from severe anaemia, the most prevalent malaria complication.  
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Suggestions were that the protection from SMA are more pronounced in 
homozygous alpha
+
-thalassaemia (Wambua et al., 2006, William et al., 2005, 
Mockenhaupt et al., 2004, May et al., 2007); that the mechanism for this protection 
against SMA might be an increased in erythrocyte count and microcytosis thus 
maintaining the Hb concentration above 5.0g/dL (Fowkes et al., 2008). Contrary to 
these findings we observed in this study an increased susceptibility to Plasmodium 
falciparum malaria and parasitaemia among both heterozygous and homozygous 
alpha
+
-thalassaemia whose haemoglobin concentration were 5.0g/dL compared 
to those with haemoglobin concentration of > 5.0g/dL. Our finding suggests that 
SMA might be implicated in increased GMPD among heterozygous and 
homozygous alpha
+
-thalassemia.  
The protective effect from the severe manifestation of Plasmodium falciparum by 
alpha+-thalassaemias have been discussed and that the GMPD were lower 
among the homozygous and heterozygous alpha+ thalassaemia compared to the 
normal genotype but whether this protective effect is directly linked to the alpha+--
thalassaemia genotype or that the protection wanes once the patient grows out of 
the high-risk zone of 60 months was investigated. Within the age groups of 
children >60 months and children 60 months, the proportion of severe 
Plasmodium falciparum and GMPD were significantly different between the 
homozygous and heterozygous alpha+-thalassaemia compared to the normal 
genotype (p<0.001).  
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Between children >60 months and 60 months Plasmodium falciparum densities 
for the homozygous, heterozygous and normal alpha+ thalassaemia genotypes 
were not statistically significant (p=0.207). Our findings suggest that alpha+ 
thalassaemia children irrespective of age group were protected from the severe 
manifestation of Plasmodium falciparum parasitaemia and by implication the 
protection conferred by alpha+ thalassaemia against severe Plasmodium 
falciparum parasitaemia might not wane with age. 
The frequency of alpha+- thalassaemia in the study population was 29.3% and the 
fact that iron deficiency (ID) occurs in alpha+-thalassaemia might require that 
future study discriminate ID from alpha+-thalassaemia before investigating the 
protective effect from Plasmodium falciparum parasitaemia. The epistasis 
relationship between notable haemoglobinopathies like Hb AS and HbAC and 
alpha+-thalassaemia have been suggested to erode the protection conferred by 
alpha+-thalassaemia against Plasmodium falciparum parasitaemia. Therefore it 
might be prudent to investigate this interaction as it could provide important 
information why malaria mortality is high in this population. Alpha+-thalassaemia 
has been suggested to protected decline in haemoglobin concentration however 
severe anaemia as observed in this study resulted in increased parasitaemia 
Further works might have to discriminate other causes of hypochromic and 
microcytic anaemia like worm infestation and examine why severely anaemic     
children were not protected from Plasmodium falciparum parasitaemia. Finally 
increasing the sample size and the age of subjects could enable the enrolment of 
more homozygous alpha+ thalassaemia, which has been the limitation to this study
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